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Abstract: In 2004, 4.8 million (59.4 percent) of the estimated 8.1 million Indian deaths 
were due to NCDs. With India’s population aging over time and a higher incidence of 
NCDs in older age groups, and with evidence emerging that the India’s poor are at 
heightened risk of acquiring NCDs owing to high rates of smoking and tobacco use, 
occupational risks, and residential living conditions, a better understanding the economic 
impact of NCDs becomes urgent. 
In 2004, Indians spent nearly INR 846 billion out of pocket on health care expenses, 
amounting to 3.3 percent of India’s GDP for that year. The share of NCDs in out of 
pocket health expenses incurred by households increased over time, from 31.6 percent in 
1995-96 to 47.3 percent in 2004. More than one-half of the out-of-pocket expenses on 
health care were incurred on purchases of medicines, diagnostic tests and medical 
appliances. 
The odds of incurring catastrophic hospitalization expenditures are nearly 160 percent 
higher with cancer than the odds of incurring catastrophic spending when hospitalization 
is due to a communicable condition. By comparison, the odds of incurring catastrophic 
hospital spending due to CVD or injuries are about 30 percent greater compared to 
communicable conditions that result in hospital stays. 
In 2004, assuming that all care-givers and sick individuals above the age of 15 years were 
productive yielded an annual income loss from NCDs of one trillion rupees. More than 
one-third of all income losses were due to CVD and hypertension. 
If NCDs were completely eliminated, the estimated GDP in a year such as 2004, using 
two different assumptions, would have been 4-10 percent higher. Per capita GDP would 
also be higher. The primary driver of these results on GDP is the change in life 
expectancy at birth. 
Our analysis suggests that NCDs constitute a significant economic burden on India.  
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Executive Summary 
 
This report contributes to the literature on the economic implications of NCDs in 
developing countries by focusing on the case of India. First, we examine available 
evidence on the economic impact of NCDs in India. Second, we present new estimates of 
impact of NCDs, both on household economic well being as well as on aggregate 
economic outcomes in India. India is a worthwhile case to study for many reasons, 
beginning with the large numbers involved. In the year 2004, an estimated 8.1 million 
Indians died from all causes. Based on WHO data on the distribution of deaths by cause, 
estimated deaths from non-communicable conditions1
For the purpose of defining NCDs, we followed closely the NCD classification 
adopted in the WHO burden of disease analysis, albeit with 
 (including injuries) amounted 
roughly to 4.8 million, or about 59.4 percent of all deaths in the year. Moreover, about 24 
percent of these deaths from non-communicable conditions occurred in the 35-64 age-
group as per data from medically certified deaths from hospitals located in urban areas of 
India. Available data also indicate that 34 percent of all injury-related deaths occurred 
among individuals in the 35-64 year age group. India’s population is also ageing over 
time, an issue of concern given the higher incidence of NCDs in older age groups. All of 
these developments are occurring in a setting where health expenditures are growing 
rapidly led by an unregulated private sector and where health insurance and pension 
coverage are still limited. These financial concerns are further exacerbated by the 
emerging evidence that the India’s poor are at heightened risk of acquiring NCDs owing 
to high rates of smoking and tobacco use, occupational risks, and residential living 
conditions. 
two
 
 modifications. We 
included injuries in our definition of non-communicable diseases because these account 
for nearly 10 percent of all deaths in India; or 16 percent of all deaths not classified under 
communicable and/or maternal and child health conditions. To address the concern that 
injuries are not included in some  standard definitions of NCDs, we present our results on 
the economic impacts of NCDs for two cases: one where injuries were included in the 
definition of NCDs, another where NCDs were so defined as to exclude injuries. We 
excluded congenital anomalies since the datasets we used provided very limited 
information on such conditions. This category, along with “unclassified conditions” and 
communicable, maternal & child health conditions will henceforth be referred to as “non-
NCDs” for our purposes.   
                                                 
1In WHO burden of disease analysis, non-communicable diseases include CVD, cancers, 
diabetes, chronic obstructive pulmonary disease (COPD), asthma, neuro-psychiatric 
conditions (e.g., mental disorders, epilepsy, Alzheimer’s), congenital conditions, skin and 
musculoskeletal conditions (e.g., arthritis), eye conditions, skin diseases, diseases of the 
digestive systems (e.g., peptic ulcer) and genitourinary conditions (prostate disorders, 
nephritis). Accidents and injuries are considered as a category separate from NCDs 
(World Health Organization (WHO) 2004). 
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Existing Evidence on the Economic Impact of NCDs in India and its Limitations 
Existing studies on the economic impact of NCDs in India have focused primarily 
on health conditions with a significant morbidity and/or mortality impact – CVD, 
diabetes, respiratory conditions (COPD, asthma) and injuries. Although limited in 
number, these studies highlight the potentially large economic burden associated with 
NCDs in India.  
The gaps in the existing literature on economic impacts of NCDs in India are the 
following. Firstly, not all of the major NCDs are covered. Conditions such as cancer are 
inadequately addressed, as also neurological and psychiatric disorders. Secondly, existing 
analyses on India tend to downplay the role of co-morbidity and of competing risks in 
assessing the economic impacts of NCDs. The presence of co-morbidities – the existence 
of one condition is associated with the increased likelihood of acquiring another - implies 
that economic impacts allocated to a specific disease ought to involve some sort of 
netting out exercise (or alternately, consolidation), depending on the health condition 
involved. Similarly, mortality risks from two competing (say on account of some 
common cause) conditions imply that standard methods used to allocate costs allocated to 
a disease (based on the identified cause of death or illness) ought to be corrected because 
of their implicit assumption of statistical independence of the risk of acquiring the two 
conditions. Thirdly, existing analyses for India exclude consideration of subsidies on 
health services, whether provided by the public sector or private enterprises. Most tend to 
focus on out of pocket spending by households. It might appear first sight that, if our 
interest is in the identification of economic impacts on individuals and households, the 
exclusion of such subsidies is not only correct but is, in fact, a necessity. However, 
information on public subsidies is required if we wish to go beyond simply estimating 
household economic impacts to understanding the factors that drive them. Moreover, 
information on public subsidies is an essential input if we wish to estimate the aggregate 
economic outcomes of NCDs. To see this, observe that if health expenditures result in 
lower savings and investment (whether by private entities or the government) they will 
adversely impact aggregate economic outcomes. Fourthly, with few exceptions no effort 
is made in the Indian literature to use existing theoretical and/or empirical models of 
economic growth to assess aggregate outcomes. This omission typically leads to 
exaggerated claims of income losses with a myriad of diseases, usually when the authors 
follow a cost-of-illness methodology to infer aggregate economic outcomes. Fifthly, with 
only one or two exceptions, existing analyses of the economic impacts of NCD on 
households in India do not inquire into the impact of morbidity and mortality on the 
household allocation of labor within domestic work, on children’s schooling, on supply 
of labor, on the likelihood of falling into poverty, and so forth.  
 Finally, existing work for India does not permit an easy “adding up” of estimates 
of the economic impacts of different categories of NCDs. This stems partly from the 
different methods employed in each study. Some studies neglected the effects of 
mortality on economic outcomes but others did not. Others downplayed economic effects 
working through morbidity, focusing instead on deaths. However, an important element 
of the story is the differences in the type of data used for individual studies. Some 
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analyses used information from a variety of small sample surveys to arrive at an 
acceptable prevalence rate for a disease. Others relied on a single small sample to arrive 
at estimates of aggregate prevalence. Other studies relied on data from large household 
surveys. The net result is a series of numbers on morbidity and mortality for different 
health conditions that lack consistency and hamper efforts to arrive at an aggregated 
estimate of the impact of NCDs in India.  
Methodology Issues 
One way of assessing the economic impacts of NCDs is to estimate the associated 
costs of health care – the so-called ‘direct costs’ of ill health. It is important to appreciate, 
however, that ‘direct costs’ of NCDs do not necessarily indicate the economic burden that 
NCDs impose on households. This is firstly due to the fact that households are not the 
only party that pays for the costs of health care. Governments, insurance agencies and 
firms typically account for a significant portion of this amount. Secondly, households 
with sick members may incur lost wages either because the sick members are unable to 
work, or that care-givers have to give up productive labor time, neither of which is 
included in the calculation of direct costs. Future incomes may also be foregone if 
children are pulled out of school and these are typically also not included in direct cost 
calculations. 
It is also not obvious that health expenditures are a “bad” that needs to be 
deducted from some household (or social) measure of economic well being. Indeed, the 
level of health spending (and its growth) can be directly related to improved health 
outcomes, in and of itself, a good thing. Moreover, consider a competing risks 
formulation, where there are a large number of competing sources of morbidity (and 
mortality). Here, the emergence of effective prevention efforts for one disease may lead 
to increased household spending on other sources of morbidity that now acquire greater 
priority for the society or household in question. That permits the possibility that 
observed health spending may not change by much (and may even increase) with 
improvements in health outcomes. Related to this point, increased investments in 
technological innovations in newly prioritized health conditions can also explain higher 
health expenditures. This argument would be even stronger if there is a positive feedback 
loop from good health to income 
The preceding discussion suggests that in assessing the ‘economic burden’ of 
health spending, we should also consider any relevant health gains (or lack thereof) that 
might have been achieved by such spending. At the very least, we ought also to include a 
measure of income loss/gain to make the analyses comparable across households who 
may make different choices about health care (and spending) when confronted with an 
episode of ill health.  
There are important exceptions to the arguments made above. The first is the issue 
of efficiency. If, for instance, desired levels of health can be attained by purely preventive 
behavior at zero cost, one could say that all of the health expenditure is excessive and 
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could have been used for other purposes. The same argument would hold if the 
treatments that health expenditures support are ineffective in improving health outcomes.  
Concern with the cost of treating a disease from the point of view of 
households/society may arise from at least two other considerations. If the members of a 
society are highly averse to financial risk, then the risk of incurring high out of pocket 
expenses in the event of illness can potentially impose very large welfare costs on such 
individuals, for which providing for some form of insurance may be desirable. Also, if 
there are substantial socioeconomic inequalities in society, then high levels of out of 
pocket expenses on illness can be considered “unfair” even for individuals who are 
“neutral” to risk if these costs fall disproportionately upon backward social groups. These 
concerns (along with income losses linked to ill health) form the bases for analyses that 
look at ‘consumption smoothing’ by households in response to illness, the impacts of ill-
health on poverty, and catastrophic levels of health spending by households.    
Health spending on NCDs and Public Subsidies  
In Chapter 3 we assess firstly the direct costs of NCDs in India. We use 
information on direct costs to infer the economic burden of NCDs on Indian households 
by describing how these costs are financed and how the economic burden on households 
varies by income class. Because formal insurance is limited and firms pay for only a 
small portion of total health spending in India, we focused primarily on the distribution of 
health care costs between the public sector and household out of pocket spending as a 
way to infer the burden of NCDs on households. We also inquired into the methods by 
which Indian households financed their out of pocket spending for NCDs. Analyses of 
the impact of NCDs on households’ likelihood of incurring catastrophic spending and of 
falling into poverty were also undertaken. 
According to National Sample Survey Organization (NSSO) there were nearly 2.5 
billion outpatient visits and 30.6 million hospital stays in India in the year 2004. These 
numbers are considerably greater than similar categories for 1995-96. NCDs accounted 
for nearly 40 percent of all hospital stays and 35 percent of all outpatient visits in 2004; 
in 1995-96 the corresponding proportions were 32 percent and 22 percent, respectively. 
The average length of a hospital stay for NCDs was higher than for other health 
conditions suggesting a greater intensity of care received by patients admitted under the 
former category. Heart disease and accidents and injuries were the two most important 
reasons for hospital stays, along with kidney/urinary conditions, respiratory problems and 
cancers. Hospital stays and outpatient visits due to diabetes, respiratory conditions and 
injuries increased rapidly during the period from 1995-96 to 2004.  
 The private sector accounted for about 59 percent of all hospital stays in 2004, 
slightly higher than in 1995-96; and for 82 percent of all outpatient visits, similar to 
1995-96. Overall, these data confirm the important role that the private sector plays in the 
provision of health services in India. The proportion of inpatient stays in the public (or 
private) sector did not vary much by the broad categories of NCD and non-NCD; but the 
share of the public sector in outpatient visits was higher for NCDs than for the non-NCD 
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conditions. Within NCDs, the share of the public sector hospital stays was highest for 
cancers, accidents and injuries, respiratory conditions and psychiatric care. 
Indians spent nearly INR 846 billion out of pocket on health care expenses in the 
year 2004, amounting to 3.3 percent of India’s GDP for that year. This marked a 
substantial increase (in current Indian Rupees) from INR 315 billion spent out of pocket 
on health care in the year 1995-96 (about 2.9 percent of India’s GDP in 1995-96). The 
data also show that the share of NCDs in out of pocket health expenses incurred by 
households increased over time, from 31.6 percent in 1995-96 to 47.3 percent in 2004. 
That would indicate growing importance of NCDs in India in terms of their financial 
impact on households (and the underlying disease burden).  
Out of pocket expenses on care obtained at public facilities per unit of health care 
utilization (a single hospital stay, a single hospital day, or an outpatient visit) were lower 
than expenses incurred on comparable units of utilization at private facilities. All else the 
same, that would point towards public facilities providing Indian households some degree 
of financial risk protection from ill health, whether from NCDs or non-NCDs. NCDs 
impose a greater burden on out of pocket expenditures than other health conditions. Our 
data for 1995-96 and 2004 show that the out of pocket expense for a single hospital stay 
for an NCD was nearly double that of other health conditions; and expenses incurred per 
hospital day were between 30 percent and 50 percent higher in a private than in a public 
health facility. The differences in out of pocket expenses incurred on NCD and non-NCD 
conditions are less marked for outpatient visits but nonetheless exist, with visits for NCD 
being 15 to 50 percent more expensive than non-NCD visits. Within NCDs, out of pocket 
expenses per unit of utilization are particularly high for cancer, heart disease, accidents 
and injuries and kidney/urinary conditions.    
 More than one-half of the out-of-pocket expenses on health care were incurred on 
purchases of medicines, diagnostic tests and medical appliances. The proportions are 
more or less the same across broad groups of NCDs and other health conditions. A major 
chunk of overall out of pocket health spending (in excess of 45 percent) is on medicines 
and this proportion is as high as 64 and 58 percent for cases of hypertension and diabetes, 
respectively. The data on the components of out of pocket health spending highlight the 
importance of drug expenditures as a major source of household economic difficulty. 
With even users of public health facilities being forced to rely on their own resources for 
purchasing drugs in recent years, the issue of financial affordability of drugs will acquire 
increasing significance in India in the future.  
In the year 2003-4, governments in India at the central and state levels spent a 
total of nearly INR 220 billion on health. Our estimates of public subsidies to different 
health conditions show that accidents, cancers, kidney/urinary conditions and injuries 
account for the highest level of subsidies per unit of care (as well as the total amounts of 
subsidies allocated). Taken as a proportion of total out of pocket spending, however, 
government subsidies are rather small, irrespective of the health condition considered. 
This leaves the average Indian household vulnerable to considerable risk from the 
financial implications of illness.     
- xv - 
 
Financing and Vulnerability to NCD Risk among Indian Households 
Own savings and income turned out to be the most important source of financing 
for many health conditions (typically between 40-60 percent of all spending).  In 2004 
about 10-15 percent of financial resources were provided by friends & family, a form of 
community insurance. The share of reimbursements from insurance or employers 
amounted to only about 5-6 percent of all NCD-related out of pocket health spending for 
hospitalization. However, a large number of households rely upon “borrowing,” 
presumably with (or without) a collateral and potentially carrying interest payments. 
Some of the more expensive to treat health conditions (CVD, cancers, accidents and 
injuries, and neurological disorders) also involve larger shares of financing from the 
“other” category in 2004, primarily via the sale of assets. Overall, the evidence supports 
significant household financial vulnerability arising from poor health in India, be it NCDs 
or other health conditions.   
Households’ financial vulnerability to NCDs can also be assessed by comparing 
the costs of hospitalization for health conditions that comprise NCDs to income (or total 
consumption spending). In the year 2004, India’s income per capita was INR 25,320. It is 
worth noting that a single hospital stay for cancer (or heart disease) would have 
accounted for anywhere between 80 percent and 90 percent of this income if health care 
were to be obtained from private providers. Even if health care was sought at a public 
facility, the expenses out of pocket would still have amounted to between 40 percent and 
50 percent of per capita income. Yip and Mahal (2008) have further shown that the bite 
out of income per capita taken out by a single hospitalization event increased sharply 
between 1995-96 and 2004 for the poorest individuals.  
Total out of pocket health spending, taken as a proportion of per capita household 
expenditure, does not vary much across expenditure quintiles, whether we look at the 
sample population as a whole, or break down it down into rural and urban populations. 
Urban populations tend to allocate a greater share of their (out of pocket) health expenses 
on NCDs, compared to their rural counterparts. Moreover, the share of NCD expenditures 
as a proportion of total household expenditure is rising from poorest to the richest groups. 
This is in contrast to the situation of expenditures on other (non-NCD) health conditions, 
whose share in household total expenditures either remains unchanged across expenditure 
quintiles (rural), or declines with economic well being (urban). 
At first sight, our findings would appear to go against the idea that NCDs are 
creating a financial burden on the poor. However, because individuals belonging to the 
lowest expenditure quintile live much closer to the survival threshold, allocating even 
smaller proportions of income is likely to increase their likelihood to falling below the 
poverty line. Living so close to the survival threshold also means that in many cases they 
forgo needed care. Thus, while communicable disease mortality and morbidity mostly 
explain the high share of non-NCD out of pocket health spending among the less well off, 
another part of the explanation (low proportion of spending on NCD in the bottom 
quintiles) may lie in the expense of seeking treatment for NCD. This suggests looking at 
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other monetary indicators of the financial burden suffered by households on NCDs, such 
as income losses or premature mortality. 
Catastrophic Expenditures and Medical Impoverishment on Account of NCDs  
We inquired about the degree to which different categories of NCDs influence 
household risk of catastrophic spending and impoverishment. Our results indicate that the 
odds of incurring catastrophic hospitalization expenditures are nearly 160 percent higher 
with cancer than the odds of incurring catastrophic spending when hospitalization is due 
to a communicable condition. By comparison, the odds of incurring catastrophic hospital 
spending due to CVD or injuries are about 30 percent greater compared to communicable 
conditions that result in hospital stays. The odds of incurring catastrophic spending with 
cancers are nearly double compared to accidents and CVD. Our results are essentially 
unchanged when the focus is on the risks of impoverishment associated with health 
spending, with cancers greatly increasing the likelihood of falling into poverty.  
Household Income Losses from NCDs 
In Chapter 4 we estimate a second key component of the cost of illness associated 
with NCDs: namely income losses to households associated with morbidity/disability and 
premature mortality from NCDs. Usually, the calculation of income losses relies on the 
human capital methodology, whereby the lost income for each dead/disabled/sick 
individual is calculated as the present value of their expected future stream of income
The measure of income losses we report is slightly different from the strict human 
capital measure of indirect costs described in the previous paragraph. Specifically, we 
estimated income losses associated with morbidity and/or death associated with NCDs 
for one year. This measure is attractive because health care expenditures for chronic 
conditions (characteristic of many NCDs) are likely to be incurred in future years for the 
same individual. In this scenario, adding up health expenditures incurred in any one given 
year (direct costs) to the combined (discounted) income losses that occur over multiple 
periods due to premature deaths appears inconsistent. Constructing the annual estimate 
also helps us better address data limitations in India with regard to information on the 
likelihood of survival of sick patients with NCD, their future medical expenditures and 
hospital stays in estimating their cost of illness.  
, 
appropriately discounted, while allowing for growth in real wages over time, and the 
likelihood of unemployment and survival. Calculated in this way, these income losses (or 
‘indirect costs’) could be considered a lower bound of the combined present and future 
income losses likely suffered by households that have members with NCDs (because we 
exclude, for instance, human capital losses due to reduced schooling for children in 
affected households).    
We first estimated annual income losses using a standard cost-of-illness 
approach. Three different methods were used to assess the size of the population with an 
NCD in India, and to distribute this population into individuals who died during the 
preceding year and those that did not. 
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Assuming that all care-givers and sick individuals above the age of 15 years were 
productive yielded an annual income loss from NCDs of one trillion rupees in 2004. 
Much of this was in the form of income losses arising from days spent ill and in care-
giving effort. The loss on account of premature death was lower, reflecting the chronic 
nature of NCDs, so that care and treatment amount cumulatively to much larger amounts 
than incomes foregone by households owing to the premature death of their members 
from NCDs. More than one-third of all income losses were due to CVD and 
hypertension. Another 15 percent were accounted for by diabetes, so that nearly half of 
all income losses from NCDs occur on account of a fairly narrow range of conditions and 
their co-morbidities. Another significant chunk (roughly in the region of 20 percent) of 
all income losses were related to asthma and other respiratory conditions. Accidents and 
injuries made up for about 6-7 percent of all annual income losses.    
Annual incomes based on an imputed wage for all individuals above the age of 15 
years will not be an accurate reflection of household declines in income due to NCDs if 
not everybody works, or if safety nets exist that protect individuals from loss of income 
during ill health or if there is survivor pension that provides support to the family of a 
deceased income earner. The latter is not a major concern in India given that only 10 
percent of the work force is employed in the formal sector where such protections exist. 
However, the issue of work force participation most certainly is. Our sample survey data 
reveal that overall work force participation rate (proportion of people aged 15 years and 
above with NCDs who actually worked) was only about 47 percent (inclusive of injury 
cases). If we consider only those who are working, we end up with much lower estimates 
of the annual income losses to households associated with NCDs – roughly INR 280 
billion. Our findings with regard to the relative importance of different types of health 
conditions remained essentially unchanged when we adjust for worker participation rates.  
Impact of NCDs on India’s National Income and Aggregate Well-Being 
In chapter 5 we constructed estimates of two different versions of aggregate 
impacts: one on the gross domestic product (GDP) or national income, and the other on 
the value of statistical lives lost. For estimating impacts of NCDs on GDP and GDP per 
capita we used Solow-type production functions with two sets of empirically estimated 
parameters. Under the first of these scenarios we estimated parameter values on the set of 
baseline explanatory variables used in Bloom, Canning and Sevilla (2004). A second set 
of parameter estimates were obtained from cross-provincial study for India undertaken 
Duraisamy and Mahal (2005).  Our analysis suggests that were NCDs to be completely 
eliminated, the estimated GDP in a year such as 2004 would have been 5 to 10 percent 
higher under the Bloom, Canning and Sevilla estimates, and 4 to 9 percent higher under 
the Duraisamy and Mahal estimates. Per capita GDP would also be higher. The primary 
driver of these results on GDP is the change in life expectancy at birth. In this, our 
findings differ from those of Abegunde et al. (2007) whose focus is on a Solow-type 
production function downplays the influence of the quality of labor (life expectancy) on 
national output.  
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If our interest is in the welfare implications of eliminating NCDs, the size of the 
GDP (or GDP per capita) is probably not the right metric as it captures only one 
dimension of the potential gains that result. Indeed, the more significant gain is likely to 
be the increase in the number of years lived. For this reason, we focused on the value of 
statistical lives that could be saved by eliminating NCDs. We used two sets of estimates 
for annual income in India – the average imputed wage for people with NCDs in our 
sample survey; and GDP per adult worker. This information was combined with 
information on the value of a statistical life of US$4.35 million for a sample of workers 
in the United States, and an income elasticity of the value of a statistical life of 0.55 
(US$1=INR 45 in 2004), to obtain the value of a statistical life for India. This was 
roughly INR 90.9 million if we used the GDP per worker as an estimate of income and 
INR 89.7 million if we used the imputed wage method (or about US$2 million in both 
cases).  
Using a discount rate of 5 percent and a life expectancy for a worker aged 25 of 
47.5 years (based on life tables for India) we obtained the value of a statistical life year as 
INR 473 thousand (using the GDP per worker method) and INR 467 thousand (using the 
imputed wage method). These estimates were used to assess the potential gains to 
newborns in the year 2004 in terms of the value of additional life years lived. Because the 
gains in 7.4 additional life years (on average) due to the elimination of NCDs occurring 
far in the future, the present discounted monetary value of this gain was in the range of 
INR 133 thousand and INR135 thousand. With roughly 25.9 million births in 2004, the 
potential gains from eliminating NCDs to the cohort born in 2004 could be anywhere 
between INR 3,445 billion and INR 3,497 billion. These (potential) welfare gains amount 
to between 13 percent and 14 percent of GDP – slightly higher than our estimates of the 
impact of NCDs on GDP.  
The Impact of NCDs on Economic Outcomes in India: Taking Account of Competing 
Risks 
Standard methods for assessing the cost of illness and/or economic impacts 
typically assume that the risks of morbidity/mortality from NCDs and other (non-NCD) 
conditions are statistically independent. While this generally makes it easier to undertake 
the desired analyses, this assumption is inappropriate owing to the existence of 
statistically dependent competing risks. In chapter 6 we illustrate, using cross-sectional 
household survey data for India, the use of a propensity score matching approach to 
address the bias resulting from not taking account of interdependent competing risks 
when attributing direct health care expenses, and other economic impacts to NCD.  
For each individual with NCD (in this chapter we use CVD, cancers and injuries 
for illustrative purposes), we find a control possessing similar observed pre-determined 
characteristics. We can then assess the economic impact of acquiring NCD by comparing 
the outcome for each person with his, or her, matched control. We show below that our 
matched control group is quite different from our random sample of people, both in terms 
of their observed characteristics such as education level, age, location of residence, and in 
terms of their health and economic outcomes. Matching to the control group therefore 
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makes a significant difference to our estimates of the economic impact of CVD, cancers 
and injuries.  
Our analysis suggests that estimates of the impact of NCDs ought to adjust for 
competing risks in assessing the economic impacts of disease. Our results point to a 5 
percent to 20 percent reduction in estimates of household economic impacts that do not 
use matched controls. The significance of our findings is tempered by our relatively 
small-sized treatment group, and the fact that we had only a limited set of pre-determined 
variables to match. Ideally, one would have liked information on smoking history, 
alcohol consumption, family history of heart disease/cancer and obesity. Unfortunately, 
the National Sample Surveys do not include this type of historical information in the 
survey instrument. Indeed, the lack of a longitudinal dataset to examine these questions 
(which really underpins the preceding sentence) is serious issue of concern. If 
unobservable characteristics influenced the risk for acquiring an NCD, or health care 
utilization – such as high rates of discounting the future, or if health facilities were in 
close proximity in the past (enabling early treatment and medical advice), matching on 
currently observable characteristics will not yield reliable estimates of the economic 
impact of NCDs in India. This remains an area of potential importance for future research 
in NCDs.   
Research Implications 
Along with other recent efforts in the field, this paper constitutes a first step in the 
overall research goal of assessing the economic impacts of NCDs in India and other 
similarly placed developing countries. As noted at several points in the following text, 
there are several methodological weaknesses in the study, ranging from its use of 
household survey data that may underestimate the prevalence of disease, not taking full 
account of disabilities associated with NCDs, the inadequate treatment of competing 
disease risks in assessing economic impacts, and perhaps in its inability to adequately 
consider (and bring together) scenarios that take a more careful account of disease 
prevalence estimates from elsewhere in the literature, such as those of the Shah et al. 
(2004), the World Health Survey data, and so forth. We believe that all of these are valid 
concerns and ought properly, to belong to any reasonable agenda for future work on the 
economic impacts of NCDs in India. Here we consolidate some of more important 
research ideas emerging from earlier chapters, add some new ones, and highlight what we 
think are likely to be some of the more productive avenues for further work.  
Perhaps the biggest single gap that exists in India relates to information on 
disease-specific morbidity and mortality on a scale appropriate for India and an 
appropriate linkage of this information to economic variables, ranging from health 
spending to socioeconomic status of households. We also believe that longitudinal studies 
that focus on the economic angle of health are needed to better take account of the 
poverty impacts of NCDs (and other health conditions). There are none that we are 
currently aware of on a suitably large scale although one that is currently in the pipeline 
is the NIH funded Longitudinal Ageing Study of India (LASI) led by David Bloom and 
colleagues at Harvard and Rand, the first wave of which is expected to take place in 
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2010-11. It may be a while before these studies can bear fruition. Thus, it might be more 
useful, at least in the short-run, to exploit what appear to be excellent sources of 
longitudinal information on health and financing – namely the Indian railways and the 
armed forces.  
Missing also in the existing work is good information on care-giving and support 
within the family, as well as within communities, related to the financial and disease 
burdens associated with NCDs. The NSS health care utilization and expenditure data 
offer a useful data source for this purpose, given that they document some information on 
the support systems for Indians aged 60 years and above. But this information is very 
limited, and is generally expressed in qualitative terms. Moreover, we know little about 
how families respond to crises in the presence of NCDs (or NCD-related deaths) among 
prime income earners, who appear to be at increased risk of NCDs in India.     
Policy Implications 
 Irrespective of what these more refined analyses may or may not conclude at 
some point in the future, it is unlikely that they will overturn the major conclusions 
reported here - that NCDs constitute a significant economic burden on India. This study 
specifically points to the high levels of out of pocket spending incurred by households 
that have members with NCDs, the limited levels of insurance coverage (including 
subsidized public services) and the income losses that befall affected households. 
Moreover, these findings strengthen conclusions by other recent studies on the economic 
implications of ill health for India that emphasize the associated risks of catastrophic 
spending and impoverishment. The study also points to the adverse aggregate economic 
implications of NCDs.    
How to address these economic challenges in a cost effective and equitable 
manner while ensuring financial risk protection for affected households is an obviously 
important policy goal. Governments at the national and state levels in India are beginning 
to wake up to this challenge. The Indian state of Andhra Pradesh, for instance, launched 
the Arogyasri health insurance scheme in 2007 on a pilot basis and is now in the final 
stages of extending it throughout the state. The scheme provides for a tax funded 
insurance plan that (fully) covers all poor people in the state for care sought for a wide 
range of high-end treatments at public and private health care providers. Moreover, the 
state government has used the financial clout resulting from the large financial base of the 
scheme to negotiate quite reasonable rates for a range of different interventions in tertiary 
facilities. On a national level, the government of India also recently introduced the 
Rashtriya Swasthya Bima Yojana (RSBY) that provides financial coverage for health 
care for up to INR 30 thousand to poor households. These schemes run on a “cashless” 
basis in that any health care expenses covered under the schemes are paid directly by the 
insurer to the health care provider, greater reducing inconvenience to households who 
might otherwise have to run after insurance agencies to get their out of pocket expenses 
reimbursed.   
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Clearly these schemes mark a fairly radical departure from the situation until the 
first half of this decade where a long period of decline (following the 1991 fiscal crisis) in 
public financing of health led households to increasingly rely on the private sector and 
out of pocket spending to meet their health care requirements. Whether these new 
schemes provides adequate financial risk protection  to people who need such protection 
the most, and their ability to do so in an efficient manner is, however, still open to 
question. There are questions about how well they target poor households and there are 
serious questions about their ability to contain health care costs. The Arogyasri scheme, 
although ostensibly directed towards the poor, has ended up covering nearly 80 percent of 
the population of Andhra Pradesh (about 64 million people) owing to the way it has 
defined a ‘poor’ household as one holding a ration card. Moreover, the scheme does not 
emphasize preventive aspects of health, so that it is likely to lead to pressures for more 
advanced treatment methods and promote either health care cost inflation, or 
alternatively, financial breakdown. Similarly, the RSBY scheme appears not to have any 
built-in mechanisms to promote preventive care, and is geared primarily to curative 
treatment. It is also unclear what the implications of these schemes would be for the 
public health care sector, that has often served as a provider of the last resort and as a 
competitor to the private sector, albeit inefficiently, for the less well off. Moreover, there 
are concerns about the quality of care provided to the insurees given the limited 
regulatory capacity over health care provision in India. As further steps are taken towards 
scaling up, our analysis points to the need to evaluate these schemes from a variety of 
different perspectives.   
 Treatment, however, ought to be only part of the picture. Long term sustainability 
of financing mechanisms, requires the diffusion of more effective prevention methods, so 
that early onset of NCDs can be prevented and their effects on long term disability 
limited. This calls firstly for curtailing tobacco consumption and smoking that have been 
linked to cardiovascular disease and different types of cancers. To be sure, the Indian 
government has recently initiated steps such as the banning of smoking in public places. 
However, there is a long way to go in terms of implementation, particularly in the use of 
‘bidis’ that are popular among lower socioeconomic groups. Other interventions, such as 
the promotion of physical exercise, may not be as urgent for rural populations; although 
the same is not true for urban populations in India. Sedentary lifestyles, common among 
Indian middle classes probably reflect some combination of prevailing social norms, and 
importantly a lack of opportunity for undertaking physical exercise, particularly in the 
larger cities. Existing constraints include limited spaces for walking or bicycling and call 
for a fundamental rethinking about urban planning in India. Dietary habits of Indian 
households could also be targeted, whether by means of changing agricultural pricing 
policies, taxes (subsidies) on less (more) nutritionally desirable foods and public health 
messages; and the significant costs of respiratory conditions points to addressing indoor 
air pollution and workplace conditions, particularly in the informal sector that tends to 
stay under the policy radar. Prevention ought also to be a major focus of concern in 
education in Indian medical schools, where the predominant focus has been on high-end 
clinical interventions at the cost of expertise in community medicine and public health.   
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 By highlighting the large economic consequences of injuries and deaths, a 
significant portion of which are traffic-related in India, our study points to the need for 
effective measures to promote traffic safety, including better training of drivers, the use 
of seat belts and helmets, improved vehicle designs and roads, separate lanes for different 
classes of traffic (when possible), developing trauma centers and so forth. The existing 
literature points to a number of lacunae in this regard, including the extensive use of 
bribes in the grant of drivers’ licenses and lack of helmet use, particularly in the smaller 
towns and cities of India. The well known problems of private sector providers turning 
away traffic injury ‘police’ cases needs increased policy attention, as also a focus on 
trauma centers that are urgently needed. The increasing use of 108 ambulance services on 
a call-center platform to speedily recover and help direct patients to needed emergency 
care in many parts of India is an important innovation in this direction. Further work on 
assessing the net economic benefits from 108 services is obviously desirable.      
Traffic injuries are only one component of the category of accidents and injuries. 
Particularly important are suicides and burn injuries, underpinned in India by significant 
violence against women, often in the context of dowry demands. As is usually the case in 
India, there already exist a range of laws and regulatory mechanisms to this end, so the 
issue is often one of implementation and information provision. The emergence of 
women’s groups in different settings in India – among sex workers, self-help groups in 
villages and elsewhere – has helped in some cases to empower women and to help protect 
them against this violence. Policies to further strengthen these groups including providing 
economic opportunities via expanded microfinance mechanisms may be a useful 
direction to pursue.   
 Finally, we wish to make an important closing observation.  Many of the issues 
highlighted here are not specific to NCDs.  An efficient and equitable health care system 
becomes a key tool for NCD control as it is for control of other health conditions. 
However, with the NCDs becoming more common, improving efficiency, quality, and 
access to a sound health care system is good strategy for NCD control. Likewise, efforts 
to improve health care delivery and access for NCDs will improve the infrastructure for 
the broader health care system. The ultimate challenge is to strategically focus on policies 
that will yield the best returns.   
 
 
C H A PT E R  1.  B A C K G R OUND:  R E V I E W  OF  T H E  L I T E R A T UR E  ON T H E  
E C ONOM I C  I M PA C T  OF  NC DS I N I NDI A  
 
1.1. Introduction 
The role of ill health in influencing the economic well being of nations and 
households has long been appreciated. In the early economic literature on the subject, 
researchers primarily estimated direct medical care costs and productivity losses on 
account of illness using the so-called “cost of illness” method to arrive at an aggregate 
measure of the economic costs of disease (Rice 1966). Recent literature has utilized 
somewhat different methodological tools to emphasize the same point. For instance, 
Gallup and Sachs (2001) used cross-country data in a regression model to demonstrate 
that countries with high levels of malaria had much lower levels of per capita income. 
Cuddington (1993) using mathematical modeling, and MacDonald and Roberts (2006) 
using cross-country panel data regressions, found that the AIDS epidemic was associated 
with lower rates of growth in per capita income. Instead of focusing on specific diseases, 
some studies have sought to assess the implications of “health” in the form of broad 
health measures such as life expectancy at birth. Bloom et al. (2004), in a review of this 
literature, concluded that a 5-year increase in life expectancy at birth translates into 
increases in the annual average rates of growth of gross domestic product (GDP) per 
capita that range (depending on the study) from 0.06 to 0.58 percent.  
The large national level economic impacts are underpinned by adverse economic 
outcomes for households affected by disease. Russell (2004) reviewed the literature on 
the economic impact of malaria, tuberculosis and HIV on households in a number of 
developing countries and concluded that medical care expenditures and lost labor 
earnings associated with these conditions were large relative to household incomes. He 
found that poorer groups were less able to cope effectively with the adverse economic 
implications of ill health, whether in terms of being able to finance health expenditures 
without incurring significant borrowing cost or reallocating labor supply within the 
household; and they tended to be at greater risk for forgoing treatment for their health 
conditions. Another study, that used panel data for Indonesia assessed that rural 
households were unable to fully insure themselves against the financial risk of serious 
illness, particularly income losses associated with disease as shown by their sample of 
households experiencing sharp declines in consumption following episodes of ill health 
(Gertler and Gruber, 2002).  
 
Households’ inability to cope with the economic impacts of ill health is also 
reflected in data that show a large proportion of individuals falling into poverty on 
account on ill health. In a major review of field studies summarizing household dynamics 
of poverty in developing countries in Africa, Asia and Latin America, Krishna (2007) 
identified health-related causes as accounting for between 60 percent and 90 percent of 
all households that fell into poverty. Using household survey data from 11 low- and 
middle-income Asian countries, Doorslaer et al. (2006) concluded that measured poverty 
was 2.7 percent greater than the base-line estimate once health care expenditures were 
excluded from household consumption estimates. Another study, focused on the United 
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States, found that nearly half of all individuals filing for bankruptcy in the United States 
did so for medical reasons (Himmelstein et al. 2006). Finally, Xu et al. (2003) 
demonstrated using survey data that health expenditures in several developing countries 
were at a “catastrophic” level for between 2 percent and 10 percent of the households.  
 
The concerns about aggregate economic impacts are particularly acute in 
developing countries in South Asia and sub-Saharan Africa which account for about 40 
percent of deaths and nearly half of the Disability Adjusted Life Years (DALYs) lost 
worldwide (World Health Organization 2004). Collectively, these countries account for 
only about 3.5 percent of the world’s income; and an average income per person that 
amounts to only 2 percent of the average income per person in the high-income nations in 
the world (World Bank 2007). For these countries, high rates of morbidity will not only 
lead to a significant diversion of an already low income to health care, but also lowered 
opportunities for economic advancement. Non-communicable health conditions account 
for major portion of this disease burden making up about 44.4 percent of all deaths in low 
income countries of South Asia and sub-Saharan Africa and 40.4 percent of all disability 
adjusted life years lost according to the World Health Organization. Moreover, it has 
been noted that deaths from key cardiovascular diseases, cancers, diabetes and injuries 
appear to be occurring at increasingly younger ages in many developing nations. In a 
recent study of four developing countries with large populations, Leeder et al. (2004) 
noted that a significant proportion of all cardiovascular deaths occurred in the 35-64 
years age-group, very much considered a part of the work force, under any definition. 
Injuries and injury-related deaths are common among younger populations in developing 
countries (Nantulya and Reich 2002; Kopits and Cropper 2003).  
Stemming perhaps from concerns about the world-wide HIV/AIDS epidemic, 
there is a voluminous literature examining the impacts of HIV on individual and national 
economic outcomes in developing countries (Over 1992; MacDonald and Roberts 2006; 
Mahal 2004; Young 2005). There is also a large literature on the economic impacts of 
tuberculosis and malaria, two other major killers in developing countries (Bloom et al. 
1996; Gallup and Sachs 2001; Russell 2004). In contrast to the prominence accorded to 
existing work on the impact of infectious disease morbidity and mortality on economic 
outcomes, the literature on the economic impact of non-communicable conditions in 
developing countries is less visible. This is partly a consequence of the fact that in many 
developing countries, including India, there is a dearth of research on the economic 
impact of ill health, be it related to HIV/AIDS or any other. Indeed, a recent review of the 
Indian literature on the economic implications of disease found only a few analyses, 
related to HIV/AIDS and tuberculosis that could be construed as rigorous (Mahal 2005). 
However, this lack of attention to non-communicable conditions is also likely a 
consequence of the perception, and one not necessarily valid for developing countries, 
that such conditions relate to mainly older age groups that are typically less economically 
productive (Leeder et al. 2004).  
It is not obvious that non-communicable conditions, even if confined to older 
ages, would have negligible effects on economic outcomes. This is clearly not the case 
for households, an issue that we revisit in Chapter 2. In fact, one can make a strong case 
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that aggregate economic outcomes and non-communicable health conditions, even if 
confined to older age groups, are closely linked. For instance, there are the economic 
implications of time spent as care-givers by young adults. Also, aggregate economic 
outcomes associated with disease are not simply a function of the (lower) number of 
younger labor units available. Older individuals likely enjoy a greater stock of firm-
specific capital and have longer years in the work force that raise their productivity. 
Moreover, the higher expenditures typically required for treating non-communicable 
conditions would have implications for savings habits and human capital accumulation at 
younger ages, depending on the nature of insurance/social safety nets available. In the 
absence of social protection mechanisms (whether social insurance or subsidized public 
provision), individuals might have to save more for financing NCD treatment in older 
ages, or alternatively invest more in children (by raising fertility for instance), who could 
care for them in their old age and finance their treatment. In these circumstances, both 
physical capital and human capital could potentially increase. Of course, the reverse 
would hold if the governments funded social insurance and/or subsidized public health 
services in pay-as-you-go systems.  
This report contributes to the literature on the economic implications of NCDs in 
developing countries by focusing on the case of India. First, we examine available 
evidence on the economic impact of NCDs. Second, we present new estimates of impact 
of NCDs, both on household economic well being as well as on aggregate economic 
outcomes. India is a worthwhile case to study for many reasons, beginning with the large 
numbers involved. In 2004, an estimated 8.1 million Indians died from all causes. Based 
on WHO data on the distribution of deaths by cause, estimated deaths from non-
communicable conditions (including injuries) amounted roughly to 4.8 million, or about 
59.4 percent of all-cause deaths in the year. Moreover, about 24 percent of these deaths 
from non-communicable conditions occurred in the 35-64 age-group as per data on 
medically certified deaths from hospitals located in urban areas of India (Registrar 
General of India 2007). Available data also indicate that 34 percent of all injury-related 
deaths occurred among individuals in the 35-64 year age group (Registrar General of 
India 2007). India’s population is also ageing over time, an issue of concern given the 
higher incidence of NCDs in older age groups (Bloom et al. 2007). All of these 
developments are occurring in a setting where health expenditures are growing rapidly, 
led by an unregulated private sector, and health insurance and pensions are limited. These 
financial concerns are further exacerbated by the emerging evidence that the India’s poor 
are at heightened risk of acquiring NCDs owing to high rates of smoking and tobacco 
use, occupational risks and residential living conditions (e.g., indoor pollution). 
In the remainder of this chapter we review existing work on the economic impact 
of NCDs in India. The review is used to highlight the major gaps in coverage, data and 
methodology that exist in the Indian literature on the economics of NCDs and lay out the 
case for generating new estimates for the economic impact of NCDs in India that we 
construct in this report.    
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1.2. Economic Implications of Non-Communicable Diseases in India: The 
Evidence 
We begin with a working definition of “non-communicable” health conditions. As 
used in the burden of disease statistics presented by the World Health Organization, non-
communicable diseases include conditions such as CVD, cancers, diabetes, chronic 
obstructive pulmonary disease (COPD), asthma, neuro-psychiatric conditions (e.g., 
mental disorders, epilepsy, Alzheimer’s), skin and musculoskeletal conditions (e.g., 
arthritis), congenital anomalies, oral conditions, eye conditions, skin diseases, diseases of 
the digestive systems (e.g., peptic ulcer) and genitourinary conditions (prostate disorders, 
nephritis). Accidents and injuries are considered as a category separate from NCDs 
(World Health Organization (WHO) 2004). These “burden of disease” categories are 
fairly easily matched to the formal ICD-10 classification of heath conditions (WHO 
2007), and to the medical certification system of causes of deaths in India, given its basis 
in the ICD-10 system (Registrar General of India 2007).  
A recent report of the WHO, however, refers to non-communicable conditions as 
“…major chronic diseases and
 We followed closely the NCD classification adopted in the burden of disease 
analysis, albeit with 
 their behavioral risk factors” (Yach and Hawkes, 2004, p 
5). This definition excluded, among other health conditions, mental illness. While such a 
definition is “practical” in the sense that it helps focus attention on the most important 
sources of mortality and morbidity in NCDs and their underlying drivers, it is at once a 
narrower and broader definition than we are interested in. Narrower, because it omits 
mental illness which is a major health challenge, and broader because of its focus on 
behavioral risk factors – presumably including smoking, alcohol intake, obesity and so 
forth, which are not usually included in standard disease classifications.    
two
Evidence on the Economic Impact of NCDs in India 
 modifications. We included injuries in our definition of non-
communicable diseases because these account for nearly 10 percent of all deaths in India; 
or 16 percent of all deaths not classified under communicable and/or maternal and child 
health conditions (WHO 2004). To address the concern that injuries are not included in 
any standard definition of NCDs, we present our results on the economic impacts of 
NCDs for two cases: one where injuries were included in the definition of NCDs, another 
where NCDs were so defined as to exclude injuries. We excluded congenital anomalies 
since the datasets we used provided very limited information on such conditions. This 
category, along with “unclassified conditions” and communicable, maternal & child 
health conditions will henceforth be referred to as “non-NCDs” for our purposes.   
 Cardiovascular Disease (CVD) 
We begin with analyses of the economic impact of CVD. Gupta et al. (2006) 
estimated the economic burden of CVD in the Indian state of Kerala, indicating that this 
could amount to as much as 20 percent of its state domestic product. The study used 
estimates of CVD prevalence in the Kerala population  to estimate the total number of 
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CVD cases in the state. It assumed that 25 percent of all deaths in the 25-70 year age-
group to be due to CVD (Gupta et al. 2006, p.38). For estimating (direct) health care 
spending per CVD case, Gupta et al. relied on insurance claims data in a single firm, plus 
drug spending incurred by that firm (and its employees). They multiplied these costs by 
estimates of the absolute number of CVD cases (dead or not) to get at the direct costs. 
Indirect costs were estimated by multiplying the total number of cases by an estimate of 
the days lost per case (based again on data from a single firm), and an estimate of state 
per capita income (converted to its equivalent daily income). Indirect costs of dead 
individuals were estimated by assuming that on average, a CVD death result in a loss of 
10 years of work and using the state per capita income, appropriately discounted, and 
allowing for unemployment.      
The Gupta et al. (2006) analysis was original in its use of insurance claims data to 
estimate CVD costs in the Indian context, and in its careful assessment of available local 
evidence on CVD prevalence. Similar approaches could presumably be used for analyses 
for employees of large enterprises such as the Indian Railways, members of the armed 
forces and elsewhere. At the same time, there are a number of areas where the 
methodology used in the paper could be improved upon. Specifically, their findings on 
the direct costs of CVD for the entire state of Kerala were based on the sample of 
employees of a single firm, which appears problematic. Moreover, the authors allocated 
to each individual with CVD the average income for the state, which may not be a valid 
assumption, if there is an economic gradient associated with the risks of acquiring CVD. 
Finally, they assumed that each individual who died of CVD lost the same number of 
years (10) of productive work – assumed to die at 50 years and retiring at 60 years. Again 
this may not be entirely appropriate, both because retirement ages are not fixed, 
especially in the unorganized sector (the bulk of the employed work force in India), and 
also because a more careful analysis would proceed with age-specific death rates from 
CVD.    
Another analysis of the economic impacts of CVD on India was undertaken by 
Leeder et al. (2004) in the context of a multi-country study of the impacts of CVD in 
Brazil, India, China, Russia and South Africa. This study used information on death rates 
from CVD from WHO mortality statistics. The authors combined population projections 
(by age and sex) with disease-specific death rates to predict CVD deaths (by age) over 
several decades into the future; and estimated “productive life years lost” from CVD-
related mortality as the difference between 65 years (their assumed age of retirement) and 
the mid-point of the age category where a CVD death occurred. Similar to the approach 
of Gupta et al. (2006) the study assumed forgone annual income per CVD death as 
equivalent to the average industrial wage for urban residents and half the wage for rural 
residents, for each person dying of CVD. For individuals aged between 35-64 years the 
authors estimated the total “payroll” losses to be in the region of US$200 million. In an 
effort to assess the impact of disability (and not just death) they used the WHO burden of 
disease data on DALYs lost on account of CVD, in conjunction with an estimate of 
US$1,000 per DALY lost to arrive at CVD-related losses of US$30 billion per year 
(Leeder et al. 2004, p.48). This study has many of the same weaknesses as in the Gupta et 
al. (2006) analysis, although it seeks to address the issue of differential incomes across 
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individuals by distinguishing between rural and urban CVD deaths and adjusting for 
differences in labor force participation rates of men and women in India. Another 
problem with these estimates (as also those of the Gupta et al. study) is the underlying 
assumption that the workers affected by CVD cannot be replaced (no unemployment), 
which likely biases the estimates of payroll losses due to CVD upwards. The study did 
not directly estimate medical care costs associated with treating CVD.  
A third set of analyses on CVD in India is by Popkin et al. (2001), who estimated 
the combined costs of healthcare as well as lost incomes from ill-health for cancers, 
diabetes and CVD using a mix of data from the 1995-96 health care utilization and 
expenditure survey of the National Sample Survey Organization (NSSO) and estimates of 
the cost of public health care services from Mahal et al. (2002). The study points to the 
substantial healthcare costs and lost productivity associated with these health conditions. 
For instance, healthcare costs (both out-of-pocket and government spending) associated 
with just these three conditions amounted to US$13.9 billion in 1995-96, or about 0.4 
percent of GDP. Using a standard human capital methodology (and a lost work time of 10 
years on account of death) and per capita expenditure/income estimates from sample 
surveys, they estimated lost incomes in 1995-96 to be roughly US$2.25 billion (Popkin et 
al. 2001, Table 2). Apart from its results being somewhat out of date now, this study 
adopted a rather simplistic view of the problem of measuring aggregate income (or 
production) losses associated with CVD (see, for instance, Abegunde 2007). It also 
underplayed the significance of lost output due to morbidity associated with CVD.   
Recently, Abegunde et al. (2007) estimated the combined impact of major chronic 
conditions (CVD, diabetes, cancers and respiratory conditions) on current and future 
national output. Their analysis improved upon earlier work on the aggregate economic 
impacts of chronic disease by focusing directly on impacts on GDP, via the device of an 
aggregate production function (Cuddington 1993). They compared GDP levels under 
business-as-usual scenarios with GDP levels that could be achieved if deaths from 
chronic disease were to be eliminated completely. Their analysis for India relied on 
mortality (by cause) statistics for rural and urban areas from the Registrar General of 
India and projections made by Mathers and Loncar (2006). They find the loss in GDP due 
to chronic conditions to be of the order of US$1.35 billion in 2006 and amounting 
cumulatively to a total of US$17 billion by the year 2015.  
Although certainly a major improvement over existing work, the economic 
analyses in Abegunde et al. (2007) are somewhat rudimentary compared to the state-of-
the-art modeling techniques now available. Unlike much of modern empirical work, their 
analysis does not consider the quality of labor lost on account of deaths – be in terms of 
education, experience or health. Secondly, their analysis excludes any consideration for 
days lost on account of illness and disability for individuals who did not die from these 
health conditions, which could potentially be quite substantial. They also did not clarify 
how they obtained information on health expenditures of chronic diseases in India. In a 
previous paper that appears to be the source of the results reported in Abegunde et al., 
there is a reference to national health accounts as one of the sources of this information 
(Abegunde and Stanciole 2006). However, a careful examination of the national health 
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accounts for India reveals no such information, at least in their published form (Mahal et 
al. 2005).  
 We understand that some recent studies on the economic impact of CVD have 
also been undertaken by the Public Health Foundation of India. We were unable to access 
these studies which appear not to be in the public domain as of now.  
Diabetes 
Apart from the analyses by Abegunde et al. (2007) and Popkin et al. (2001), 
which did not provide separate estimates for different chronic conditions, there is only 
one other major study that we are aware of that estimated the economic impact of 
diabetes on aggregate economic outcomes in India. The Economist Intelligence Unit 
(EIU 2007) specifically estimated the economic costs of the diabetes epidemic in 4 
countries, including India. It did so by assessing direct medical care costs, lost 
productivity as a result of mortality, morbidity and disability associated with diabetes. 
Their estimates of the costs for India are about 2.1 percent of GDP, about 1.2 percent of 
GDP in the USA, and 0.4 percent and 0.6 percent of the GDP in UK and Denmark, 
respectively.  
 The approach adopted by the EIU team was essentially a version of the cost-of-
illness methodology. For direct healthcare costs, they proceeded as follows. Firstly, the 
number of diabetes patients was estimated, using population and diabetes prevalence data 
for India. Data on prevalence (by age) was obtained from 3rd edition of the International 
Diabetes Federation (2007) which, in turn, is based on a number of community level 
surveys in India. This was multiplied by an estimate of the medical care costs per 
diabetes patient (the sum of the cost of hospitalization, outpatient care and drug costs). 
Estimates of per patient costs were based on the work of Rayappa et al. (1999). For 
assessing lost income on account of diabetes-related mortality, they used the “human 
capital” method, while allowing for growth in real wages over-time, and labor force 
participation rates. Estimates of real wages per worker were based on EIU’s own models 
that the study did not describe fully. The EIU study also used life tables to assess survival 
in the event that the diabetic individuals in question did not die,  assuming that the 
mortality risks from other conditions were statistically independent of dying from 
diabetes-related conditions. These were used to estimate income losses due to diabetes-
related morbidity. Unfortunately the approach followed by the authors seemed rather ad 
hoc. The authors used data from the American Diabetes Association for American 
patients to guess at the extra number of days lost by survivors in the countries studied – 
hospital days, leave (about 11 days for men, and 9 days for women) in their set of 4 
countries – which seems unrealistic The number of lost days were multiplied by 
estimated per-worker wages to get at the income losses due to morbidity. 
 In addition to the above, there are a number of small-scale studies of the costs of 
treating diabetes in India, which can serve can useful indicators of household economic 
impacts.  Shobhana et al. (2000) estimated the out-of-pocket spending by a sample of 
about 600 diabetic in-patients in Chennai (Tamil Nadu) hospitals. They estimate the 
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average expenditure during hospitalization to be about INR 5,300. Diabetic patients with 
a longer history of diabetes (5 years or more) spent 70 percent more during their 
hospitalization than those with a recent history of diabetes. Shobhana et al. (2002) 
focused on out of pocket expenditures incurred on 209 diabetes Type 1 cases in South 
India. They found expenses ranging from INR 2,050 to INR 87,150, with a median of 
INR 14,000. Not surprisingly, they found that poor families were spending much greater 
proportions of their income, some as much as 60 percent of their household income, on 
the care of their diabetic household members. Finally Grover, et al., (2005) assessed the 
costs of treatment in a sample of 50 diabetes patients in a North Indian hospital as 
roughly INR 10,000, and another INR 4000 as losses on account of morbidity. Although 
the sample sizes are small, with a per capita annual income of INR 41,000 in 2004, these 
analyses point to significant financial implications of diabetes in India.  
Respiratory Conditions 
Two recent studies (Murthy and Sastry 2005a, b), along with Abegunde et al. 
(2007) provide the only available economic analyses of the impact of chronic obstructive 
pulmonary disease (chronic bronchitis and emphysema), and asthma in India. As part of 
their work for the Indian National Commission on Macroeconomics and Health, Murthy 
and Sastry (2005a) estimated the direct and indirect costs of treatment of COPD.  
Focusing on individuals over the age of 30 years, and based on a number of small 
community-level studies in India, they first estimated the total number of chronic COPD 
cases. The numbers were estimated separately for men and women, and for rural and 
urban areas. They used data from a study in Greece to divide up the chronic COPD cases 
in India into mild, moderate and severe categories. All severe cases were assumed to be 
hospitalized once (per year) and all three categories were assumed to follow the same 
medication regimen, excluding the hospitalization phase. They used a large scale 
community study from Hyderabad district (Andhra Pradesh) to estimate the spending on 
hospitalization, outpatient services and medication. According to their estimates, 
treatment costs for a patient with severe COPD was nearly INR 33,000 in 2001.    
Assuming no change in prevalence rates over time, and  no change in urbanization 
patterns (urban areas had double the COPD prevalence rates than rural areas) they 
projected future populations with COPD. These projections were combined with simple 
forecasts of the future costs of treating various cases (mild, moderate, and severe) of 
COPD to arrive at the aggregate national health care costs of COPD in Murthy and Sastry 
(2005a) – of INR 169 billion in 2001, and INR 483 billion in 2016.   
 Separately, Murthy and Sastry (2005b) used out of pocket expenditures incurred 
by asthma patients to get a set of “cost” estimates for asthma from their Hyderabad study. 
Unlike their work on COPD where estimates of prevalence were constructed from a 
meta-analysis of a large number of small sample studies, in the case of asthma they 
obtained  information on population prevalence from the 2nd National Family and Health 
Survey of 1998-99 for India. Asthma cases were then classified into acute and chronic 
cases based on their study for Hyderabad. Based also on the Hyderabad study they 
estimated it would cost about INR 16,200 for moderate to severe cases of asthma, and 
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INR 436 for mild asthma; and an additional INR 4,379 for a single hospitalization stay. 
Using an essentially similar analysis to that for the COPD, they concluded that aggregate 
healthcare costs of asthma would have been in the order of INR 49.8 billion in 2001, and 
projected these costs to rise to INR135.3 billion in 2016.  
 These two studies are remarkable in the careful attention that was paid to 
prevalence data on COPD and asthma in India. However, because the data for Hyderabad 
district (which surrounds the provincial capital) is likely to overstate treatment and 
expenditure rates, the studies likely overestimated the healthcare costs of COPD and 
asthma for India. No estimates of public subsidies in the provision of care, or lost labor 
income of households’ are available in these analyses. The only other study relevant to 
assessing the impact of COPD and asthma on aggregate economic outcomes in India is 
by Abegunde et al. (2007) who estimate the impact of mortality arising for a set of 
chronic conditions (including COPD and asthma) on GDP. This work has already been 
referred to above and does not provide separate estimates for COPD and/or asthma.  
Cancers 
 There does not appear to be much information available on the economic impact 
of cancers in India with the exception of two studies that have been noted previously. 
Abegunde et al (2007) included cancer-related deaths in their work assessing the 
aggregate economic impact of mortality from chronic diseases on GDP. Popkin et al. 
(2001) included cancers in their assessment of the impact of diet-related health conditions 
in terms of health spending and on income losses experienced by households. These 
apart, we are unaware of economic impact of cancers on individuals, households and the 
economy as a whole.  
A reading of the popular press does, however, reflect concerns about economic 
impacts and some information of the magnitudes involved. For instance, in an article in a 
leading Indian newspaper (The Hindu), Hiddleston (2008) points to the significant 
economic impacts of cancer on poor households. She cites estimates by the head of major 
government-run specialty hospital in Tamil Nadu indicating that the hospital spent 
INR12-16,000 on each of its inpatients for which it had provided treatment free of cost 
owing  to their low-income status. In the same news article, representatives of a charity 
hospital estimated spending substantially higher amounts, in the range of INR 200,000 on 
some patients, or more. Also in the Hindu, Charan (2007) cites experts that private 
corporate hospitals could charge as much as INR 50,000 for a cancer-related surgery, 
with chemotherapy also costing as much per cycle. One oncologist also stated that 
individuals often discontinued treatment owing to cost. The consequence in this latter 
case could be higher income losses compared to the alternative of effective treatment 
having been obtained, particularly if the cancer patient were someone who was 
employed.    
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Injuries 
 The final set of health conditions for which we have some evidence on the 
economic impacts is available for India is injuries. We were able to access results from 
three types of analyses – one that estimated costs of injury treatment (and associated 
impacts) on households using a nationally representative survey, and two additional 
analyses of household impacts of traffic injuries. Gururaj (2005) cites yet another study, 
by Mohan (2004) that estimated large aggregate economic effects of road traffic injuries, 
amounting to some 3 percent of India’s GDP. We were unable, however, to access the 
paper or the methodology used to derive these conclusions.  
 Gumber (1995) used data from the National Sample Survey round of 1986-87 to 
estimate the cost of treating injuries in public and private hospitals in India in five Indian 
states – Gujarat, Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal. He found the 
average out of pocket payment for hospitalization for injuries to range from INR 621 in 
West Bengal and INR 6,034 in Gujarat. Public hospitals were somewhat cheaper with 
spending on injury-related medical care ranging from INR 324 to INR 1,740 in the two 
states. Among households with an injured member, expenditures averaged around 80 
percent of the household monthly income. Gumber also noted that many (minor) injuries 
go unreported, so one might conclude that these estimates correspond to the more severe 
injury cases and comprise a lower bound of the actual economic impact.  
 Thomas et al. (2004) report the results of a large household survey in Bangalore 
in the Indian state of Karnataka that focused on injuries. They found that households that 
had members who sustained injuries reported an average of INR 18,000 in health 
spending, declines in earnings, increase incidence in debt, and limited access to financial 
support from other entities. Another analysis of the economic impact of traffic injuries on 
households was recently conducted by Mohanan (2008). He notes that the likely two-way 
relationship between ill health and incomes makes assessments of the causal implications 
running from health to household economic outcomes difficult. Using data from traffic 
injuries in Karnataka (which he argued constituted exogenous health shocks, conditional 
on matching across key pre-determined variables) he compared the economic outcomes 
for households with injured members with comparable households that did not have any 
injured members. He found that households were unable to smooth consumption fully, 
and experienced declines in educational spending. Households with members who 
sustained injuries relied to a much greater extent on debt financing than their counterparts 
without injuries. 
1.3. Key Gaps and Lessons from the International Literature 
 Clearly, there exists some research relating to the economic impacts of NCDs in 
India relating to CVD, diabetes, injuries and respiratory conditions. However, it should 
also be apparent that there are several areas where existing analyses could be improved 
upon and gaps that could be filled.  
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Firstly, not all NCDs are covered by the existing Indian literature on the economic 
impacts of disease and some major conditions, such as cancer, appear to be inadequately 
addressed, as also are neurological and psychiatric disorders. Together these two 
conditions accounted for nearly 11 percent of the worldwide disease burden. Depression 
alone resulted in 3.4 percent of the worldwide burden of disease (Hyman et al. 2006). As 
studies elsewhere have shown, depression can result in quite significant losses in 
productivity and health care costs under the cost of illness method (Simon et al. 2002).  
The potential economic impact estimates for cancer available in the international 
literature also points to a substantial gap in this area for India. Estimates in a National 
Institutes of Health (NIH) report indicate that cancer cost the US nearly US$210 billion 
in 2005 – US$74 billion in direct healthcare costs and US$135.9 billion in productivity 
losses. Estimates of productivity losses were based on the human capital approach 
(discounted lifetime earning) – based on age-specific mortality and morbidity and 
earnings for each group, and expected productivity increases, and discount rate of 3 
percent (NIH 2005). Health Canada (2002) estimated the costs of cancer in 1998 using a 
standard cost of illness approach – direct health care costs; value of activity days lost due 
to disability (morbidity costs) and value of life lost due to mortality – human capital 
approach. Total costs were C$14.3 billion, of which C$2.5 billion were direct costs and 
C$11.8 billion were indirect costs. Of the indirect costs, C$1.3 billion were due to 
disability.  
 Secondly, existing analyses on India tend to downplay the role of co-morbidity 
and of competing risks in assessing the economic impacts of NCDs. For instance, one 
would expect persons with diabetes to be more likely to experience CVD, all else the 
same. Narayan et al. (2006) note that mortality risk is substantially higher for those with 
diabetes than for those without; and that a majority of deaths among persons with 
diabetes, at least in rich countries, are due to CVD. Similarly, depression can go hand in 
hand with diabetes and CVD (Moussavi et al. 2007), and smoking has been associated 
with an increase in both respiratory deaths and CVD deaths (Gajalakshmi et al. 2003). 
Many of the underlying factors that increase the risk of heart disease also increase the 
risk of developing cancers (Honore and Lleras-Muney, Forthcoming). The presence of 
co-morbidities – the existence of one condition is associated with the increased likelihood 
of acquiring another - implies that economic impacts allocated to a specific disease ought 
to involve some sort of netting out exercise (or alternately, consolidation), depending on 
the health condition involved. Similarly, mortality risks from two competing (say on 
account of some common cause) conditions imply that standard methods used to allocate 
costs allocated to a disease (based on the identified cause of death or illness) ought to be 
corrected because of their implicit assumption of statistical independence. As one 
example, a decline in communicable conditions increases the likelihood of acquiring a 
non-communicable condition. The obvious implication is that we need either to think of 
diseases falling under NCD as one consolidated sum, or account for this fact in our 
calculation of economic impacts of specific diseases. Most of the existing analyses 
carried out for India ignore allocative issues associated with co-morbidity and competing 
risks.  
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By including cancers, CVD and diabetes under one all encompassing category, 
Abegunde et al. (2007) got around the problem of problem of addressing co-morbidities 
and competing risks somewhat, but other potentially more attractive ways of addressing 
these methodological challenges exist. The international literature has some good 
examples of how one might go about estimating economic impacts in the light of such 
concerns. For instance, the American Diabetes Association’s (ADA) (2007) calculation 
of the health care costs of diabetes takes careful account of co-morbidities associated 
with diabetes, by assigning to diabetes, “extra” costs associated with other health 
conditions (i.e., costs that would not have been incurred had the person been without  
diabetes). The ADA also sought to address the question of competing risks by controlling 
for age- and sex- prior to comparing the costs of people with and without diabetes. 
Kessler et al. (2008, see also Insel 2008) estimated the economic costs of mental illness 
in the United States. Their analysis was based on a cross-sectional survey of 5,000 
individuals (probability weighted) that included information on mental disorders, 
earnings in the preceding 12 months (excluding unearned income) , age, gender, 
education, marital status, occupation, and so forth. Similar to the ADA approach, Kessler 
et al. estimated a relationship between earnings and a collection of socio-demographic 
characteristics, plus indicators of mental health. Their estimation led to two sets of 
“fitted” estimates: one for earnings given the socioeconomic and demographic 
characteristics; and one if no one had mental ill health. The difference (averaged across 
all individuals with mental health problems) was taken as the average difference in 
earnings due to mental ill health. Given population prevalence of mental ill health, this 
was used to assess the difference in earnings for the population as whole due to mental 
disease. They estimated the societal-level effect to be US$193.2 billion. The share of 
women’s costs was US$62 billion, which they attributed to their not valuing the 
opportunity cost of women’s work. Kessler et al. showed that earnings were lower by 
nearly 40 percent for men with serious mental illness (in the previous 12 months) 
compared to their mental illness free counterparts. 
 Thirdly, existing analyses for India exclude consideration of subsidies on health 
services, whether provided by the public sector or private enterprises (with the possible 
exception of Abegunde et al. 2007). Most tend to focus on out of pocket spending by 
households. It might appear first sight that, if our interest is in the identification of 
economic impacts on individuals and households the exclusion of such subsidies is not 
only correct but is, in fact, a necessity. That is a valid assertion, but only up to a point. 
Information on public subsidies is necessary if we wish to go beyond simply estimating 
household economic impacts to understanding the factors that drive them. Moreover, 
information on public subsidies is an essential input if we wish to estimate the aggregate 
economic outcomes of NCDs. To see this, observe that if health expenditures result in 
lower savings and investment (whether by private entities or the government) they will 
adversely impact aggregate economic outcomes (e.g., Cuddington 1993).  
Fourthly, with the exception of Abegunde et al. (2007) no effort is made in the 
existing economics literature to use existing theoretical and/or empirical models of 
economic growth. This omission typically leads to exaggerated claims of income losses 
with a myriad of diseases, usually when the authors follow a cost-of-illness methodology 
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to infer aggregate economic outcomes. Even when a cost of illness approach is used to 
estimate aggregate income losses, the typical analysis for India relies on assumptions that 
are unrealistic. These assumptions include taking labor market conditions (see Chapter 4 
for more on this) as unchanged from the type a person falls sick/dies to their actual 
retirement/death in the absence of the disease in question. Related to this point, most of 
the cost-of-illness literature for India does not attempt to identify the actual incomes of 
individual affected workers/households, resorting instead to hand-waving assumptions 
that worker incomes equal the average for the country as a whole.    
Fifthly, with the exception of Mohanan (2008) who studied the impact of traffic 
accident injuries on households, existing analyses of the economic impacts of NCD on 
households in India do not go much beyond estimating out of pocket health care 
expenses. Much of the existing research does not inquire, for example, into the impact of 
morbidity and mortality on the household allocation of labor within domestic work, on 
children’s schooling, on supply of labor, on the likelihood of falling into poverty, and so 
forth (for examples from the international literature, (Basu et al. 1997; Doorslaer et al. 
2006; Gertler and Gruber 2002; Yamane and Jayne 2004).  
 Finally, existing work for India does not permit an easy “adding up” of estimates 
of the economic impacts of different categories of NCDs. This stems partly from the 
different methods employed in each study, ranging from cost-of-illness analyses of 
varying rigor to standard growth models. Some studies neglected the effects of mortality 
(e.g., Murthy and Sastry) on economic outcomes but others did not (Leeder et al. 2004; 
Gupta et al. 2006, Abegunde et al. 2007). Others downplayed economic effects working 
through morbidity, focusing instead on deaths as in the estimates of Abegunde et al. 
(2007). However, an important element of the story is the differences in the type of data 
used for individual studies. Some analyses, such as those of Murthy and Sastry (2005a, b) 
and Gupta et al. (2006) used information from a variety of small sample surveys to arrive 
at an acceptable prevalence rate for a disease. Others relied on a single small sample to 
arrive at estimates of aggregate prevalence. Other studies relied on data from household 
surveys. The net result is a series of numbers on morbidity and mortality from different 
health conditions that lack consistency and hamper efforts to arrive at a combined 
estimate of the impact of NCDs in India.  
1.4. Goals for the Report 
In the remainder of this report we have two main goals. The first is to generate a 
set of estimates for the economic impact of NCDs that build on the existing work and are 
closer to the ‘state of the art’ than the literature that currently exists on this subject in 
India. The economic impact estimates that we are interested are intended to highlight not 
just the aggregate (economy-wide) impact of NCDs – such as GDP per capita – but also 
in terms of impacts on households, whether in terms of poverty, catastrophic expenses or 
the burden placed on members of different income groups. We will also seek to inquire 
about the extent to which government provision and financing of health care in India is 
likely to have influenced these outcomes. The second goal of this report is to generate 
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insights about the appropriate policies to follow with regard to NCDs in India and other 
developing countries that find themselves in a similar situation.  
 To this end, the report devotes the next chapter (Chapter 2) to a formal definition 
of the economic impacts that we are concerned about and the methodology we intend to 
follow to estimate these impacts. We assess existing data on NCDs in light of the data 
requirements necessitated by the methods we intend to use, and describe the data that we 
do intend to use. Chapters 3 to 6 provide our estimates of the economic impacts of NCDs 
at the household and national levels. Chapter 7, the concluding section, presents the 
research and policy implications of these results.      
  
  
- 15 - 
 
 
C H A PT E R  2. T H E  E C ONOM I C  I M PA C T  OF  NC DS I N I NDI A :  
M E T H ODOL OG Y  A ND DA T A  SOUR C E S 
 
2.1. Methodology 
In estimating the economic impacts of NCDs, we will be concerned with impacts 
at the level of the household as well as at the level of the economy.  The general approach 
that we will adopt in assessing these impacts is described in the sub-sections that follow. 
This chapter can be skipped by individuals who wish to proceed to the results and 
conclusions in Chapters 3 to 7. 
2.1.1. The “burden” of Health Spending 
One way of assessing the economic impacts of NCDs is to estimate the associated 
costs of health care – the so-called ‘direct costs’ of ill health. As we shall see in Chapter 
3, our results point to a significant economic “burden” of the direct costs from providing 
medical care to treat NCDs in India, whether considered in absolute Rupee terms, or as a 
proportion of GDP. This finding is also supported by several of the studies that we cited 
in Chapter 1.  
It is important to appreciate, however, that ‘direct costs’ of NCDs do not 
necessarily indicate the economic burden that NCDs impose on households. This is firstly 
due to the fact that households are not the only party that pays for the costs of health care. 
Governments, insurance agencies and firms typically account for a significant portion of 
this amount. Secondly, households with sick members may incur lost wages either 
because the sick members are unable to work, or that care-givers have to give up 
productive labor time, neither of which is included in the calculation of direct costs. 
Future incomes may also be foregone if children are pulled out of school and these are 
typically also not included in direct cost calculations. Some of these elements of the 
economic burden are captured in cost of illness studies by the estimation of the ‘indirect 
costs’ of illness, although typically these studies do not consider factors such as social 
security, or unemployment/disability insurance that could reduce these costs. Nor do such 
studies consider the impact of an adult member’s health on child schooling/health.       
It is also not obvious that health expenditures are necessarily a “bad” that needs to 
be deducted from some household (or social) measure of economic well being. Indeed, 
the level of health spending (and its growth) can be directly related to improved health 
outcomes, in and of itself, a good thing (Doyle 2007, Jones 2002). To see this, consider 
Figure 2.1 which describes on the X axis, a single consumption good (which can also be 
used for purchasing health care) available to a society (or to a household). The Y-axis 
describes the average health attainment of this society. Let the total amount of the 
consumption goods available to this society be denoted by *C . The curve AB describes 
how health attainment improves with the consumption of health services. To understand 
how this works, if the amount of health spending is zero (i.e., if all spending is diverted to 
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non-healthcare activities) the society attains a non-health consumption level of B (call 
this the GDP, or household income). On the other hand, if all income is devoted to health 
care, the society ends up at health level A. Presumably, something intermediate is chosen, 
so that h* is health attainment, and C* the consumption (of non-health goods) in this 
society. The expenditure on health care then is the segment BC * .   
 
 
There is nothing in the above set-up that would imply that health spending is bad, 
per se. Moreover, consider a competing risks formulation, where there are a large number 
of competing sources of morbidity (and mortality). Here, the emergence of effective 
prevention efforts for one disease may lead to increased household spending on other 
sources of morbidity that now acquire greater priority (e.g., Dow, Philipson and Sala-i-
Martin 1999) for the society or household in question. That permits the possibility that 
observed health spending may not change by much (and may even increase) with 
improvements in health outcomes. Related to this point, increased investments in 
technological innovations in newly prioritized health conditions can also explain higher 
health expenditures (Jones 2002). In Figure 2.2 we illustrate this as a movement of health 
technology from AB to BC, and a new point chosen by society at E , where health 
spending is even greater than at E.  This argument would be even stronger if there is a 
positive feedback loop from good health to income, which could now increase beyond B. 
Empirical research in support of the causality running in the direction from health 
improvements to national income can be found in Bloom et al. (2004), and the evidence 
at the individual and household levels is even more easy to find (Strauss and Thomas 
1998). 
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The preceding analysis suggests that in assessing the ‘economic burden’ of health 
spending, we should also consider any relevant health gains (or lack thereof) that might 
have been achieved by such spending. At the very least, we ought also to include a 
measure of income loss/gain to make the analyses comparable across households who 
may make different choices about health care (and spending) when confronted with an 
episode of ill health. Interviews that one of the authors carried out with slum dwellers in 
Ahmedabad (India) underline this point. Several of the respondents pointed out that the 
major reason they incurred large amounts of health spending on seemingly trivial health 
problems was to avoid missing work and losing jobs in an informal sector characterized 
by a lack of unemployment insurance and paid medical leave.     
There are important exceptions to the arguments made above. The first is the issue 
of efficiency. Going back to Figure 2.1, if it so turns out that health spending by society at 
a level of health attainment given by h*, exceeds BC * , then we do have an economically 
inefficient outcome. Indeed, if we assume in the extreme that h* can be attained by 
purely preventive behavior at zero cost, one could say that all of the health expenditure
BC * is excessive and could have been used for other purposes, including more 
consumption of services and goods other than health care related. The same argument 
would hold if the treatments that health expenditures support are ineffective in improving 
health outcomes. In this sense, health expenditures constitute a negative economic impact 
on social outcomes.  
Concern with the cost of treating a disease from the point of view of 
households/society may arise from at least two other considerations. If the members of a 
society are highly averse to financial risk, then the risk of incurring high out of pocket 
expenses in the event of illness can potentially impose very large welfare costs on such 
individuals, for which providing for some form of insurance may be desirable. Also, if 
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there are substantial socioeconomic inequalities in society, then high levels of out of 
pocket expenses on illness can be considered “unfair” even for individuals who are 
“neutral” to risk if these costs fall disproportionately upon backward social groups. These 
concerns (along with income losses linked to ill health) form the bases for analyses that 
look at ‘consumption smoothing’ by households in response to illness, the impacts of ill-
health on poverty and catastrophic levels of health spending by households (Doorslaer et 
al. 2006; Gertler and Gruber 2002; Krishna 2007; Xu et al. 2003).    
  In Chapter 3 we assess firstly the direct costs of NCDs in India. We use 
information on direct costs to infer the economic burden of NCDs on Indian households 
by describing how these costs are financed and how the economic burden on households 
varies by income class. Because formal insurance is limited and firms pay for only a 
small portion of total health spending in India (Mahal et al. 2005), we focus primarily on 
the distribution of health care costs between the public sector and household out of 
pocket spending as a way to infer the burden of NCDs on households. We also inquire 
into the methods by which Indian households finance their out of pocket spending for 
NCDs. Analyses of the impact of NCDs on households’ likelihood of incurring 
catastrophic spending and of falling into poverty were also undertaken along the lines of 
Doorslaer et al. (2006) and Xu et al (2003). 
 In Chapter 4 we estimate the second key component of the cost of illness 
associated with NCDs: namely the income losses to households associated with 
morbidity/disability and premature mortality from NCDs. Usually, the calculation of 
income losses relies on the human capital methodology, whereby the lost income for 
each dead/disabled/sick individual is calculated as the present value of their expected 
future stream of income
The measure of income losses we use in this report is slightly different from the 
strict human capital measure of indirect costs described in the previous paragraph. 
Specifically, we estimated income losses associated with morbidity and/or death 
associated with NCDs for one year. In the framework of Figure 2.1, the annualized 
version of income loss can be thought of as an inward shift of the curve AB in any given 
year, because the point of maximum income (B) moves to the left. This measure is 
attractive because health care expenditures for chronic conditions (characteristic of many 
NCDs) are likely to be incurred in future years for the same individual. In this scenario, 
adding up health expenditures incurred in any one given year (direct costs) to the 
combined (discounted) income losses that occur over multiple periods due to premature 
deaths appears inconsistent. Constructing the annual estimate also helps us better address 
data limitations in India with regard to information on the likelihood of survival of sick 
patients with NCD, their future medical expenditures and hospital stays in estimating 
their cost of illness.  
, appropriately discounted, while allowing for growth in real 
wages over time, and the likelihood of unemployment and survival. Calculated in this 
way, these income losses (or ‘indirect costs’) could be considered a lower bound of the 
combined present and future income losses likely suffered by households that have 
members with NCDs (because we exclude, for instance, human capital losses due to 
reduced schooling for children in affected households).    
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2.1.2. Aggregate Economic Impacts of NCDs  
We shall estimate two types of aggregate impacts. First, we shall estimate output 
losses associated with NCDs to the economy as a whole. The human capital measure of 
indirect costs has been used in the literature to arrive at a measure of output losses to the 
economy as a whole (e.g., Rice 1966; Yang 1992). This method of estimating aggregate 
output losses is open to a number of important criticisms, however. For instance, it is 
difficult to justify the sum (across individuals) of the present discounted value of future 
income as lost national income. If the elasticity of labor supply is large at the existing 
wage rate, there may be no income loss at all because any losses in workers owing to 
disease would be quickly replaced. Even if one were to assume that any recent deaths 
from the work force are not readily replaceable by other workers (a highly doubtful 
assumption in a country such as India with large numbers of underemployed working age 
individuals) and hence results in net income loss in the short run, it is difficult to envisage 
that this loss continues into the future, up until the time the individual would have lived 
had they not contracted the fatal disease in question. Indeed, one would imagine that 
labor markets respond fairly rapidly to address such shortfalls, particularly for low skilled 
jobs. For skilled jobs, the period of adjustment might take a little longer, but probably not 
enough to justify using each individual’s human capital measure as an indicator of loss to 
the national economy.  
The economy may also respond in other ways, such as via reorganization of 
production processes that ameliorate the impact of any shortfalls in labor supply, 
including by changes in labor intensity of production processes. Moreover, health 
spending itself can impact current and future national incomes and its distribution. Rising 
health expenditures can, via a multiplier effect, contribute to rising national incomes, just 
as military spending does. One might also argue that this multiplier effect will be quite 
large given that healthcare is a highly labor intensive activity, particularly if owners of 
labor have higher propensities to consume than owners of other types of resources, such 
as land and capital. As against this, one could argue that rising health spending due to 
NCD (or communicable conditions) reflects a diversion of consumption spending to uses 
that do not add to the economy’s productive capacity. Clearly, a more direct formulation 
that models the GDP loss (gain) associated with disease directly is desirable, if our 
interest is in aggregate losses to the economy.  
In Chapter 5, we provide estimates of annual GDP losses associated with NCDs 
using results on the determinants of national income from the existing empirical literature 
that relies on standard models of economic growth. Here it is worth noting that estimates 
based on the use of theoretical models of economic growth (and their empirical 
counterparts) to simulate the adverse economic impacts of disease may be limited by an 
inadequate accounting of all of the channels (pathways) through which ill health may 
influence GDP (Bloom and Mahal 1997).      
A second monetary measure of aggregate impacts that we shall be concerned with 
is the ‘value of lives lost’ on account of NCDs. Indeed, another interpretation of the 
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human capital measure of indirect costs of premature deaths is that it gives us a monetary 
measure of the value of life lost on account of NCDs. A more attractive measure in this 
regard, however, is the “value of statistical lives” lost on account of illness. This usually 
relies on empirical methods that help to identify the additional compensation that an 
individual needs to avoid small mortality risks (Viscusi and Aldy 2003). If V is the 
additional monetary compensation needed to face a “small” added risk of death of p, the 
value of a statistical life is
p
V . Some authors also use the human capital method to assess 
the value of an individual’s life, relying on economic theory that suggests estimates based 
on the human capital method constitute a lower bound to the monetary value of a 
statistical life. Both approaches lead to very large monetary estimates of “indirect costs”, 
but experts using one or the other of these methods differ markedly in their emphasis on 
the interpretations of their respective findings. For instance, authors using the “value of a 
statistical life” approach tend to emphasize the losses to the aggregate of individual well 
being from the disease (Viscusi and Aldy 2003). Proponents of the human capital 
approach tend to emphasize income losses.  
The value of life (or the willingness to pay) approach to assessing indirect costs 
due to disease is not without its problems. It has been argued by Broome (1985) that the 
money metric may not be an appropriate measure of the value of lives lost. Specifically, 
the monetary value of any life lost should be infinitely large since the value to any given 
person of their life is infinite. Broome objects to the measure of the value of statistical 
life as defined by
p
V , since that is dependent on the person not knowing for sure whether 
they would die, even if it is known that they face some (small) risk of death. However, 
his point is that while this may be true of any single individual facing a small mortality 
risk, the society (or the planner) as a whole (enjoying the benefit of “large numbers”) 
knows that some individuals would surely die. If Broome’s argument is taken as valid 
and monetary measures are unsatisfactory, direct measures of the “quality of life years” 
lived (or lost) can be used. Prominent examples include Disability-Adjusted Life Years 
(DALY), Disability Free Life Expectancy (DFLE), numbers of deaths, and so forth.      
In Chapter 5 we also estimate the value of statistical lives lost in India on account 
of NCDs using information from Viscusi and Aldy (2003) and data on incomes for India. 
We focus solely on mortality and not on the value of DALYs lost. Apart from the 
difficulty of getting systematic information on disabilities linked to disease in India, we 
would also face the challenge of linking NCD-associated disabilities with socio-economic 
and demographic characteristics. This would constitute a whole new project best 
addressed in a separate report.  
2.1.3. Implications of Co-morbidity and Competing Risks for Assessing the 
Economic Burden of NCDs  
There are well known weaknesses associated with the methods described above 
when it comes to estimating economic impacts, whether at the level of households, or 
national economies. Here we highlight one key problem – related to the existence of co-
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morbidities and competing risks - which is addressed in estimates of economic impacts in 
Chapter 6 of this report. Specifically, if some health conditions (e.g., diabetes) are a risk 
factor for other health conditions (e.g., CVD), namely we have co-morbidity, economic 
impacts attributed to CVD are likely to be upwardly biased estimates of the impact of 
CVD, unless the added effects associated with diabetes are netted out. Similarly, and this 
is a point we referred to in Chapter 1, health care costs (or, for that matter, income losses) 
assigned to specific diseases are problematic if there are competing risks from other (non-
NCD) health conditions. Specifically, in the presence of statistically dependent 
competing disease risks,2
The methods adopted in Chapter 6 to estimate the economic impacts of selected 
NCDs and injuries attempt to address this problem. In the context of cross-sectional 
household survey data for India, we use a (propensity score) matching approach to 
address the potential bias that might result from not taking account of potentially 
interdependent competing risks when attributing direct health care expenses, and other 
economic impacts to NCD. For each individual with a specific NCD (in this chapter we 
use CVD, cancers and injuries), we find a control possessing similar observed pre-
determined characteristics. Because individuals with NCD are likely to be a self-selected 
sample, competing risks for such individuals are likely to systematically differ from 
randomly selected survey participants. The propensity score matching approach that we 
use also addresses this selection effect by creating a control group of individuals from our 
random sample. We then assess the economic impacts – such as consumption spending 
and out of pocket spending on health - of acquiring NCD by comparing the outcome for 
each person with his, or her, matched control.  
 to attribute the income loss from any death/disability fully to 
the NCD identified as its immediate cause will result in biased estimates of the added 
cost, additional out of pocket expenses associated with a specific disease. This bias is 
likely to be magnified as we disaggregate economic/health care utilization impacts 
further by disease, since one would expect competing risks of death (from causes other 
than the disease in question) to increase in magnitude.  
Our analysis goes beyond simply looking at utilization of health services, 
consumption expenditures and out of pocket spending. We also use the matching 
framework to assess impacts of NCDs on households’ risk of falling into poverty and of 
incurring catastrophic spending.   
2.2. Data  
Data requirements for estimating the economic impacts of NCDs are described in 
the first sub-section. The later sub-sections focus on the quality of data available in India 
for this purpose. 
 
                                                 
2In circumstances where competing risks can be described by multinomial logit models or the Cox latent 
survivor model where the hazards are statistically independent, traditional methods of estimating direct and 
indirect costs suffice. However, this is not likely to be as common as its counterpart with dependent 
competing risks (Honore and Lleras-Muney 2006)  
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2.2.1. An Assessment of the Needs  
The discussion in Chapter 1 as well as of the methodology that we propose to use 
to estimate of economic impacts of NCDs points to a number of key data requirements 
for carrying out effective analysis of the economic impacts of NCDs in India. These 
include firstly, the requirement that information on the prevalence of NCD-specific 
morbidity and mortality be available, preferably by age- and sex- and by rural and urban 
populations. This information is relevant both because the NCD prevalence is likely to 
vary by demographic categories (e.g., some ages are more at risk from asthma, COPD 
and cancers) and it is known that urban populations are currently more at risk from NCDs 
that India’s rural populations (e.g., Leeder et al. 2004). Moreover, for the data to be 
useful in making inferences about economic impacts, be it at the national and regional 
levels, or for the future, it ought to be representative of the population of concern.     
 Secondly, available data on morbidity and mortality should be able to be matched 
at the level of each sampled individual, by type of health condition, to out of pocket 
spending, health-care utilization (both inpatient and outpatient, and by public and private 
services) and types of health spending, such as on drugs, on consultations, and on 
diagnostics. This will enable calculations of health care expenditures associated with 
specific-NCD conditions. If information on multiple health conditions is available for the 
same individual, it could enable the separating out of effects of co-morbidity, and 
competing risks.     
Thirdly, when our interest is in household economic outcomes, the data on NCDs 
at the individual level ought to be matched to additional individual socioeconomic and 
demographic characteristics, such as caste, region of residence, educational status, 
indicators of income and assets, work status, earnings, household size and consumption 
expenditures. Ideally, the data should be longitudinal so as to help net out any unobserved 
individual-level and household-level effects that could confound results on the economic 
impact of NCDs. Additional crucial information at the household (or individual level) 
includes the way health expenditures are financed and on the availability of social safety 
nets (unemployment and disability allowances, sick leave, life and health insurance, food 
and housing aid, community support, etc.) to which the household members have access.     
 The fourth set of data that are likely to be useful relate to translating individual 
and household-level findings on the economic impacts of NCD to the regional and 
national levels. One could, of course, “add up” the economic impact results at the 
household unit-level (for instance) from say, sample surveys, but they cannot tell us 
anything about how an individual’s (or a set of individuals’) departure from the labor 
market would affect output in his (their) former jobs. To be sure, if the number of people 
sick or dying from NCDs were relatively small compared to the total labor force and if 
there were no unemployment, the estimated sum of individual level income losses would 
very likely equal national income losses. But, if the numbers are large relative to the 
work force, and if NCDs are concentrated among the more experienced and educated 
members of the work force, or if there is substantial unemployment, this is no longer the 
case. Moreover, as we noted earlier, health spending can influence the national economy 
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through its impact on capital formation. These effects cannot be captured simply by 
relying on household-level information. Data that are likely to be relevant in this context 
include information on private and public investments in physical/infrastructural capital, 
labor market conditions (unemployment rates, labor supply elasticities) and measures of 
national output (Gross Domestic Product). Population data (by age and sex) are obviously 
necessary to understand the labor market context as well. All-cause death rates by age 
and sex- could be useful for developing human capital indicators when assessing 
aggregate economic impacts. Data that can help in the construction of trends in all of 
these aggregate demographic and economic variables will help in projecting aggregate 
economic impacts if needed.    
2.2.2.  Socioeconomic, Demographic and National Income Data 
In general, data on aggregate demographic and economic variables are readily 
available in India. Thus, long-term time series on various indicators of national income, 
private sector investment, government expenditures on capital account (a proxy for public 
sector investment) are readily available from the Central Statistical Organization (CSO) 
and the Reserve Bank of India. Demographic data – such as the distribution of total 
population by age-groups, age-specific all-cause death rates and population projections 
(by age group) are readily available for India and its constituent states. The CSO also 
provides information on growth in wages of industrial workers, a measure (along with 
GDP per adult worker) that can be used to develop long term wage-growth projections.  
Information on aggregate unemployment rates (constructed from labor-force 
sample surveys) is readily available from publications of the Ministry of Labor. Such 
estimates are usually constructed from the “employment-unemployment” sample surveys 
undertaken regularly by India’s National Sample Survey Organization. These surveys 
also collect individual- and household-level information on a range of socioeconomic and 
demographic characteristics of individuals, their employment status, occupation, earnings 
as well as unearned income. The data, however, are not matched to individual health 
status, utilization or health spending.   
2.2.3. Information of Health: Community Level Surveys  
 There are several sources of information on NCD-related morbidity and mortality 
status of Indians. Firstly, a large number of small community-level or facility-level cross-
sectional sample surveys have been undertaken to estimate the prevalence of various 
types of health conditions. In their analysis of COPD, Murthy and Sastry (2005a) 
reviewed 11 studies from different regions of India, both rural and urban, concluding that 
COPD prevalence rates in India were about 5 percent in males over 30 years of age, and 
2.7 percent among females over 30 years of age. The 11 studies, mostly small scale, 
ranged over a period from 1964 and 1995. Murthy and Sastry (2005b, p.252) reviewed a 
few such studies for estimating asthma prevalence, concluding that while the sample 
sizes were much too small to be useful in making inferences about current prevalence, the 
combined evidence from these surveys indicated that asthma prevalence was increasing 
over time in India.  
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As another example, Gupta et al. (2006) summarized the results of 21 studies on 
CVD with household sample sizes ranging from about 200 to 25,000. These studies 
varied by type of primary health condition studied (hypertension, coronary heart disease, 
diabetes, stroke, rheumatic heart disease) and region (rural and urban, and different parts 
of India). The studies cited in Table 2 of Gupta et al. (2006) suggest heart disease 
prevalence ranging from 4.6 to 13.9 percent, higher in north India than in South India, 
and higher in urban areas compared to rural areas. Recently Joshi et al. (2006) used 
verbal autopsy methods to identify the cause of roughly 1350 deaths that occurred in a 
sample of 45 villages in the Indian state of Andhra Pradesh during 2003-4. The crude 
death rate of 7.5 per 1000 estimated for the population in these villages was about the 
average for India as a whole. 14 percent of all deaths were due to ischemic heart disease, 
13 percent to strokes and 13 percent to injuries and external causes. No cause of death 
could be identified for 18 percent of the cases.    
 The Indian Council of Medical Research (ICMR) undertook a series of “meta-
analyses” for a range of NCDs in 2004 that sought to consolidate the information from 
these small region- and disease-specific studies (Shah et al. 2004). Using six studies for 
urban areas, and four for rural studies, they concluded that diabetes prevalence rates were 
12 percent among urban adults and 4 percent among rural adults. Again, using eight 
studies for urban areas and three for rural areas, they concluded a hypertension 
prevalence rate of roughly 16 percent in both sets of (adult) populations. They also 
estimated the prevalence of Ischemic heart disease among adults to be 6.4 percent in 
urban areas and 2.7 percent in rural areas (using 9 studies); and stroke prevalence at about 
0.2 percent.  
 An illustrative example of the use of such studies in the context of mental illness 
can be found in Gururaj et al. (2005) who summarizes a number of small Indian studies 
and two sets of meta-analyses. He concludes that the prevalence of major mental 
disorders in India is of the order of 6.5 percent, including common mental disorders 
(about 2 percent), and mood disorders (e.g., depression) ranging from 2 to 4 percent. 
Gururaj (2005) also contrasted the incidence rate of injuries from small regional studies 
with official injury statistics put forth by the National Crime Records Bureau of India, 
concluding that officially recorded injuries are no more than 8 percent of all injuries, 
presumably reflecting serious versus non-serious injuries.   
 The consensus among Indian experts seems to be that firstly that disease 
prevalence estimates from the large number of small cross-sectional population surveys, 
while they have certain advantages, also suffer from a number of obvious problems. On 
the plus side, several of these studies were led by experienced researchers and thus likely 
to have resulted in lower measurement errors of the health condition. In a large country 
such as India, cost considerations might also be used to justify such studies. However, 
apart from the small sample sizes (and associated large standard errors), the studies have 
been conducted at different times, and at different places, making it difficult to make 
inter-temporal or interregional comparisons. Gururaj et al. (2005) point out that the 
majority of psychiatric epidemiology studies in India have focused on small sized 
samples, often using “convenience” samples. As a consequence prevalence rates 
- 25 - 
 
estimated from these studies ranged from 10/1000 to 370/1000. In any event, most of 
these studies are unsuited to assessing economic impacts of households. With the 
exception of the Hyderabad study cited by Murthy and Sastry (2005a, b) and the analysis 
by Thomas et al. (2004), the data collected from these surveys lack corresponding 
information on earnings, health care utilization, health expenditures, and so forth.  
Murthy and Sastry (2005b) also note that variation in definitions – such as those of 
asthma – used in survey instruments may further hinder cross-study comparisons of 
prevalence estimates.   
2.2.4. Information on Health: Official Records 
 Information on NCDs in India can also be obtained from records compiled by 
agencies such as the Registrar General of India and the National Crime Records Bureau 
in the Ministry of Home Affairs. The Registrar General of India collects information on 
deaths under three different mechanisms: the Civil Registration System (CRS), Medical 
Certification of Causes of Death (MCCD) and the Sample Registration System (SRS). 
The MCCD and the SRS systems (and the latter’s predecessor – the survey of causes of 
death (SCD), rural) are evaluated in Mahapatra and Rao (2001). Comments on the former 
are available in Roy (2003).  
The CRS collects information on a very large number of deaths - roughly of the 
order of 5 million annually. The reporting of births and deaths is, under Indian law 
compulsory, but with an estimated 8 millions annually, the coverage amounts to about 60 
percent of all deaths, so it is not complete. More importantly for our purposes, while the 
registration form for CRS-recorded deaths does provide space for reporting the “cause” 
of death, in practice the cause goes unreported. A large proportion of deaths are recorded 
in the CRS as having either non-specific causes, or none at all, since they often rely on 
self-reports of the person filling out the form. The CRS in its current form, therefore, is 
not particularly useful for the purpose of figuring out the distribution of deaths by cause.     
 The Medical Certification of Causes of Death (MCCD) database typically 
contains information on about 0.5 million deaths that are certified by medical doctors and 
include information on the cause of death. Typically, doctors prepare a report specifying 
the cause of death, using the ICD-10 classification and then forward it to municipal 
authorities, who then provide this information to the Registrar General’s (vital statistics) 
office. Obviously certification by the doctor is preferable to verbal reports, and that is an 
advantage of the MCCD data. However, note that only about 6 to 7 percent of all 
estimated deaths in India were covered by the MCCD in the most recent year for which 
data are available.  Also, Mahapatra and Rao (2001) note that the performance of MCCD 
has been uneven across states, with some states recording a very large number of deaths, 
whereas other states (some with very high populations, e.g., Bihar) tend not to report a 
large number of MCCD deaths. They attribute this occurrence partly to a mix of uneven 
application of the MCCD guidelines across states, across public and private hospitals, and 
rural and urban health facilities. Moreover, they found uneven levels of awareness among 
hospital and municipal staff of the need to transmit medical certification to data to the 
vital statistics department. It is also possible that some categories of deaths are more 
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likely to be certified than others. Traffic injuries are an obvious example, given the 
involvement of the police. Because most of the MCCD data is based on reporting by 
hospitals in urban areas, there is also the potential of disproportionate recording of deaths 
among urban residents.  
 Until 1998, rural deaths were recorded under the survey of causes of death (SCD)-
rural, by the Registrar General of India. The technique was to survey deaths in rural areas 
under the jurisdiction of a sample of primary health centers. A structured questionnaire 
(that also specified symptoms) was used to elicit responses on the cause of death from 
individuals who knew the dead person. The SCD-R was discontinued in 1999 owing to 
its relatively small coverage of deaths in rural areas – about 40 thousand in its most 
recent year (1998). SCD-R had a large proportion of non-specific causes of death (20 to 
28 percent of deaths in the database, a proportion that was double that for MCCD 
recorded deaths) (see also Gajalakshmi 2003). Beginning 1999, the SCD-R was replaced 
by record keeping of rural deaths under the SRS (Sample Registration System) that spans 
both rural and urban deaths. Again deaths were recorded under a verbal autopsy method, 
using the ICD-10 classification of diseases. Roughly 50 thousand deaths are recorded 
each year by the SRS. Published data under the SRS are available under extremely broad 
disease categories making them less than useful for understanding disease-specific causes 
of death. In recent years, the Registrar General of India has begun an large collaborative 
enterprise with the Center for Global Health Research at the University of Toronto (Jha et 
al. 2008) to improve the coverage and validity of cause of death information recorded 
under the SRS. The data are not publicly accessible and could not, therefore, be used in 
this study. 
 A final source of official information that is sometimes useful, particularly for 
collection of data on traffic deaths, other injuries and suicides are the annual reports of 
the National Crime Records Bureau (NCRB). Some Indian researchers believe that 
NCRB data on traffic deaths are very reliable (given the involvement of the law 
enforcement agencies) (communication with professor Dinesh Mohan, Indian Institute of 
Technology, New Delhi). Estimates from the NCRB suggested that more than 80 
thousand deaths occurred due to road traffic injuries in India in 2002. These, however, 
are considerably smaller than the estimates of traffic deaths for India reported in Kopits 
and Cropper (2003) whose estimates are from the Global Burden of Disease study. It has 
to be said that the rationale for the Kopits-Cropper estimates is not obvious, at least when 
one considers the available data on injuries in India. Some support for NCRB road traffic 
death estimates comes from the work of Thomas et al (2004) in Bangalore. Less reliable 
are NCRB estimates on suicides and injuries, particularly among women given the 
widespread concern about dowry-related murders masquerading as suicides. Moreover 
Thomas et al. (2004) show from their Bangalore study that injury/death ratio from traffic 
accidents is much higher than reported in NCRB. 
 All of the administrative data on NCDs suffer from the problem that they cannot 
be matched to economically relevant information at the individual level, or to information 
on health care utilization and spending. Thus these numbers are unlikely to be very 
valuable for undertaking economic impact assessments at the individual and household 
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levels. They may sometimes be useful for carrying aggregate economic impact exercises 
of the kind reported in Leeder et al. (2004) and Abegunde et al. (2007). 
2.2.5. Large Scale Sample Surveys 
 A third major source of information on morbidity and mortality by cause is large-
scale sample surveys undertaken by various organizations. The National Sample Survey 
Organization (NSSO) periodically conducts nationally representative health care 
utilization and expenditure surveys with coverage often exceeding 100 thousand 
households. These surveys include information on self-reported ailments and treatments 
in the 15 days preceding the survey, and hospitalizations in the one year preceding the 
survey. Because the 15-day reference period covers both newly-acquired conditions as 
well as ongoing health problems, in principle it ought to be able to capture not just acute 
conditions, but health problems of a “chronic” nature. Three such surveys have been 
conducted by NSSO over the last two decades, in 1986-87, 1995-96 and 2004.  
Another set of large surveys are the National Family Health Surveys (NFHS I-
III), undertaken in 1992-93, 1998-99 and 2005-6. These surveys are undertaken by the 
International Institute of Population Sciences (IIPS) in Mumbai, in collaboration with 
Macro-International. Because the focus of the NFHS on reproductive health, these 
surveys contain few questions on NCDs, mainly confined to self-reported diabetes and 
asthma. The surveys also not include any questions on health expenditures, limiting their 
usefulness (relative to the NSSO surveys) in assessing economic impacts on households. 
Financing information is also limited. Other surveys, usually undertaken for a limited 
purpose, and typically with smaller sample sizes are undertaken by the National Council 
for Applied Economic Research (NCAER), based in New Delhi. Specifically NCAER 
has undertaken two recent surveys on human development, only one the older version of 
which (undertaken in 1994) the authors were able to access. These surveys sometimes 
contain information on ailments and expenditures, but because of their focus on “human 
development” more generally, a limited set of questions are asked on the nature of 
ailments, health spending and associated financing of health care expenses by 
households.     
 Another sample survey dataset of relevance for our purposes is the World Health 
Survey (WHS) undertaken by the IIPS, with assistance from the World Health 
Organization. The survey covered 6 states (Assam, Karnataka, Maharashtra, Rajasthan, 
Uttar Pradesh and West Bengal), about 11 thousand households, or about 60 thousand 
individuals (Arokiaswamy et al. 2006). The health portion of the questionnaire was 
administered to about 10 thousand individuals aged 18 years and above. This survey, 
while much smaller in size, and confined to only 6 of the 14 major provinces, covers 
many of the same questions as the NSS health care utilization and expenditure surveys, 
some in greater detail. A comparative analysis of WHS surveys is obviously desirable, 
although not pursued in this report.     
Sample surveys where the health condition is self-reported, whether small or 
large, raise obvious concerns. The self-reported nature of ailments is likely to result in the 
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underestimation of the prevalence of different types of health conditions, and there may 
be a misclassification of diseases as well. Moreover, people may be more likely to report 
an ailment if they are aware of it and seek treatment. Individuals may also be unaware of 
a disease that they may have acquired. Murthy and Sastry (2005b) cite a study for 
Mumbai that showed that the ratio of treated to untreated cases of asthma was about 1:7. 
EIU (2007) also cites evidence from Chennai that suggests that in rural areas, diabetes 
cases are likely to go undetected and rural populations do not seek care for diabetes until 
quite late. Cultural taboos may lead to some women revealing their diabetic status in case 
it reduces their chances of finding a spouse. A comparison of Tables 2.1-2.3 which report 
prevalence data for a 15-day reference period in NSSO data with previously reported 
estimates of disease prevalence in the 35 year+ age group reflects these points, 
particularly when one notes that treatment rates in the NSSO sample are in excess of 70 
percent. 
 The above concerns are particularly relevant in the case of psychiatric disorders. 
Gururaj et al. (2005) make the point that mental health has gained recognition in India 
only in recent years as a serious public health problem. With stigma attached to mental ill 
health, a shortage of mental health professionals, and facing a broad set of conditions – 
from mild anxiety states to severe behavioral abnormalities – sample surveys are more 
likely than not to under-record such conditions. Wang et al. (2007) used data from World 
Mental Health Surveys to conclude that very small proportions of people with mental 
disorders sought treatment, particularly in developing countries. Nair et al. (2005) echo 
these concerns, noting that the diagnostic infrastructure for cancer is limited in India, so 
that there will be lots of cases of undiagnosed cancers, especially in rural areas, with only 
advanced cases being diagnosed.   
 On the plus side, large sampling surveys such as those undertaken by the NSSO, 
and the National Family and Health Surveys have the advantage of linking individual 
socioeconomic and demographic characteristics to health conditions, health care 
utilization, expenditures and health financing. Moreover, in the case of NSSO,  it is 
relatively easy to undertake a matching exercise that extrapolates earnings, experience 
and schooling regression results from labor force surveys (also undertaken by the NSSO) 
to the health surveys. The nationally representative nature of the NSSO surveys also 
makes them more attractive (relative to the WHS) when seeking to draw implications for 
India-level outcomes. If we believe that individuals accurately report all of their health 
spending, then our results would capture the financial implications of specific health 
conditions at the household level, even if the overall prevalence levels are downwardly 
biased. In this, sampling surveys have an advantage of simplistic exercises that multiply 
estimated number of cases (using prevalence data) with an indicator of “average” 
treatment costs.    
 One example of a large survey (of 18,000 individuals) that avoided self reporting 
was conducted by Sadikot et al. (2004) as part of the Prevalence of Diabetes in India 
Study (PODIS). According to this survey, the prevalence rate for diabetes mellitus was 
4.3 percent for India as a whole, with the rate for urban areas (5.9 percent) more than 
double that for rural areas (2.7 percent). Because the survey did not include enough 
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corresponding socioeconomic information, the resulting data are unlikely to be 
particularly useful for conducting the type of economic impact analyses that we are 
interested in (assuming we could access the data!). However, carefully conducted surveys 
by clinicians such as this can shed light on the value of information produced by the 
surveys such as those of the National Sample Survey Organization. Thus, NSS data from 
its health care utilization and survey for 2004 assess self-reported diabetes prevalence to 
be 2.1 percent in urban areas and 0.7 percent in rural areas (see Tables 2.1-2.2) for the 
15-day reference period. Although self-reported prevalence rates are much lower than 
those produced by PODIS, it is noteworthy that the estimated ratio of rural to urban 
diabetes prevalence is about the same. Because of the censoring of disease reporting 
common in surveys such as that conducted by the NSSO (usually the major “acute” 
problem is likely to be reported) and low levels of testing for glucose impairment, it is 
not surprising to find self-reported diabetes prevalence lower.      
2.2.6.  Other Data Sources 
 There are a number of other data sources that could potentially be used for an 
economic impact analysis, with varying degrees of accessibility for researchers. For 
instance, the Indian railways and the armed forces maintain detailed information of the 
health status, health care use, days absent from work and socioeconomic and 
demographic characteristics of their service members and their dependents. The highly 
subsidized care provided to employees and their dependents also means that the bulk of 
medical care sought by these employees (and their dependents) is obtained at health 
facilities operated by their respective employers. Data from these organizations has the 
potential to address all of the concerns raised above for various data sources available in 
the Indian context. The size of the study population, likely in excess of 1 million in each 
of the two cases is obviously a plus. Private sector organizations such as the Tata 
Company which operates its own facilities to care for its tea estate employees might be 
another possible source of information. None of these datasets are likely to be easily 
accessible. Claims information from insurance companies is another possibility, although 
in its current form, this will yield information mainly for the better off groups. However, 
as insurance coverage expands in the country, claims data will become an increasingly 
attractive source of health expenditure information, just as in the case of Medicare in the 
United States. 
 Other datasets that are accessible include information from the cancer registries in 
different parts of India. There are two main problems with Indian cancer registry data. 
Firstly, as Nair et al. (2005) point out, a large number of cancer cases present themselves 
in advanced stages of the disease. They highlight the need for establishing cancer 
registries, both in rural and in urban areas, if undercounting is to be avoided (and better 
treatment results achieved). Secondly, we continue to face the problem of being able to 
match cancer cases to health expenses, their financing and socioeconomic characteristics 
of individuals with cancer. 
 Finally, we can rely on estimates published by the WHO for India on its burden of 
disease website. The advantage of using this data is that the mortality estimates are based 
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on the “best possible use” of death statistics available in India and are available by 
disease. The disadvantages possibly are that the data and methods used for arriving at 
disability measures are less transparent, and cannot be readily associated with economic 
outcomes.  
 In the absence of India-specific data, one option is to rely on information from 
neighboring countries. Of course, this would mean that we would no longer be able to 
connect individual economic information with that of their disease status. Examples 
would be a recent study reported in the Lancet (Mannino and Buist 2007) that provides 
estimates of COPD prevalence in China. Similarly, Ghaffar et al. (2004) present, in 
addition to India, estimates of diabetes in neighboring countries (Bangladesh, Sri Lanka, 
Pakistan), which can serve as an approach to address the paucity of data for some 
categories of NCDs. 
2.3. Data Used for the Estimates in this Report 
Given the relative strengths and weaknesses of the different types of data 
available in India, we decided to use a combination of datasets for producing the 
estimates of the economic impacts of NCDs in India in this report. Thus, we relied on 
data from the National Sample Survey health rounds of 1995-96 and 2004, in 
combination with information from the MCCD and the WHO mortality statistics, labor 
force survey data from the NSSO from the 1999-2000 rounds, data on macroeconomic 
variables (government and private investment spending, GDP), and demographic data 
from the Registrar General of India (age-specific death rates, population age distribution) 
to estimate the economic impact of NCDs on India. Further details on these datasets will 
be provided in later chapters. 
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Table 2.1:  Prevalence (per 100) of Selected NCD Ailments, in the Rural Indian Population 
35 years and over (15-day reference period), 2004 
 
 
Income 
Quintile 
 
CVD 
 
Respiratory 
Conditions 
(incl. 
asthma) 
 
Diabetes 
 
Accidents 
& Injuries 
 
Cancer 
 
All 
NCDs 
 
Non-
NCDs 
 
Bottom 
20% 
 
 
0.44 
 
1.04 
 
0.17 
 
0.34 
 
0.08 
 
3.52 
 
7.91 
 
II 
 
 
0.78 
 
1.43 
 
0.29 
 
0.26 
 
0.04 
 
4.75 
 
7.94 
 
Middle 
20% 
 
 
1.00 
 
1.55 
 
0.32 
 
0.43 
 
0.11 
 
5.74 
 
9.42 
 
IV 
 
 
1.54 
 
2.27 
 
0.69 
 
0.35 
 
0.12 
 
7.38 
 
9.43 
 
Richest 
20% 
 
 
3.71 
 
2.43 
 
1.84 
 
0.53 
 
0.22 
 
12.70 
 
11.37 
 
All 
Groups 
 
 
1.49 
 
1.73 
 
0.66 
 
0.39 
 
0.11 
 
6.79 
 
9.22 
Source: Authors’ estimates, using NSS health care utilization and expenditure data from the 60th 
round, conducted in 2004. 
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Table 2.2:  Prevalence (per 100) of Selected NCD Ailments, in the Urban Population 35 
years and over (15-day reference period), 2004 
 
Income 
Quintile 
 
CVD 
 
Respiratory 
Conditions 
(incl. 
asthma) 
 
Diabetes 
 
Accidents 
& Injuries 
 
Cancer 
 
All 
NCDs 
 
Non-
NCDs 
 
Bottom 
20% 
 
 
1.96 
 
1.48 
 
0.89 
 
0.54 
 
0.15 
 
7.05 
 
8.13 
 
II 
 
 
2.64 
 
1.97 
 
1.18 
 
0.44 
 
0.18 
 
9.23 
 
7.69 
 
Middle 
20% 
 
 
3.89 
 
1.30 
 
1.89 
 
0.34 
 
0.10 
 
10.72 
 
6.98 
 
IV 
 
 
6.61 
 
1.95 
 
 
3.05 
 
0.39 
 
0.12 
 
15.04 
 
7.50 
 
Richest 
20% 
 
 
7.35 
 
1.71 
 
4.14 
 
0.29 
 
0.25 
 
17.18 
 
7.76 
 
All 
Groups 
 
 
4.32 
 
1.67 
 
2.05 
 
0.40 
 
0.16 
 
11.58 
 
7.61 
Source: Authors’ estimates, using NSS health care utilization and expenditure data from the 60th 
round, conducted in 2004. 
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Table 2.3: Prevalence (per 100) of Selected NCD Ailments, in the Indian Population 35 
years and over (15-day reference period), 2004 
 
Income 
Quintile 
 
CVD 
 
Respiratory 
Conditions 
(incl. 
asthma) 
 
Diabetes 
 
Accidents 
& Injuries 
 
Cancer 
 
All 
NCDs 
 
Non-
NCDs 
 
Bottom 
20% 
 
 
0.85 
 
1.16 
 
0.36 
 
0.40 
 
0.10 
 
4.46 
 
7.97 
 
II 
 
 
1.33 
 
1.59 
 
0.55 
 
0.32 
 
0.08 
 
6.07 
 
7.87 
 
Middle 
20% 
 
 
1.80 
 
1.48 
 
0.75 
 
0.41 
 
0.10 
 
7.11 
 
8.74 
 
IV 
 
 
2.70 
 
2.19 
 
1.23 
 
0.36 
 
0.12 
 
9.13 
 
8.99 
 
Richest 
20% 
 
 
4.70 
 
2.24 
 
2.46 
 
0.46 
 
0.23 
 
13.91 
 
10.39 
 
All 
Groups 
 
 
2.25 
 
1.71 
 
1.06 
 
0.39 
 
0.13 
 
8.08 
 
8.78 
Source: Authors’ estimates, using NSS health care utilization and expenditure data from the 60th 
round, conducted in 2004. 
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C H A PT E R  3. H E A L T H  SPE NDI NG  ON NC DS, F I NA NC I NG   
A ND H OUSE H OL D I M PA C T S 
 
3.1. Introduction 
This chapter has 3 main objectives. First, we seek to estimate the annual medical 
care expenses incurred in the treatment of NCDs in India. As we shall see, the results in 
the chapter point to a significant annual economic “burden” resulting from medical care 
of NCDs in India, whether evaluated in absolute Rupee terms, or taken as a proportion of 
GDP. Moreover, these expenditure estimates are broadly in line with estimates produced 
for India, China, and other developing countries in Asia that have been used by scholars 
to argue for increased efforts to prevent NCDs. Second, we inquire how these expenses 
are financed, including out of pocket spending by affected households, support from 
family and friends, the government and insurance. Limited insurance coverage and lack 
of social safety nets leads households in India to undertake high levels of out of pocket 
spending that are not reimbursed from other sources. Third, we explore the implications 
of the current patterns of financing health spending for NCDs. Specifically, high levels of 
out of pocket expenditures exposes households to increased risks of catastrophic levels of 
spending, which we measure using the methods of Xu et al. (2003). We conclude by 
undertaking an exercise similar to that of Doorslaer et al. (2006) who estimated poverty 
rates using consumption expenditures, both gross and net of health spending. This 
difference has been interpreted by some authors as the ‘impact’ of health spending on 
poverty.   
3.2. Data and Methods 
The calculations reported in this chapter are based on data from several sources. 
Firstly, information on health care utilization and out of pocket health spending by 
disease category was derived from the 52nd and the 60th rounds of health care utilization 
and expenditure surveys of the National Sample Survey Organization (NSSO) conducted 
in 1995-96 and 2004, respectively. In addition to information on patterns of health care 
utilization and expenditures incurred on treatment, the surveys also collected household-
level information on the way health expenses were financed, whether from borrowing, 
own resources, community support, or asset sales; and whether any of these expenses 
were reimbursed by employers or insurance companies. The 1995-96 survey covered 
nearly 120 thousand households, or 600 thousand individuals. The 2004 survey covered 
nearly 80 thousand households and some 380 thousand individuals. The 1995-96 survey 
was carried out, on a rolling basis, throughout India over a period of 12 months, to help 
address seasonal shifts in ailments and health care use. In contrast, the 2004 survey was 
undertaken over a six-month period, from January to June. To the extent that seasonal 
variations are important, results from the two surveys are not readily comparable.3
                                                 
3Because these are stratified random sample surveys, all our estimates are derived by applying sampling 
weights supplied by the NSSO (National Sample Survey Organization). Even after applying these weights, 
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 The NSSO survey data on health care utilization and financing were 
supplemented by information on financing from a recently undertaken National Health 
Accounts (NHA) analysis for India (Mahal et al. 2005), and from public spending data in 
the health sector from the ‘demand for grants’ in the central and state government 
budgets of India for the corresponding years. 
Methods 
We used the household health surveys of 1995-96 and 2004 to first assess 
healthcare utilization patterns by type of NCD. For each category of NCD for which 
information was available in the survey data, we inquired about public and private health 
care use, days spent as an inpatient in health facilities, and the number of outpatient 
visits. Data on hospitalizations (and associated conditions) were available for a one-year 
reference period to capture the relative rarity of hospitalization events. In addition, data 
on reported illnesses (and associated treatments) was collected using a 15-day reference 
period preceding the survey. Utilization over the 15-day reference period was multiplied 
by 24.33 to obtain an annualized counterpart to hospitalizations (after netting out any 
hospitalizations reported in the 15-day reference period).  
In trying to match diseases (under the NCD category) with health care utilization, 
we found that the list of health conditions provided for in the household health care 
utilization and expenditure surveys was smaller (and aggregated) than say, disease 
categories available in the ICD-9, or ICD-10 classification of health conditions. The 
survey data, being self-reported, are also likely subject to classification error, recall 
problems and so forth as noted in Chapter 2. Specifically, given the rather broad scope of 
the health conditions classified in the survey, there is a risk of classification bias in that 
some constituent diseases end up being reported as belonging to a specific health 
category, whereas they might properly belong elsewhere. It is also possible that specific 
NCD and non-NCD conditions end up being reported under other headings by 
respondents. To consider a specific example, consider the category, “respiratory 
conditions, including ear/nose/throat ailments” (disease code = 08) used in the 2004 
survey. Because only two under respiratory conditions are separately identified: namely, 
asthma and tuberculosis, it is very possible that several childhood respiratory infections 
end up being included in the same category as say, COPD (chronic obstructive 
pulmonary disease), the latter being an NCD. Similarly, CVD included only two 
categories: “heart disease” and “hypertension”. There appears to be no obvious slot for 
acute conditions such as “cerebral stroke,” except perhaps in the category “neurological 
disorders.” But there is no way to be sure, since we have no information on the health 
conditions covered under these categories. About 10 percent of the health conditions 
could not be identified by the respondents in the survey. These difficulties aside, we 
matched the disease categories in the sample survey to the ICD-9 classification of 
                                                                                                                                                 
we found that total population estimates produced by the survey were an underestimate for India’s 
population as a whole for the corresponding years. For this reason, our estimates in this study were 
constructed by adjusting (scaling up) sample weights using the interpolated census population data for 
1995-96 and 2004. 
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diseases to distinguish between NCDs and other conditions. Table 3.1 describes the 
classification system (into NCDs and non-NCDs) we adopted vis-à-vis the 2004 health 
survey health condition categories. Because injuries are usually not considered part of 
NCDs, we present some our calculations for NCDs for two settings: a definition that 
includes NCDs and another that excludes injuries. 
This exercise will, of course, exclude conditions not adequately described in the 
health care utilization and expenditure survey, or conditions that go unreported. In this 
circumstance, there are at least three cases that merit consideration. Firstly, a health 
condition may have been experienced by an individual and care is sought, but the 
individual fails to report it in the survey. Secondly, the health condition may exist and the 
person does not report it, but s/he does not seek health care for it. Finally, the condition 
may exist and the person reports it, but s/he does not seek treatment from some health 
care provider.   
Allowing for the first of the three possibilities would imply that our survey-based 
estimate of utilization (when multiplied by estimates of health spending) cannot be used 
to arrive at national-level aggregates of NCD health spending. Rather, we will need to 
combine per-case expenditure by NCD with (upwardly adjusted) estimates of overall
 If, on the other hand, a respondent underreports an ailment but does not seek care 
either, there is no effect on direct spending on health care. In this respect, this case is no 
different from the third scenario where the condition is actually reported but no treatment 
is sought. To be sure, we would have underestimates of specific health conditions in the 
population at large as noted in Chapter 2. That, in turn, may influence estimates of 
“indirect costs”, income losses and so forth. But that is a separate problem which we 
partially address in Chapter 4 by obtaining additional disease-specific mortality 
information from other sources. For the remainder of this chapter, we will assume that if 
there is mismatch between what we call “NSS survey-based” estimates of health 
conditions and estimates obtained from independently obtained epidemiological data, the 
individual 
 
health care use from “other” sources. This, to us, sounds unrealistic, since there are no 
other nationally representative sources that link the reporting of health conditions to 
health care use. The alternatives are unreliable administrative data from government 
annual reports for public hospitals, or data from small-scale surveys conducted in specific 
states/regions of India, as seen in Chapter 2. Indeed a future project might aim to assess 
consistency between nationally representative surveys such as those of the NSSO and 
information available from more intensive local studies. There is also the worry that 
health expenditure estimates revised in this manner will no longer be consistent with 
separately assessed national health accounts estimates based on consumer expenditure 
surveys. In addition, underreporting of such cases may have resulted because treatment 
costs were small. ‘Adjusting’ for costs in the manner outlined above would then amount 
to overestimating the true costs of treatment. 
did not seek care
 Out of pocket spending is not the only source of health financing in India. 
Considerable amounts are also spent by governments in India, at the central and state 
 for the conditions so omitted.   
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levels, on public facilities that provide subsidized care. On a smaller scale, employers, 
both in the public and private sector, often reimburse employees for expenses incurred. 
Some large employers, such as the Indian Railways, the Indian armed forces, and the 
Tata Steel Company, also operate their own medical facilities that provide free care to 
their patients. That said, the bulk of the health sector spending in India is financed by out 
of pocket expenses and the government via its provision of subsidized public facilities 
(Mahal et al. 2005). Thus, we will focus primarily on only these two sources of financing 
health, referring to other funding sources when appropriate.      
Estimating Public Subsidies by Health Condition 
It is not straightforward to estimate the public subsidy component of health care 
spending on NCDs. Because public expenditures occur at both the central and state levels 
we will need to add the expenditures by both sets of entities to arrive at the overall 
magnitude of subsidies. Further break-down of subsidies by disease is complicated by the 
fact that there are no studies we are aware of that cost out health care provision for 
different diseases, and none in any case, that are nationally representative. At the very 
least, we need assumptions on the relative magnitude of public subsidies on inpatient 
days and outpatient visits across diseases. The assumptions are necessary because there is 
no reason to believe that the two types of health service utilization cost the same at a 
public facility; and also because the intensity of care varies by disease.  
Our best source of information to help formulate realistic assumptions for 
estimating public subsidies came from out of pocket payments incurred on private care. 
Because health insurance in India is practically non-existent, household expenditures on 
inpatient days and outpatient visits could be used as indicators of the relative expense of 
the two components of health care use (inclusive of associated expenses for diagnostic 
tests, drugs, consultations and so forth). This ratio was 4.5 on average for out of pocket 
expenses incurred for non-NCD health conditions. Moreover, an examination of out of 
pocket expense data on outpatient visit and inpatient day expenses for NCDs at private 
facilities suggests that the median ratios across the different health conditions that 
comprise NCDs are about the same as for non-NCDs. Thus we took the public subsidy 
per inpatient day at a public facility to be about 4.5 times the public subsidy on an 
outpatient visit, conditional on a specific disease. However, the amount of public subsidy 
varies by health condition because of disease-specific variation in the average number of 
inpatient days and outpatient visits.  
Financing of Health Services for NCDs 
Public subsidies are an important way in which health care expenses for NCDs 
are financed in India. Specifically, in the case of NCD-related health services provided by 
public facilities, the primary source of funds is general taxation, and only a negligible 
share accounted for by user charges. However, households burden a considerable 
financial burden in the form of out of pocket expenses for treating NCDs both because 
public services themselves are limited, and because of the relative absence of other forms 
of insurance coverage.  
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In trying to describe the different ways in which households finance their out of 
pocket spending on health care for NCDs (or other health expenditures), we faced a 
difficulty in that health financing information by source in the 2004 NSSO survey was 
available only at the household, and not the individual, level. Thus, if members of a 
single household experienced several episodes of illness and associated expenditures for 
treatment, we would have no obvious way of knowing how they separately financed each 
treatment. If our concern is with how households finance their overall health 
expenditures, there is obviously no problem. However, given our interest in how 
households finance NCDs, we needed some way of relating the pattern of financing to a 
specific health condition (and treatment). For this purpose, we made the assumption that 
the description of the way households financed their health spending in the survey 
corresponds most closely to the treatment (and the associated health condition) that the 
households spent the most money on. In contrast, information on the sources of financing 
for out of pocket spending on health in the 1995-96 survey was collected at the individual 
level, by episode of illness, lending itself to more straightforward calculation.  
We also analyzed how the burden of health financing in general (and specially 
expenditures on NCDs) differed across different socioeconomic groups. For this purpose, 
we divided the population into 5 groups (quintiles) ranked by per capita household 
expenditure (sample weights were used to construct quintiles) and assessed how health 
spending (per capita and as a proportion of mean expenditure) varied across quintiles, 
separately for rural and urban populations.   
Catastrophic Spending and Impoverishment Among Households 
Following Xu et al. (2003) and Doorslaer et al. (2006, 2007), we considered two
jD
 
measures of the impact of health spending on NCDs on the economic situation of 
households. The first is an indicator of the contribution of health spending on NCD-
related hospitalization to “catastrophic” expenses incurred by households. Here 
“catastrophic” spending is defined as occurring when health expenditure on 
hospitalization for a given household exceeds a certain proportion of a suitably defined 
measure of ability to pay: household consumption spending less combined survival 
income for all household members. We used a threshold of 30 percent for our analysis, 
although other cut-offs are obviously possible. Survival income was defined as the 
poverty line level of expenditure multiplied by household size. Mathematically, for each 
household “j”, we defined a variable  as 
PnE
h
D
jj
j
j −
=  
Here, jh is the combined health spending on all hospitalizations for household “j”,
jE is total household consumption spending, jn is the size of household “j”, and P is the 
poverty line level of spending. Catastrophic spending is said to occur whenever jD
exceeds 0.3 in our framework. We assessed the contribution of NCDs to catastrophic 
spending of households by estimating the following equation in a logit model: 
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Here jC is a dummy variable indicating whether the household incurred catastrophic 
spending, ijNCD is a dummy variable indicating the presence of major NCDs of type “i” 
in household “j” and jX refers to a collection of other characteristics of household “j”. 
Our second measure indicated whether health spending would be impoverishing, 
all else the same. Specifically, we considered (total) hospitalization spending as 
impoverishing if, after subtracting it from total household spending, a household would 
fall below the poverty line (more formally, per capita expenditure within the household 
falls below the poverty line). Thus, consider household “j” and a variable indicating total 
household spending jE where
j
j
j
b
n
E
E = indicates the household’s per capita spending 
(gross of health spending). Let
j
jj
j
a
n
hE
E
−
= as per capita household spending after 
deducting total hospitalization spending.  
If PE jb > and PE ja < if , we say that the health expenses of this household are 
impoverishing
We assessed the contribution of NCDs to impoverishment among households by 
estimating the following equation in a logit model: 
. Of course, modeling the poverty impact in the manner of the previous 
paragraph requires the assumption that there are no economies of scale in the allocation 
of household spending. Incorporating such considerations, by using equivalence scales, 
such as in Xu et al. (2003), or as in Doorslaer et al. (2006, 2007), is straightforward.  
More tricky is the assertion (that the impoverishing impact suggests) that household 
expenditure would have remained unchanged in the counterfactual situation where no ill 
health occurred in the household. In general, this claim is difficult to defend and our 
findings relating to the impoverishing impact of NCDs are subject the appropriate 
caveats.    
 
∑
=
+++=
K
i
jjjijij XNCDI
1
εθβα  
Here jI is a dummy variable indicating whether health care resulted in household 
impoverishment, ijNCD is a dummy variable indicating the presence of major NCDs of 
type “i” in household “j” and jX refers to other household characteristics used as 
controls.  
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3.3. Findings and Discussion 
We first assessed the utilization of health services in India. Table 3.1 reports 
estimates of the total number of hospital stays, days spent in hospitals, the average length 
of a hospital stay and the total number of outpatient visits in 2004 and 1995-96. We 
found that among individuals who reported visiting a health care provider in the reference 
period of 15 days, one visit was the norm. This does not, of course, imply that the during 
an illness episode an individual visits an outpatient provider just once. Episodes may 
have a length exceeding the 15-day period, in which case more than one outpatient visit 
may result. There was no way, however, of capturing this information in the survey, and 
in any event our interest lies in estimating the aggregate annual number of outpatient 
patients. This we did by multiplying the number of visits reported in the 15-day reference 
period by 24.33 (= 365/15).  
From Table 3.1, we see that were nearly 2.5 billion outpatient visits and 30.6 
million hospital stays in the year 2004. These numbers are considerably greater than 
similar categories for the 1995-96 survey, which indicates a rapid increase in health care 
service utilization. Another plausible scenario is that the differing utilization reflects 
differences in the survey methodologies used, although it is probably not sufficient to 
account for the entire difference over the two survey years. NCDs accounted for nearly 
40 percent of all hospital stays and 35 percent of all outpatient visits in 2004; in 1995-96 
the corresponding proportions were 32 percent and 22 percent, respectively. The average 
length of hospital stay for NCDs is higher than for other health conditions, suggesting a 
greater intensity of care received by patients admitted under the former category. Heart 
disease and accidents and injuries were the two most important reasons for hospital stays. 
Other noteworthy conditions in this respect were kidney/urinary conditions, respiratory 
problems and cancers. Hospital stays and outpatient visits due to diabetes, respiratory 
conditions and injuries increased rapidly between 1995-96 and 2004.  
Table 3.2 reports results on the relative share of public and private sectors in 
health care utilization, by health condition, from the two household surveys. The private 
sector accounted for about 59 percent of all hospital stays in 2004, slightly higher than in 
1995-96; and for 82 percent of all outpatient visits, slightly lower than in 1995-96.  
Overall, these data confirm the important role that the private sector plays in the 
provision of health services in India. The proportion on inpatient stays in the public (or 
private) sector did not vary much by the broad categories of NCD and non-NCD; but the 
share of the public sector in outpatient visits was higher for NCDs than for the non-NCD 
categories. Within NCDs, the share of the public sector hospital stays was highest for 
cancers, accidents and injuries, respiratory conditions and psychiatric care. This is easily 
rationalized for accidents and injuries given that private providers tend to avoid “police-
cases” and emergencies associated with traffic injuries, suicides, female burn injuries, 
and the like. Most psychiatric wards in India are provided in the public sector, so that too 
is not a surprise. Moreover, the high cost of treating cancer may result in individuals 
treating public facilities as providers of the last resort. Average lengths of stay fell 
between 1995-96 and 2004, in both the public and private sectors, possibly reflecting 
higher costs of treatment, more efficient interventions, or some combination of the two.   
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In Tables 3.3 and 3.4 we present information on out of pocket expenditures 
incurred for treatment of health conditions by Indians in the years 1995-96 and 2004. 
Indians spent nearly INR 846 billion out of pocket on health care expenses in the year 
2004, amounting to nearly 3.3 percent of India’s GDP in that year. This marked a 
substantial increase (in current Indian Rupees) from INR 315 billion spent out of pocket 
on health care in the year 1995-96 (about 2.9 percent of India’s GDP in 1995-96). The 
data in Tables 3.3 and 3.4 also show that the share of NCDs in out of pocket health 
expenses incurred by households increased over time, from 31.6 percent in 1995-96 to 
47.3 percent in 2004. That would indicate growing importance of NCDs in India in terms 
of their financial impact on households (and the underlying disease burden).  
Some other findings are noteworthy as well. Out of pocket expenses on care 
obtained at public facilities per unit of health care utilization (a single hospital stay, a 
single hospital day, or an outpatient visit), are less than expenses incurred on comparable 
units of utilization at private facilities. All else the same, that would point towards public 
facilities at least playing some role in providing Indian households financial risk 
protection from ill health, whether from health conditions of the NCD, or of the non-
NCD, variety. Nonetheless NCDs do impose a greater burden on out of pocket 
expenditures than other health conditions. Our data for 1995-96 and 2004 show that the 
out of pocket expense for a single hospital stay for an NCD was nearly double that of 
other health conditions; and expenses incurred per hospital day were between 30 percent 
and 50 percent higher in a private than in a public health facility. The differences in out 
of pocket expenses incurred on NCD and non-NCD conditions are less marked for 
outpatient visits but nonetheless exist, with visits for NCD being 15 to 50 percent more 
expensive than non-NCD visits. The difference of per episode cost of treatment between 
public and private facilities is sharper if expenses on drugs and medicines are taken out of 
consideration, although we do not present those findings here. Within the category of 
NCDs, out of pocket expenses per unit of utilization are particularly high for cancer, heart 
disease, accidents and injuries and kidney/urinary conditions.  
Components of Out-of-Pocket Expenses  
 In order to evaluate the relative importance of different items of out of pocket 
expenditure on health care, we present information on expenditure sub-categories from 
the 2004 sample survey of the NSSO. Analogous information is not available from the 
1995-96 survey.  
 As can be observed from Table 3.5 more than one-half of the out-of-pocket 
expenses on health care are incurred on purchases of medicines, diagnostic tests and 
medical appliances. The proportions are more or less the same across broad groups of 
NCDs and other health conditions. A major chunk of overall out of pocket health 
spending (in excess of 45 percent) is on medicines and this proportion is as high as 64 
percent and 58 percent for cases of hypertension and diabetes, respectively. In general, 
consultation fees account for between 5 to 12 percent of total out-of-pocket expenses, 
irrespective of whether the patients has an NCD, or not.  
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 The data on the components of health spending highlight the key role of drug 
expenditures as a major source of household economic difficulty. With even users of 
public health facilities being forced to rely on their own resources for purchasing drugs in 
recent years (Garg and Karan 2008), the issue of access to drugs will acquire increasing 
significance in India in future years.  
Public Subsidies on Health Care: NCDs and Other Health Conditions 
Table 3.6 presents our estimates of public subsidies “allocated” to the treatment of 
different categories of NCDs as well as for other health conditions. These subsidies were 
calculated by estimating the cost to the government per day spent as an inpatient at a 
public hospital (by NCD type) and the cost per outpatient day at a public facility.  
In the year 2003-4, governments in India at the central and state levels spent a 
total of nearly INR 220 billion. We excluded local governments who typically account 
for only up to 5 percent of all government spending, a situation that has persisted even 
after recent reforms towards decentralization (Mahal et al. 2005). Our estimates of public 
subsidies to different health conditions are reported in Table 3.6. Given that accidents, 
cancers, kidney/urinary conditions and injuries are easily the most expensive of the 
conditions treated in the private sector, it is not surprising that subsidies per unit of care 
as well as the total amounts of subsidies allocated to these conditions are also large. Note, 
however, that taken as a proportion of total out of pocket spending, government subsidies 
are rather small, irrespective of the health condition considered. This leaves the average 
Indian household vulnerable to considerable risk from the financial implications of 
illness. 
Financing and Vulnerability to NCD Risk Among Indian Households 
National Health Accounts analyses show that the overwhelming contribution to 
health financing in India comes from two sources: the government, through its provision 
of subsidized medical services (about 20 percent of all spending), and the households, via 
out of pocket expenses (about 72 percent of all spending). Contributions by private and 
social insurers are quite small thus far in India. Only about 4 percent to 5 percent of 
health financing comes from employers and insurers via reimbursements for expenditures 
already incurred (Mahal et al. 2005).  
Information on how households financed their out of pocket spending on health is 
available from the NSSO survey data for 1995-96 and 2004. However, using this 
information required care and moreover, response categories in the two surveys were 
different, making inter-temporal comparisons difficult. For the 2004 survey, we explored 
responses to questions on how households financed their health expenditures with the 
options being: income/saving, borrowing, contribution from friends & family and other 
sources. The last category primarily covered the sale of assets such as jewelry, draught 
animals and other physical assets. Because the information on the way health 
expenditures were financed was available only for the household (and not at the 
individual level), matching the pattern of financing to a specific disease required an 
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additional adjustment to address the possibility that a household incurred expenditures on 
two or more (and different) health conditions in the reference period. Specifically, we 
assumed that the pattern of financing reflected the health condition on which the 
household incurred the most expenditure in the reference period. Information on 
expenditures that were reimbursed by employers and insurance companies was obtained 
from responses to another question in the survey. The 1995-96 survey did not include any 
information on the contributions by friends and family but instead included 
reimbursement as a separate response category alongside sales of assets, borrowing and 
financing from income/savings. For this reason, any comparisons across the two surveys 
related to the financing of health spending must be undertaken with caution. 
Tables 3.7 and 3.8 present our results, by source of financing, for 2004, and for 
1995-96, respectively for expenses incurred for inpatient care. In both years, own savings 
and income turned out to be the most important source of financing for many health 
conditions (typically between 40-60 percent of all spending).  In 2004, about 10-15 
percent of financial resources were provided by friends and family, a form of community 
insurance. The share of reimbursement in 1995-96 amounted to only about 5-6 percent of 
all NCD-related out of pocket health spending for hospitalization. Data (not presented 
here) from the 2004 NSSO survey also provide a similar estimate of reimbursements 
from employers and insurance companies – about 6 percent – for out of pocket spending 
on inpatient care. However, it can be seen that a large number of individuals rely upon 
“borrowing,” presumably with (or without) a collateral, and potentially interest payments. 
Some of the more expensive to treat health conditions (CVD, cancers, accidents and 
injuries, and neurological disorders) also involve larger shares of financing from the 
“other” category in 2004, primarily via the sale of assets. Overall, the evidence supports 
significant household financial vulnerability arising from poor health in India, be it NCDs 
or other health conditions.   
Another way to inquire about the extent to which households are financially 
vulnerable to NCDs is to assess how large the costs of hospitalization for health 
conditions that comprise NCD are, relative to income (or total consumption spending). In 
the year 2004, for instance, India’s income per capita was INR 25,320. It is worth noting 
that a single hospital stay for cancer (or heart disease) would have accounted for 
anywhere between 80 percent and 90 percent of this income if health care were to be 
obtained from private providers. Even if health care was sought at a public facility, the 
expenses out of pocket would still have amounted to between 40 percent and 50 percent 
of per capita income. Yip and Mahal (2008) have further shown that the bite out of 
income per capita taken out by a single hospitalization event increased sharply between 
1995-96 and 2004 for the poorest individuals.  
In Tables 3.9-3.11 we present statistics on per capita health spending incurred on 
NCDs and other health conditions, ranked by household expenditure quintiles, our 
indicator of economic status. We use this information to inquire how out of pocket health 
spending varies by economic status. Note from Tables 3.9-3.11 that total out of pocket 
health spending, taken as a proportion of per capita household expenditure, does not vary 
much across the quintiles, whether we look at the sample population as a whole, or break 
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it down into rural and urban populations. Note also that urban populations tend to allocate 
a greater share of their (out of pocket) health expenses on NCDs, compared to their rural 
counterparts. Moreover, the share of NCD expenditures as a proportion of total household 
expenditure is rising from poorest to the richest groups. This is in contrast to the situation 
of expenditures on other (non-NCD) health conditions, whose share in household total 
expenditures either remains unchanged across expenditure quintiles (rural), or declines 
with economic well being (urban). 
At first sight, our findings would appear to go against the idea that NCDs are 
creating a financial burden on the poor (for instance, Ghaffar et al. 2004). However, 
because individuals belonging to the lowest expenditure quintile live much closer to the 
survival threshold, allocating even smaller proportions of income is likely to increase 
their likelihood to falling below the poverty line. Living so close to the survival threshold 
also means that in many cases they forgo needed care. Thus, while communicable disease 
mortality and morbidity mostly explain the high share of non-NCD out of pocket health 
spending among the less well off, another part of the explanation (low proportion of 
spending on NCD in the bottom quintiles) may lie in the expense of seeking treatment for 
NCD. This suggests looking at other monetary indicators of the financial burden suffered 
by households on NCDs, such as income losses or premature mortality. 
Catastrophic Expenditures and Medical Impoverishment on Account of NCDs  
 Previously we highlighted the potential financial risks that NCDs are likely to 
impose on households. Here we address this issue more formally by inquiring about the 
degree to which different categories of NCDs influence household risk of catastrophic 
spending and impoverishment. Table 3.12 presents the results of simple logit regressions 
of indicators of household catastrophic spending and medical impoverishment on disease 
categories that comprise NCDs and non-NCDs. The results indicate that the odds of 
incurring catastrophic hospitalization expenditures are nearly 160 percent higher with 
cancer than the odds of incurring catastrophic spending when hospitalization is due to a 
communicable condition. By comparison, the odds of incurring catastrophic hospital 
spending due to CVD or injuries are about 30 percent greater compared to communicable 
conditions that result in hospital stays. The odds of incurring catastrophic spending when 
the hospitalization is due to cancer are nearly double compared to accidents and CVD. 
Our results are essentially unchanged when the focus is on the risks of impoverishment 
associated with health spending with cancer greatly increasing the likelihood of falling 
into poverty.  
Concluding Remarks 
This chapter has focused on health spending associated with NCDs in India, the 
way such spending is financed in India, and the potential implications for the financial 
risks to which Indians are exposed. We find that out of pocket expenses for treating 
health conditions categorized as NCD have risen sharply over the period from 1995-96 to 
2004. Non-communicable diseases generally cost more than non-NCD to treat and so 
imply a higher financial risk burden on affected individuals and households, all else the 
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same in the absence of insurance. Unfortunately, social and private insurance, as well as 
de facto risk coverage provided by Indian governments at the central and state levels in 
the form of subsidized public health facilities is limited. Nearly three-quarters of health 
expenditures on NCD are likely to be borne by households. The survey data suggest that 
about 40 percent of these expenditures are financed by household borrowing and sales of 
assets which appears to indicate significant levels of financial vulnerability to NCD (or 
non-NCD health conditions). Cancers appear to be a major factor in households incurring 
catastrophic levels of health spending and falling into poverty. 
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Figure 3.1 Classifying the 2004 Household Survey Response Categories into Communicable, 
Non-Communicable and Other Categories 
 
 
I. Communicable Conditions/Childhood Diseases 
 
• Diarrhea/Dysentery, Gastritis/peptic ulcer, worm infestation, Amoeboisis, 
Hepatitis/Jaundice  
• Malaria, Mumps, Diphtheria, Whooping Cough, Fever of Unknown Origin 
• Tetanus 
• Filariasis 
• Diseases of the skin,  
• Gynecological disorders 
• Under-nutrition, anemia 
• Sexually transmitted diseases 
• Respiratory (including ear/nose/throat) ailments for ages < 15 years 
• Tuberculosis 
 
II. Non-Communicable Conditions 
 
• Heart disease, hypertension 
• Bronchial asthma 
• Respiratory (including ear/nose/throat) ailments for ages > 15 years 
• Disorders of joints and bones 
• Diseases of the kidney/Urinary system 
• Neurological disorders 
• Psychiatric disorders 
• Diabetes 
• Cancers and other tumors 
• Accidents/injuries/burns/fractures/poisoning 
 
III. Other Conditions/Disabilities 
• Goiter 
• Eye ailments (cataract, glaucoma, conjunctivitis) 
• Diseases of the mouth, teeth and gum 
• Disabilities: locomotor, visual, speech hearing 
• Other undiagnosed ailments 
 
Note: We classified the age-category for respiratory ailments to get around the problem 
of confusing childhood conditions with conditions such as COPD.  
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Table 3.1: Hospital Stays and Outpatient Visits in India, 1995-96 and 2004, By Disease 
 
Disease 
1995-96 2004 
Hospital 
Stays 
(millions) 
Average 
Stay (days) 
Hospital 
Days 
(millions) 
OP Visits 
(millions) 
Hospital 
Stays 
(millions) 
Average 
Stay (days) 
Hospital 
Days 
(millions) 
OP Visits 
(millions) 
 
Heart Disease 
 
0.734 
 
11.8 
 
8.683 
 
18.846 
 
1.664 
 
9.9 
 
16.443 
 
67.602 
 
Hypertension 
 
0.304 
 
12.4 
 
3.757 
 
26.188 
 
0.689 
 
6.8 
 
4.685 
 
129.846 
 
Other Respiratory 
 
0.303 
 
9.5 
 
2.885 
 
17.900 
 
1.015 
 
6.9 
 
6.970 
 
177.117 
 
Asthma 
 
0.381 
 
8.1 
 
3.095 
 
84.311 
 
1.009 
 
8.4 
 
8.512 
 
90.640 
Joints & Pain 0.423 20.4 8.621 51.622 0.765 12.7 9.669 163.802 
 
Kidney/Urinary 
 
0.507 
 
14.7 
 
7.468 
 
10.013 
 
1.365 
 
9.7 
 
13.211 
 
27.636 
 
Neurological 
 
0.267 
 
17.6 
 
4.701 
 
12.102 
 
0.986 
 
12.3 
 
11.876 
 
50.714 
Psychiatric 0.154 36.5 5.637 7.604 0.267 15.3 4.077 16.903 
 
Diabetes 
 
0.158 
 
15.1 
 
2.381 
 
18.204 
 
0.598 
 
9.9 
 
5.931 
 
88.831 
 
Accidents/Injury 
 
1.085 
 
13.9 
 
15.052 
 
26.656 
 
2.962 
 
12.6 
 
37.398 
 
67.215 
 
Cancer 
 
0.442 
 
26.4 
 
11.661 
 
6.066 
 
0.898 
 
15.0 
 
13.432 
 
13.372 
 
NCD 
 
4.757 
 
15.5 
 
73.940 
 
279.513 
 
12.200 
 
10.8 
 
132.204 
 
893.677 
NCD  
(no injuries) 
 
3.672 
 
16.0 
 
58.888 
 
252.857 
 
9.238 
 
10.3 
 
94.806 
 
826.462 
 
Non-NCD 
 
10.454 
 
10.4 
 
109.133 
 
1,014.538 
 
18.382 
 
8.1 
 
148.479 
 
1,636.053 
Total 15.211 2.1 183.885 1,294.230 30.582 9.2 280.684 2,529.730 
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Table 3.2: Health Care Utilization in the Public and Private Sectors in India, 1995-96 and 2004, By Disease 
 
Disease 
1995-96 2004 
Public Sector 
(%) Share 
Hospital 
Stays 
Public Sector 
(%) Share 
OP Visits 
Average 
Hosp Stay 
(Public 
Sector) 
Average 
Hosp Stay 
(Private 
Sector) 
Public Sector 
(%) Share 
Hospital 
Stays 
Public Sector 
(%) Share 
OP Visits 
Average 
Hosp Stay 
(Public 
Sector) 
Average 
Hosp Stay 
(Private 
Sector) 
 
Heart Disease 
 
37.8 
 
17.9 
 
11.2 
 
12.2 
 
39.2 
 
26.0 
 
11.6 
 
8.8 
 
Hypertension 
 
35.7 
 
12.8 
 
10.6 
 
13.3 
 
29.5 
 
19.5 
 
7.8 
 
6.4 
Other 
Respiratory 
 
45.2 
 
9.2 
 
10.6 
 
8.6 
 
37.9 
 
15.9 
 
8.6 
 
5.8 
 
Asthma 
 
40.7 
 
13.4 
 
9.5 
 
7.2 
 
45.0 
 
21.9 
 
9.7 
 
7.4 
Joints & Pain 40.9 11.5 25.5 16.9 33.6 17.4 17.6 10.1 
 
Kidney/Urinary 
 
39.0 
 
16.0 
 
15.6 
 
14.2 
 
34.0 
 
18.6 
 
11.1 
 
8.9 
 
Neurological 
 
38.1 
 
11.6 
 
29.0 
 
10.5 
 
38.4 
 
24.9 
 
12.6 
 
12.1 
Psychiatric 54.4 13.1 49.6 20.9 42.7 17.9 18.3 13.0 
 
Diabetes 
 
38.5 
 
18.4 
 
20.5 
 
11.7 
 
32.0 
 
18.2 
 
11.4 
 
9.2 
 
Accidents/Injury 
 
52.1 
 
17.6 
 
14.5 
 
13.2 
 
44.3 
 
23.5 
 
14.5 
 
11.1 
 
Cancer 
 
52.7 
 
24.2 
 
31.7 
 
20.6 
 
48.7 
 
31.6 
 
17.4 
 
12.6 
 
NCD 
 
44.0 
 
14.0 
 
18.5 
 
13.3 
 
39.7 
 
19.7 
 
12.8 
 
9.5 
NCD 
(No Injuries) 
 
41.6 
 
13.6 
 
20.0 
 
13.3 
 
38.2 
 
19.4 
 
12.2 
 
9.0 
 
Non-NCD 
 
44.0 
 
14.7 
 
11.7 
 
9.5 
 
41.4 
 
17.1 
 
9.7 
 
6.9 
Total 44.0 14.5 13.8 10.7 40.7 18.0 10.9 8.0 
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Table 3.3: Out of Pocket Health Expenses on Health Care in India, 2004, By Disease 
 
Disease 
Inpatient Care Outpatient Care  
All Out of Pocket 
Expenses 
(INR, billions) 
Expenses per 
Stay (Public) 
INR 
Expenses per 
Stay 
(Private) 
INR 
Expenses per 
day (Public)  
INR 
Expenses per 
Day (Private) 
INR 
Expenses per 
Visit (Public) 
INR 
Expenses per 
Visit 
(Private) 
INR 
 
Heart Disease 
 
8,342 
 
22,203 
 
722 
 
2,522 
 
341 
 
485 
 
58.18 
 
Hypertension 
 
2,392 
 
7,026 
 
305 
 
1,105 
 
198 
 
336 
 
44.00 
Other 
Respiratory 
 
1,969 
 
5,682 
 
228 
 
980 
 
176 
 
143 
 
30.64 
 
Asthma 
 
2,079 
 
5,840 
 
215 
 
785 
 
230 
 
 322 
 
31.54 
Joints & Pain 4,872 11,703 276 1,157 165 222 41.94 
 
Kidney/Urinary 
 
5,134 
 
14,359 
 
462 
 
1,606 
 
445 
 
1,073 
 
41.75 
 
Neurological 
 
5,749 
 
15,484 
 
456 
 
1,284 
 
291 
 
366 
 
28.97 
Psychiatric 4,238 8,353 231 641 369 288 6.87 
 
Diabetes 
 
4,052 
 
8,280 
 
355 
 
897 
 
246 
 
390 
 
36.43 
 
Accidents/Injury 
 
5,556 
 
12,585 
 
383 
 
1,132 
 
350 
 
390 
 
53.62 
 
Cancer 
 
11,659 
 
23,868 
 
670 
 
1,888 
 
1,128 
 
603 
 
26.38 
 
NCD 
 
5,585 
 
13,213 
 
435 
 
1,388 
 
264 
 
320 
 
400.31 
NCD 
(No Injuries) 
 
5,596 
 
13,398 
 
460 
 
1,484 
 
256 
 
207 
 
346.69 
 
Non-NCD 
 
2,770 
 
6,716 
 
286 
 
967 
 
228 
 
213 
 
445.87 
Total 3,865 9,352 354 1,170 242 250 846.18 
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Table 3.4: Out of Pocket Health Expenses on Health Care in India, 1995-96, By Disease 
 
Disease 
Inpatient Care Outpatient Care  
All Out of Pocket 
Expenses 
(INR billions) 
Expenses per 
Stay (Public) 
INR 
Expenses per 
Stay 
(Private) 
INR 
Expenses per 
day (Public)  
INR 
Expenses per 
Day (Private) 
INR 
Expenses per 
Visit (Public) 
INR 
Expenses per 
Visit 
(Private) 
INR 
 
Heart Disease 
 
4,193 
 
15,117 
 
374 
 
1,239 
 
243 
 
608 
 
18.30 
 
Hypertension 
 
2,167 
 
3,906 
 
204 
 
293 
 
124 
 
218 
 
6.39 
Other 
Respiratory 
 
1,685 
 
2,861 
 
159 
 
331 
 
411 
 
272 
 
5.79 
 
Asthma 
 
1,009 
 
1,854 
 
106 
 
259 
 
112 
 
128 
 
11.20 
Joints & Pain 4,106 4,990 161 295 196 251 14.59 
 
Kidney/Urinary 
 
3,421 
 
9,599 
 
219 
 
678 
 
610 
 
448 
 
8.39 
 
Neurological 
 
2,522 
 
5,441 
 
87 
 
516 
 
160 
 
357 
 
5.20 
Psychiatric 5,913 5,877 119 281 160 280 2.92 
 
Diabetes 
 
2,903 
 
4,549 
 
142 
 
389 
 
110 
 
264 
 
4.90 
 
Accidents/Injury 
 
3,505 
 
6,451 
 
241 
 
489 
 
307 
 
340 
 
14.24 
 
Cancer 
 
5,047 
 
10,732 
 
159 
 
522 
 
419 
 
794 
 
7.68 
 
NCD 
 
3,467 
 
7,554 
 
188 
 
570 
 
208 
 
267 
 
99.61 
NCD 
(No Injuries) 
 
3,453 
 
7,821 
 
173 
 
587 
 
195 
 
260 
 
85.37 
 
Non-NCD 
 
1,727 
 
3,522 
 
148 
 
373 
 
165 
 
188 
 
215.39 
Total 2,271 4,784 164 445 174 205 315.00 
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Table 3.5: Percentage Distribution of Out of Pocket Health Expenses on Health Care by Components, 2004, By Disease 
  Doctor fees Medicines 
Diagnostic & 
medical 
appliances 
Other medical 
expenses* 
Total medical 
expenses Other expenses 
Heart disease 6.76 38.61 5.95 42.73 94.05 5.88 
Hypertension 7.59 64.20 3.95 17.79 93.52 6.60 
Respiratory 11.93 54.46 4.01 21.51 91.91 8.38 
Bronchial asthma 7.43 56.12 10.19 19.88 93.63 6.56 
Disorders of joints & pain 9.73 54.39 4.14 22.74 91.00 9.02 
Disease of kidney/urinary system 5.32 21.65 4.46 61.80 93.22 6.88 
Prostate disorders 10.49 36.63 5.18 40.87 93.17 6.85 
Neurological disorder 6.87 40.93 5.82 36.75 90.37 9.82 
Psychiatric disorder 7.94 54.04 3.69 22.68 88.34 12.13 
Diabetes mellitus 8.94 58.05 7.93 18.94 93.85 6.23 
Accidents and Injuries 9.52 32.10 4.28 46.25 92.16 7.74 
Cancer and other tumors 6.47 27.64 7.18 48.97 90.27 9.71 
Other Unknown NCD 2.07 10.33 1.25 80.40 94.04 5.96 
NCD 8.06 44.56 5.56 34.32 92.51 7.56 
Non-NCD 8.74 47.02 4.57 31.01 91.34 8.74 
NCD (No Injuries) 7.92 46.03 6.14 32.45 92.53 7.47 
Total 8.42 45.86 5.04 32.58 91.89 8.18 
Notes: * includes bed charges, attendant charges, physiotherapy, food and material, blood, oxygen cylinder etc, other services and expenditure not classified 
elsewhere 
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Table 3.6: The Distribution of Public Subsidies on Health in India, 2004, By Disease 
 
Disease 
 
2004 
Public Subsidy per 
hospital day (INR) 
Public Subsidy per 
OP visit (INR) 
Total Subsidies 
(INR Billions) 
OOP expenses  
(INR billions) 
 
Subsidies/OOP 
 
Heart Disease 
 
2,092 
 
465 
 
23.92 
 
58.18 
 
0.41 
 
Hypertension 
 
916 
 
204 
 
6.62 
 
44.00 
 
0.15 
Other 
Respiratory 
 
813 
 
181 
 
7.80 
 
30.64 
 
0.25 
 
Asthma 
 
651 
 
145 
 
5.72 
 
31.54 
 
0.18 
Joints & Pain 960 213 10.42 41.94 0.25 
 
Kidney/Urinary 
 
1,332 
 
296 
 
8.39 
 
41.75 
 
0.20 
 
Neurological 
 
1,065 
 
237 
 
7.98 
 
28.97 
 
0.28 
Psychiatric 531 118 1.47 6.87 0.21 
 
Diabetes 
 
744 
 
165 
 
4.29 
 
36.43 
 
0.12 
 
Accidents/Injury 
 
939 
 
209 
 
21.19 
 
53.62 
 
0.40 
 
Cancer 
 
1,566 
 
348 
 
13.38 
 
26.38 
 
0.51 
 
NCD 
 
1,151 
 
225 
 
111.17 
 
400.31 
 
0.28 
NCD 
(No Injuries) 
 
1,247 
 
227 
 
89.98 
 
346.69 
 
0.26 
 
Non-NCD 
 
802 
 
178 
 
108.79 
 
445.87 
 
0.24 
Total 962 196 219.96 846.18 0.26 
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Table 3.7: Sources of Funds for Out of Pocket Spending on Health Care on Inpatient Care in India, 2004, By Disease 
 
Disease 
2004 
Out of pocket 
spending on 
hospital stays (INR 
billions) 
Household Income 
or Savings 
(% share) 
Borrowing 
(% share) 
Contributions from 
friends & family 
(% share) 
Other  
(incl. sale of assets)  
(% share) 
 
Heart Disease 
 
28.4 
 
49.5 
 
26.6 
 
12.5 
 
11.4 
 
Hypertension 
 
3.6 
 
50.5 
 
28.1 
 
17.3 
 
4.1 
Other 
Respiratory 
 
4.1 
 
56.8 
 
29.8 
 
10.2 
 
3.1 
 
Asthma 
 
4.1 
 
44.9 
 
39.2 
 
9.0 
 
6.9 
 
Joints & Pain 
 
7.5 
 
53.6 
 
29.6 
 
12.1 
 
4.7 
 
Kidney/Urinary 
 
14.9 
 
47.0 
 
37.7 
 
10.5 
 
4.8 
 
Neurological 
 
11.4 
 
38.3 
 
32.1 
 
9.3 
 
20.3 
 
Psychiatric 
 
1.7 
 
38.0 
 
49.5 
 
9.4 
 
3.2 
 
Diabetes 
 
4.1 
 
54.7 
 
33.4 
 
9.4 
 
2.4 
 
Accidents/Injury 
 
28.5 
 
39.1 
 
39.0 
 
14.8 
 
7.0 
 
Cancer 
 
16.1 
 
43.4 
 
35.4 
 
14.0 
 
7.2 
NCD 124.3 45.4 33.7 12.5 8.4 
NCD  
(No Injury)  
 
95.8 
 
47.2 
 
32.1 
 
11.8 
 
8.9 
Non-NCD 93.3 50.8 33.6 11.9 3.7 
Total 217.6 47.7 33.7 12.2 6.4 
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Table 3.8: Sources of Funds for Out of Pocket Spending on Health Care on Inpatient Care in India, 1995-96, By Disease 
 
Disease 
1995-96 
Out of pocket 
spending on 
hospital stays (INR 
billions) 
Household Income 
or Savings 
(% share) 
Borrowing 
(% share) 
Reimbursement  
(% share) 
Other  
(incl. sale of assets)  
(% share) 
 
Heart Disease 
 
6.2 
 
65.1 
 
17.5 
 
3.7 
 
13.7 
 
Hypertension 
 
0.9 
 
55.6 
 
22.0 
 
4.7 
 
17.7 
Other 
Respiratory 
 
0.6 
 
55.9 
 
30.3 
 
3.5 
 
10.3 
 
Asthma 
 
0.5 
 
46.7 
 
29.7 
 
0.5 
 
23.0 
 
Joints & Pain 
 
1.8 
 
44.5 
 
36.8 
 
1.2 
 
17.5 
 
Kidney/Urinary 
 
3.7 
 
37.4 
 
36.8 
 
10.9 
 
14.8 
 
Neurological 
 
1.0 
 
37.4 
 
34.6 
 
2.0 
 
26.0 
 
Psychiatric 
 
0.9 
 
27.3 
 
33.3 
 
8.3 
 
31.1 
 
Diabetes 
 
0.5 
 
51.1 
 
34.9 
 
1.8 
 
12.2 
 
Accidents/Injury 
 
5.3 
 
34.4 
 
36.3 
 
11.1 
 
18.2 
 
Cancer 
 
3.0 
 
44.0 
 
31.7 
 
2.7 
 
21.6 
NCD 24.5 46.4 30.0 6.1 17.4 
NCD  
(No Injury)  
 
19.2 
 
49.8 
 
28.3 
 
4.7 
 
17.2 
Non-NCD 23.7 45.9 37.8 1.7 14.6 
Total 48.2 46.2 33.9 3.9 16.0 
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Table 3.9: Out of Pocket Health Expenditures per Capita (by Disease) across Expenditure Quintiles for India, 2004 
 
Expenditure 
Quintile 
Per Capita Out of Pocket Spending (INR) on: Proportion of Per Capita HH Income 
(%) 
Heart 
Disease 
Accidents Cancer All NCD Non-NCD Health All NCD NCD 
 
All Health 
Spending 
 
I 
 
13.62 
 
27.12 
 
8.98 
 
126.48 
 
251.88 
 
378.36 
 
3.53 
 
7.03 
 
10.56 
 
II 
 
20.80 
 
37.52 
 
14.08 
 
200.93 
 
327.06 
 
527.99 
 
3.78 
 
6.15 
 
9.92 
 
III 
 
41.59 
 
50.50 
 
17.49 
 
347.89 
 
398.49 
 
746.37 
 
5.08 
 
5.82 
 
10.90 
 
IV 
 
63.28 
 
49.52 
 
25.34 
 
429.68 
 
457.93 
 
887.61 
 
5.03 
 
5.36 
 
10.39 
 
V 
 
173.78 
 
102.09 
 
72.82 
 
981.92 
 
766.67 
 
1,748.58 
 
6.68 
 
5.21 
 
11.89 
 
Combined 
 
53.91 
 
49.69 
  
23.63 
 
371.41 
 
412.68 
 
784.10 
 
5.17 
 
5.75 
 
10.92 
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Table 3.10: Out of Pocket Health Expenditures per Capita (by Disease) across Expenditure Quintiles for Rural India, 2004 
 
Expenditure 
Quintile 
Per Capita Out of Pocket Spending (INR) on: Proportion of Per Capita HH Income 
(%) 
Heart 
Disease 
Accidents Cancer All NCD Non-NCD Health All NCD NCD 
 
All Health 
Spending 
 
I 
 
7.07 
 
22.31 
 
9.38 
 
89.97 
 
232.57 
 
322.54 
 
2.91 
 
7.52 
 
10.42 
 
II 
 
9.79 
 
34.50 
 
10.69 
 
145.41 
 
294.89 
 
440.29 
 
3.32 
 
6.73 
 
10.05 
 
III 
 
18.58 
 
49.20 
 
13.98 
 
280.40 
 
379.08 
 
659.49 
 
5.12 
 
6.92 
 
12.04 
 
IV 
 
35.18 
 
44.76 
 
18.34 
 
293.38 
 
445.81 
 
739.19 
 
4.26 
 
6.48 
 
10.74 
 
V 
 
119.19 
 
99.78 
 
66.13 
 
774.96 
 
763.00 
 
1,537.97 
 
6.90 
 
6.79 
 
13.69 
 
Combined 
 
32.51 
 
46.76 
 
21.12 
 
285.23 
 
396.81 
 
682.04 
 
4.92 
 
6.84 
 
11.76 
 
 -57- 
Table 3.11: Out of Pocket Health Expenditures per Capita (by Disease) across Expenditure Quintiles for Urban India, 2004 
 
Expenditure 
Quintile 
Per Capita Out of Pocket Spending (INR) on: Proportion of Per Capita HH Income 
(%) 
Heart 
Disease 
Accidents Cancer All NCD Non-NCD Health All NCD Non-NCD 
 
All Health 
Spending 
 
I 
 
31.99 
 
40.62 
 
7.86 
 
228.91 
 
306.04 
 
534.95 
 
4.62 
 
6.18 
 
10.80 
 
II 
 
48.80 
 
45.20 
 
22.71 
 
342.08 
 
408.86 
 
750.94 
 
4.44 
 
5.31 
 
9.75 
 
III 
 
109.30 
 
54.33 
 
27.83 
 
546.42 
 
455.56 
 
1,001.98 
 
5.02 
 
4.19 
 
9.21 
 
IV 
 
166.06 
 
66.95 
 
50.96 
 
928.26 
 
502.28 
 
1,430.54 
 
6.35 
 
3.44 
 
9.79 
 
V 
 
346.66 
 
109.40 
 
94.01 
 
1,637.31 
 
778.27 
 
2,415.59 
 
6.37 
 
3.03 
 
9.40 
 
Combined 
 
116.68 
 
58.28 
 
34.18 
 
624.16 
 
459.25 
 
1,083.41 
 
5.56 
 
4.09 
 
9.64 
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Table 3.12: The Impact of NCDs on Catastrophic Spending and Impoverishment among Indian Households, 2004 
 
Explanatory Variables 
Dependent variable: Catastrophic 
Spending 
Dependent Variable: Poverty Indicator 
Dummy for cardiovascular disease 5.138 
(0.120) 
1.027 
(0.091) 
Dummy for Diabetes 4.724 
(0.236) 
0.426 
(0.205) 
Dummy for Accidents 5.134 
(0.104) 
0.908 
(0.075) 
Dummy for Cancer 5.841 
(0.174) 
1.558 
(0.156) 
Dummy for other NCDs 5.015 
(0.087) 
0.888 
(0.052) 
Dummy for Communicable Diseases 4.897 
(0.078) 
0.712 
(0.034) 
Average Age 0.013 
(0.002) 
-0.040 
(0.001) 
Proportion of Females -0.312 
(0.137) 
0.562 
(0.044) 
Highest educated adult household member 0.018 
(0.006) 
-0.132 
(0.002) 
Dummy for Rural Residence 0.505 
(0.058) 
0.022 
(0.022) 
Constant -6.532 
(0.132) 
0.619 
(0.039) 
 
Number of Observations 
 
72,596 
 
72,596 
Note: Data are from the 60th round (2004) of the National Sample Survey. Standard errors are reported in parentheses. 
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C H A PT E R  4. H OUSE H OL D I NC OM E  L OSSE S F R OM  NC DS 
 
4.1. Introduction 
We now direct our attention to the second key element of the “cost” of NCDs: namely an 
annualized measure of the indirect costs (income losses) associated with morbidity/disability and 
premature mortality from NCDs that are borne by households. The main motivation for 
estimating these costs is to highlight the potential impact that illnesses can have on incomes, 
even if sometimes medical expenditures are limited by household resources or lack of insurance. 
Recent literature on the economic impacts of illness has not always taken this fact into account. 
For instance, Xu et al. (2003) in their work on catastrophic financial implications of ill health 
focus solely on medical expenditures when, in fact, for some families it is the income losses that 
are likely paramount. Similarly, Doorslaer et al. (2006) in their analysis of the impoverishing 
‘impacts’ of ill health seem to suggest that in the absence of medical expenditure, the 
income/consumption of the household would likely have remained unaffected. In fact, this would 
usually not be the case if ill health also affected household income levels.      
4.2. Data and Methods 
This section is divided into two parts. The first sub-section describes the data we use. The 
second describes the methodology. 
4.2.1. Data 
The data for the calculations we undertake here come from several sources. We relied to 
a great extent on morbidity and hospitalization data from the health care utilization and 
expenditure surveys of India’s National Sample Survey Organization for the year 2004 and 
1995-96. These surveys provided detailed self-reported information on ailments in 15-day 
reference period, and on hospitalizations in the year preceding the survey. Survey data included 
self-reported causes of morbidity/hospitalization, the length of the period of hospitalization, the 
length of time a hospitalized person reported being ill (including, both before and after 
hospitalization) and the length of ailments reported during the 15-day reference period preceding 
the survey. The surveys also provided information on the nature of the ailment/hospitalization on 
the sub-set of dead individuals who were hospitalized in the year preceding the survey, or who 
were ill in the 15 days preceding the survey. However, for individuals that did not seek treatment 
(or were not hospitalized) no information on cause of death was available in the 2004 survey.4
Another source of data that we utilized was a large labor force survey undertaken by the 
National Sample Survey Organization in 2004-5
  
5
                                                 
4This information was available for dead individuals in the 1995-96 survey, if they did not access health care in the 
reference period(s).  
. This “employment-unemployment” survey 
provided information on educational attainment, age, sex, activity status (employed or 
unemployed), status of employment (casual, regular, or self-employed), residence (rural or 
5This is the 61st round of the National Sample Survey that focused on Employment and unemployment situation in 
India. 
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urban), and wages6
Finally, we used information on mortality (including by cause of death) from two 
additional sources: statistics published by the World Health Organization on its burden of disease 
website (WHO 2004) and data from the Registrar General of India on medical certification of 
causes of death in designated hospitals (Registrar General of India 2007). Some other categories 
of demographic data (such as total population, population age distribution, all-cause mortality 
rates) and life tables were obtained from the Registrar General of India.  
. The survey covered nearly 125 thousand households and was representative 
at the national, provincial and sub-provincial levels. 
4.2.2. Methods 
We first estimated annual income losses using a standard cost-of-illness approach. As a 
first step, we classified the population with NCD into two groups (a) those individuals who died 
in 2004 on account of NCDs; and (b) individuals who reported ill with a NCD (but did not die). 
Note in this connection that individuals with an NCD, even if they do not die, might remain ill 
for an extended period, or acquire a disability that may hamper their ability to effectively 
participate in the labor market. At the same time, one might expect income losses associated with 
dead individuals to be larger if other family members are unable to step in to replace any 
associated household income losses. 
Three different methods were used to assess the size of the population with an NCD in 
India, and to distribute this population into individuals who died during the preceding year and 
those that did not. The first method
One might suspect that the distribution of deaths constructed in this manner is biased since we do 
not really know the immediate cause of death, as for instance a person discharged from a hospital 
after a CABG, but then being run over by a car while crossing the street from the hospital. While 
we do not know this immediate cause of death for any individual in the 2004 survey, the 1995-96 
NSSO health survey did provide separate self-reported information on the cause of death of 
household members by survey respondents, including for individuals who were hospitalized in 
the one year preceding the survey and individuals reporting illness in a 15-day reference period. 
Restricting our sample of deaths to only to the inpatient cases in 1995-96 resulted in a match of 
about 70% between the hospitalized condition and the specific cause of death as identified by the 
respondent. In about 20% of the cases, however, the cause of death could not be identified by the 
respondent. Overall, at least for the data in the year 1995-96, there appears to be a reasonably 
good match between the cause of death as reported by survey respondents and the cause as 
identified by the disease for which a person was hospitalized in the one year preceding the 
survey. Of course, deaths were also reported among persons who were not hospitalized during 
 relied primarily on data from the National Sample Survey 
Organization health surveys for 2004 and 1995-96. Sample-weighted estimates of dead 
individuals for whom the cause of death (by disease) was identifiable were first constructed for 
the year 2004. If a person was hospitalized, we attributed the death for that individual to the 
reported disease for which he or she was hospitalized. Very few deaths were reported for ill (but 
not hospitalized persons) exclusively in the 15-day reference period, and so these were omitted 
from our analysis.  
                                                 
6 We used data on ‘current daily status’ of a person’s employment in the 61st round of the national sample survey 
which relied on respondent activity over a 7 day reference period. 
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the survey. We assumed that the disease-specific distribution of deaths for the non-hospitalized 
cases was the same as that of the cases that were hospitalized.  
Individual deaths were further divided into two groups: those aged 15 years and above, 
and those aged below 15 years. There were two reasons for making this distinction. Firstly, 
aggregate income losses for the under-15 age group will most likely arise from care-giving by 
other family members rather than a loss of the patient’s own work income. In a country with 
substantial amounts of child labor such as India, this is probably not a satisfactory assumption. 
We do not address this concern here, except to argue that child labor, more often than not, is 
heavily exploited and underpaid and further that, any labor earnings of the child are potentially 
outweighed by long-run productivity losses owing to inadequate investments in health and 
education made on his (or her) behalf. More significantly, making this distinction helped to 
address an important concern regarding survey responses on respiratory illnesses. Because there 
were only three questions relating to respiratory conditions in the National Sample Survey – 
pertaining to tuberculosis, asthma and “other respiratory illnesses” – there was the obvious 
danger of categorizing as NCDs several childhood respiratory conditions that are usually 
considered under a separate heading in ICD-9/10 classifications.7
The total estimated (sample-weighted) all-cause deaths among those who were 
hospitalized in the year preceding the survey were 0.96 million from the National Sample Survey 
data (out of a total of 4.03 million all cause deaths in the survey). This was a much smaller 
number than estimates of all-cause deaths based on death rates of 7.5 per 1,000 population and 
population estimates for 2004 provided by the Registrar General of India. This latter estimate 
came to roughly 8.1 million deaths. For this reason we upwardly adjusted our survey estimate of 
deaths to equal the estimate of the Registrar General of India (RGI) and used the ratio of RGI all-
cause deaths to the survey estimates of all-cause deaths (8.1 divided by 0.96) to scale up sample 
survey based estimates of deaths from each disease.  
    
Individuals (in the sample survey) who did not die in the year preceding the survey were 
sub-divided into those reporting an NCD in the reference period of 15-days preceding the survey 
(but not hospitalized) and all hospitalized cases. This distinction helped to focus attention on 
serious (and lengthy) cases of illness resulting in hospitalization. By comparison, the 15-day 
reference period better identifies shorter periods of illness, although long-running chronic 
conditions are also presumably captured from survey responses, given that the survey question 
on ailments in the 15-day reference period did not explicitly distinguish between acute and 
chronic cases. The survey did not contain adequate information on disabilities associated with 
disease, NCD or otherwise; so it was difficult to identify income losses associated with being 
unable to work due to disability. In an effort to account for this, we used the length of the period 
for which a person reported ill (rather than days spent as inpatient in a hospital, which were 
considerably fewer) as our indicator of work time lost. It is possible that, at least for some 
individuals, the period of disability extended well beyond the period of illness. If so, our methods 
would result in a downwardly biased estimate of the true cost of ill-health from NCDs (or, for 
that matter, communicable conditions). It is also possible that reported ill days overstate 
household income losses due to morbidity, especially if firms provide sick leave and other 
financial benefits to the affected individual. This point has been made in Abegunde et al. (2007) 
                                                 
7Of course, some child respiratory conditions may well be considered NCDs. This would likely bias our estimates 
downwards, although we believe this bias to be small.  
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in their critique of the method that we use here. Excluding any consideration of ill days in our 
calculations would likely be a lower bound to the “true” measure of income losses based on this 
method. To address this in some measure we also estimated income losses under the assumption 
that income losses occur only if an individual was hospitalized, or died. 
Under our second method
Overall, MCCD records provided information on a total of 534 thousand deaths 
throughout India in the year 2004. This is considerably less than the estimated 8.1 million deaths 
from “all causes” in the year 2004 based on population and death rate estimates of the Registrar 
General of India. As before (as in the first method) we assumed that the cause-specific 
distribution of medically certified deaths was the same as for all deaths (including uncertified 
ones) in the population. This was used to allocate all 8.1 million deaths in the population by 
cause.  
 estimates of days ill by disease for individuals who did not die 
in the preceding year, were derived from the National Sample Survey data, just as described in 
the preceding paragraph. However, the method differs from the previous approach in its disease-
specific distribution of deaths. Specifically, this method relied on information on medical 
certification of the causes of death (MCCD) for 2004 in a large sample of hospitals as reported in 
the Registrar General of India (2007) to construct the distribution of deaths by disease. Unlike 
self-reported causes of death in the sample survey (a sort of verbal autopsy), the hospital-based 
certification of cause of death is undertaken by medical professionals and more likely to be 
accurate. As noted in Chapter 2, while detailed by age and sex, this data did not cover all of the 
estimated deaths in India; probably no more than 6 percent of all deaths were certified in this 
manner. It might also be reasonable to assume that medically certified deaths are a better 
reflection of deaths among residents in major urban centers than for deaths in remote rural areas 
and small towns. Specific health conditions may also be more likely to be medically certified, in 
particular, traffic deaths, since they involve record-keeping by the police. Deaths among males 
are also more likely to be medically certified given issues of succession and property ownership 
that are more likely to be male-related.  
Just as under the two earlier methods, our third method
 Estimates of the distribution of deaths (for the same total magnitude of all-cause 
mortality), by disease category, under the three methods outlined above are provided in Table 
4.1. Tables 4.2a-d provide information on the average number of days individuals were ill, by 
disease, under the 15-day reference period, the total number of cases reporting ill in the 15-day 
reference period (by disease), the total number of hospitalized cases in the one year reference 
period, the average length of an inpatient stay and the average length of days a hospitalized 
person reported being ill in the one-year reference period. The estimates are reported separately 
for individuals under 15 years of age and individuals over 15 years of age.  
 too estimated the distribution 
(and magnitude) of ill days (by disease) for persons who did not die during the reference period 
from the National Sample Survey data for 2004. However, in assessing the distribution of cause 
of death by disease, this method relied on the distribution of deaths (by cause) as reported by the 
World Health Organization under its burden of disease program (WHO 2004).  
Estimating Annual Income Losses   
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To estimate lost income under this method, we matched information on deaths and morbidity to 
estimates of wage losses of the affected individuals and households. We used two methods to 
construct these dates, both of which are described below.  
 
Both methods rely on imputing a (daily) wage to each individual in the household health care 
survey above the age of 15 years. For this purpose we estimated Mincer equations that describe 
the relationship between the natural log of the daily wage rate to indicators of educational 
attainment and experience and other controls. This exercise involved a number of technical 
issues. Because no wage information was available in the NSS health care utilization and 
expenditure survey, we used a separate unemployment-employment (or labor force) survey 
conducted by India’s National Sample Survey Organization for the year 2004-5 to estimate the 
Mincer wage equations referred to above. The results of this estimation exercise are reported in 
Tables 4.3a-c. Separate equations were estimated for men and women (in rural and urban areas) 
and by status of employment, to reflect potentially different conditions in their respective labor 
markets. The estimation of Mincer equations requires some care, particularly to take account of 
statistical problems related to selection and endogeneity. We did not address these concerns here 
and estimated this equation by ordinary least squares (OLS) methods, noting simply that in 
previous work on India, the results from the OLS procedure did not differ much from the 
coefficient estimates produced by more sophisticated econometric tools used to address them 
(Duraisamy 2000). The labor force survey (NSSO 61st round) did not provide any information on 
the earnings of the self-employed. Thus we assigned the all India average wage (by combining 
regular and casual workers together) to them, but after adjusting to take account of rural-urban 
and gender differences. Moreover, we did not have any information on the educational status of 
dead individuals in the sample, or the characteristics of caregivers. To them we imputed the 
average wage, corresponding to each specific disease, of currently alive individuals reporting 
that same disease. Although this assumption is somewhat ad hoc, our household health survey 
data had no information on care-giving by household members to their sick relatives.  
 
Under the first method, the imputed wage was (a) multiplied by the number of days spent as ill 
for each individual reporting sick, and further multiplied by 24.33 in case of the 15 day reference 
period to convert it into annual terms and (b) multiplied by the number of ill days in the case of 
hospitalization cases that are reported annually. This calculation was undertaken for all persons 
reporting ill in the preceding 15 days, or those who were hospitalized, by disease group (and for 
dead individuals). In addition, for persons who had died in the preceding year (whether they 
reported being hospitalized or ill or not) we multiplied their imputed daily wage by 182.5 (365 
divided by 2) to estimate annual income foregone on account of premature death (by disease 
group). The assumption underlying this last calculation was that all deaths occur in the middle of 
each year. Finally, we assumed that the imputed wage for caregivers was the same as the average 
of the imputed wages for sick individuals in each disease group. To estimate income losses for 
caregivers, we multiplied the imputed wage by one-half of the number of total ill days (including 
both the 15 day reference period and hospitalizations). The total for these different categories of 
income losses (hospitalization, premature death, illness among non-hospitalized cases and 
caregivers) was taken to be our estimate of annual income losses to households affected by 
illness (NCD or other).  
 
There are two points to note about the method used above for calculating income losses. We use 
imputed wages for all sick individuals and not just those currently working. Thus we assign a 
measure of productivity to all working age individuals and not just the employed. Our second 
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method differs from the first only in the way we apply (the same) imputed wages to calculate 
income losses. Specifically, in this case, income losses for sick individuals are considered only if 
they were reported as working in the survey. No income loss is assigned to caregivers, who are 
assumed to be non-working members of the household. For dead individuals, we make the 
simple assumption that their employment rate is/was the same as their counterparts who are 
currently alive, conditional on the disease category. This method likely describes the lower 
bound to income losses experienced by the household from NCDs. 
    
4.3. Results and Discussion 
Our results under the two different methods for calculating income losses are described in 
Tables 4.5 and 4.6. Assuming that all care-givers and sick individuals above the age of 15 years 
are productive yielded an annual income loss of one trillion rupees in 2004. Much of this was in 
the form of income losses arising from days spent ill and in care-giving effort. The loss on 
account of premature death was lower, reflecting the chronic nature of NCDs, so that care and 
treatment amount cumulatively to much larger amounts than incomes foregone by households 
owing to the premature death of their members from NCDs. 
More than one-third of all income losses are due to CVD and hypertension. Another 15 
percent are accounted for by diabetes, so that nearly half of all income losses from NCDs occur 
on account of a fairly narrow range of conditions and their co-morbidities. Another significant 
chunk (roughly in the region of 20 percent) of all income losses are related to asthma and other 
respiratory conditions. Accidents and injuries make up for about 6-7 percent of all annual income 
losses.    
Annual income loses based on an imputed wage for all individuals above the age of 15 
years will not be an accurate reflection of household declines in income due to NCDs if not 
everybody works, or if safety nets exist that protect individuals from loss of income during ill 
health or if there is survivor pension that provides support to the family of a deceased income 
earner. The latter is not a major concern in India given that only 10 percent of the work force is 
employed in the formal sector where such protections exist. However, the issue of work force 
participation most certainly is. Our sample survey data reveal that overall work force 
participation rate (proportion of people aged 15 years and above with NCDs who actually 
worked) was only about 47 percent (inclusive of injury cases). If we consider only those who are 
working, the resulting income losses would be considerably lower than the estimates presented in 
Table 4.5. Indeed, when we limited ourselves to those who are working, we end up with much 
lower estimates of the annual income losses to households associated with NCDs – roughly INR 
280 billion – as seen in table 4.6. Our findings with regard to the relative importance of different 
types of health conditions are also the same, although the contribution of CVD is now slightly 
lower than in Table 4.5, and that of accidents and injuries slightly higher. The latter reflects the 
higher work force participation rate among accident victims – around 65 percent in our survey, 
compared to the rest of the CVD.  
Because average imputed wage earnings per person (based on the results from the Mincer 
equations) came to about INR 22 thousand annually, much lower than India’s GDP per adult 
worker, we are concerned whether our indicator of income was comprehensive enough to capture 
aggregate income losses to affected households. For one, the survey question on wages does not 
-65- 
 
include benefits provided by the employer in the form of contributions to savings schemes, 
health benefits and the like. These can be as high as 30 percent in the formal sector. More 
crucially, however, focusing on household expenditure excludes information on household 
savings which, in India, is known to be quite high – national savings rates are close to 30 percent 
of GDP according to the most recent estimates available. For this reason we also considered an 
alternative formulation under which each individual aged 15 years or older was assumed to earn 
an amount equivalent to India’s GDP per adult worker. The adoption of this alternative method 
resulted in estimates of income losses that were almost twice as high as the case with survey 
based imputed wages, although we do not present the results here.   
Taking account of income losses associated with ill health is an important step in 
appreciating that it is not only out of pocket expenses but also earnings foregone by households 
that constitute a significant financial risk from NCDs. Our analysis suggests that irrespective of 
the metric used, there are significant income losses experienced by households whose members 
experience NCDs in India. From a policy perspective, the lack of social safety nets and the 
decline of the inter-familial linkages as a source of financial support imply that the burden of 
these income losses associated with NCDs will fall primarily on individuals with NCDs (or the 
household that s/he is a part of).  
Although we have tried to take account of a number of complexities in available Indian 
data, more rigorous evidence must await the availability of better quality (and longitudinal) data 
that provides us with good disease-specific information, as well as on analyses that can better 
help address the challenge of isolating the impact of competing health risks. Thus far, we have 
relied upon the assumption that competing risks are statistically independent, which simplifies 
our task of estimating income losses on account of NCDs, a somewhat unsatisfactory state of 
affairs, which likely biases upwards our estimates of income losses. Chapter 6 takes up this 
concern more directly.  
It should also be noted that adding up income losses among households that had one or 
more members experiencing an NCD does not imply anything about declines in income for the 
economy as a whole. If individuals who die are easily replaced in the labor market by other 
(previously unemployed) workers, no loss in national income will occur. Estimating losses in 
national income requires somewhat different techniques, which we illustrate in Chapter 5.   
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 Table 4.1: The All India Distribution of Deaths by Disease: Estimates using Alternative Methods, 
2004 
 
 
Disease 
Unadjusted 
NSS Data 
Unadjusted 
MCCD 
Data 
Unadjusted 
WHO Data 
Adjusted 
NSS Data 
Adjusted 
MCCD 
Data 
Adjusted 
WHO Data 
CVD (excl. 
hypertension) 
 
155,782 
 
138,881 
 
2,760,300 
 
1,313,927 
 
2,105,215 
 
2,152,541 
 
Hypertension 
 
13,393 
 
8,194 
 
49,700 
 
112,961 
 
124,207 
 
38,757 
Respiratory 
Illnesses ( 15≥ ) 
 
5,461 
 
24,808 
 
552,400 
 
46,062 
 
 
376,047 
 
430,773 
 
Asthma 
 
61,060 
 
8,194 
 
57,100 
 
515,006 
 
124,207 
 
44,528 
Disorders of 
Joints/Pain 
 
2,929 
 
329 
 
7,100 
 
24,704 
 
4,987 
 
5,537 
Disease of 
kidney/urinary 
system 
 
45,572 
 
 
11,623 
 
132,800 
 
384,368 
 
176,185 
 
103,560 
Neurological 
Disorders 
 
28,636 
 
17,435 
 
98,400 
 
241,531 
 
264,287 
 
76,734 
Psychiatric 
Disorders 
 
680 
 
688 
 
84,000 
 
5,732 
 
10,429 
 
65,505 
 
Diabetes 
 
24,449 
 
13,136 
 
156,200 
 
206,214 
 
199,121 
 
121,808 
Accidents & 
Injuries 
 
72,058 
 
114,889 
 
1,049,500 
 
607,769 
 
1,741,534 
 
818,423 
Cancers & Other 
Tumors 
 
95,479 
 
19,577 
 
757,800 
 
805,303 
 
296,756 
 
590,949 
 
Other NCD 
 
n. a. 
 
427 
 
454,900 
 
n. a. 
 
6,472 
 
354,741 
 
All NCD 
 
505,499 
 
358,181 
 
6,160,200 
 
4,263,577 
 
5,429,453 
 
4,803,857 
All other 
conditions (plus 
undiagnosed) 
 
454,070 
 
175,739 
 
4,218,300 
 
3,829,801 
 
2,663,925 
 
3,289,521 
 
All Diseases 
 
 
959,569 
 
533,920 
 
10,378,500 
 
8,093,378 
 
8,093,378 
 
8,093,378 
Note: Deaths (by cause) in NSS data from its 60th round carried out in 2004, MCCD data for 2001 and the WHO 
data were scaled up (or down) to equal the estimated number of population deaths. The latter estimated was arrived 
at by multiplying the (all cause) death rate by total population size. Mortality data (by cause) from the NSS are self-
reported, and are weighted, using sampling weights. 
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Table 4.2a: Length of Illness and Health Care Utilization, By Disease, among Individuals (Alive) 
aged 15 years and above, 2004 
 
 
Health 
Condition 
 
 
Hospitalized Cases in 1 Year Preceding the 
Survey 
Ailments (Annual) based on 
15 day Reference Period 
(excluding hospitalizations) 
 
Number 
(000s) 
Average 
Length of 
Stay (days) 
Average 
Length of 
Illness (days) 
 
Number 
(000s) 
Average 
Length of 
Illness (days) 
CVD (excl. 
hypertension) 
 
1,417 
 
9.7 
 
78.4 
 
2,713 
 
14.0 
 
Hypertension 
 
674 
 
6.8 
 
74.3 
 
5,319 
 
14.0 
Respiratory 
Illnesses 
 
494 
 
7.6 
 
43.2 
 
4,095 
 
8.7 
 
Asthma 
 
787 
 
8.7 
 
80.5 
 
3,406 
 
13.2 
Disorders of 
Joints/Pain 
 
668 
 
12.4 
 
66.1 
 
6,611 
 
13.4 
Disease of 
kidney/urinary 
system 
 
1,046 
 
9.8 
 
46.1 
 
893 
 
13.2 
Neurological 
Disorders 
 
742 
 
13.0 
 
86.1 
 
1,836 
 
13.1 
Psychiatric 
Disorders 
 
242 
 
16.2 
 
102.3 
 
639 
 
14.4 
 
Diabetes 
 
540 
 
10.2 
 
87.9 
 
3,637 
 
14.7 
Accidents & 
Injuries 
 
2,319 
 
13.7 
 
47.7 
 
2,113 
 
10.1 
Cancers & 
Other Tumors 
 
695 
 
15.1 
 
73.1 
 
505 
 
13.3 
 
All NCD 
 
9,725 
 
11.3 
 
65.9 
 
31,896 
 
12.8 
All other 
conditions 
(incl. 
undiagnosed) 
 
13,790 
 
8.3 
 
37.9 
 
43,950 
 
9.5 
 
All Diseases 
 
 
23,515 
 
9.5 
 
49.2 
 
75,845 
 
10.9 
Note: Authors’ estimates, based on data from the 60th round (2004) of the National Sample Survey Organization that 
surveyed nearly 80 thousand households on health care utilization, expenditure and other information. The number 
of illness episodes in columns (5) and (6) is “annualized” by multiplying the by 24.33 the number reported in the 15-
day reference period. We assumed that all respiratory illnesses among individuals 15 and over were NCD; and 
among those aged 15 and below, non-NCD.    
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Table 4.2b: Length of Illness and Health Care Utilization, by Disease, among individuals (alive) 
Aged less than 15 years, 2004 
 
 
Health 
Condition 
 
 
Hospitalized Cases in 1 Year Preceding the 
Survey 
Ailments (Annual) based on 
15 day Reference Period 
(excluding hospitalizations) 
 
Number 
(000s) 
Average 
Length of 
Stay (days) 
Average 
Length of 
Illness (days) 
 
Number 
(000s) 
Average 
Length of 
Illness (days) 
CVD (excl. 
hypertension) 
 
51 
 
15.3 
 
98.4 
 
61 
 
14.5 
 
Hypertension 
 
1 
 
6.6 
 
19.1 
 
18 
 
9.2 
 
Asthma 
 
131 
 
6.3 
 
32.2 
 
317 
 
9.9 
Disorders of 
Joints/Pain 
 
93 
 
14.9 
 
51.9 
 
122 
 
12.2 
Disease of 
kidney/urinary 
system 
 
152 
 
8.3 
 
36.5 
 
112 
 
12.4 
Neurological 
Disorders 
 
172 
 
7.0 
 
50.6 
 
248 
 
13.0 
Psychiatric 
Disorders 
 
24 
 
6.8 
 
37.3 
 
56 
 
14.6 
 
Diabetes 
 
21 
 
3.4 
 
330 
 
14 
 
15.0 
Accidents & 
Injuries 
 
538 
 
7.5 
 
26.2 
 
649 
 
8.2 
Cancers & 
Other Tumors 
 
49 
 
13.4 
 
57.4 
 
36 
 
13.2 
 
All NCD 
 
1,242 
 
8.5 
 
42.8 
 
1,634 
 
10.5 
All other 
conditions 
(incl. 
undiagnosed) 
 
 
4,536 
 
 
7.4 
 
 
22.6 
 
 
26,373 
 
 
6.2 
 
All Diseases 
 
 
5,778 
 
7.6 
 
27.0 
 
28,007 
 
6.5 
Note: Authors’ estimates, based on data from the 60th round (2004) of the National Sample Survey Organization that 
surveyed nearly 80 thousand households on health care utilization, expenditure and other information. The number 
of illness episodes in columns (5) and (6) is “annualized” by multiplying the by 24.33 the number reported in the 15-
day reference period. We assumed that all respiratory illnesses among individuals 15 and over were NCD; and 
among those aged 15 and below, non-NCD.    
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Table 4.2c: Length of Illness and Health Care Utilization, by Disease, Dead Individuals,  
Age 15 Years and Above, 2004 
 
 
Health Condition 
 
 
Hospitalized Cases in 1 Year Preceding the Survey 
 
Number of Hospital 
Stays 
(000s) 
 
Number of 
Individuals 
(000s) 
 
Average Length of 
Illness  (days) per 
Stay 
CVD (excl. 
hypertension) 
 
196 
 
150 
 
20.9 
 
Hypertension 
 
14 
 
13 
 
13.9 
Respiratory 
Conditions 
 
68 
 
5 
 
14.5 
 
Asthma 
 
91 
 
60 
 
31.0 
Disorders of 
Joints/Pain 
 
4 
 
3 
 
12.0 
Disease of 
kidney/urinary system 
 
49 
 
38 
 
26.4 
Neurological 
Disorders 
 
54 
 
22 
 
30.0 
Psychiatric 
Disorders 
 
1 
 
1 
 
16.0 
 
Diabetes 
 
37 
 
23 
 
46.2 
 
Accidents & Injuries 
 
107 
 
54 
 
21.0 
Cancers & Other 
Tumors 
 
154 
 
95 
 
23.4 
 
All NCD 
 
781 
 
470 
 
23.9 
All other conditions 
(incl. undiagnosed) 
 
509 
 
307 
 
25.8 
 
All Diseases 
 
 
1,289 
 
776 
 
24.7 
Note: Authors’ estimates, based on data from the 60th round (2004) of the National Sample Survey Organization that 
surveyed nearly 80 thousand households on health care utilization, expenditure and other information. Note that 
some individuals would have multiple hospital stays for different reasons. The 3rd column indicates individuals by 
the reason for their last hospitalization prior to death.     
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Table 4.2d: Length of Illness and Health Care Utilization, by Disease, Dead Individuals,  
Less than 15 Years, 2004 
 
 
Health Condition 
 
 
Hospitalized Cases in 1 Year Preceding the Survey 
 
Number of Stays 
(000s) 
 
Number of 
Individuals 
(000s) 
 
Average Length of 
Illness (days) 
CVD (excl. 
hypertension) 
 
5.5 
 
5.5 
 
4.8 
 
Hypertension 
 
0 
 
0 
 
n. a. 
 
Asthma 
 
1.6 
 
1.6 
 
15.0 
Disorders of 
Joints/Pain 
 
0 
 
0 
 
n. a. 
Disease of 
kidney/urinary system 
 
2.3 
 
2.3 
 
56.5 
Neurological 
Disorders 
 
6.6 
 
6.6 
 
26.0 
Psychiatric 
Disorders 
 
0 
 
0 
 
n. a. 
 
Diabetes 
 
1.1 
 
1.1 
 
10.0 
 
Accidents & Injuries 
 
18.1 
 
18.1 
 
15.6 
Cancers & Other 
Tumors 
 
0.6 
 
0.6 
 
15.0 
 
All NCD 
 
35.7 
 
35.7 
 
18.3 
All other conditions 
(incl. undiagnosed) 
 
147.5 
 
147.5 
 
10.4 
 
All Diseases 
 
 
183.2 
 
183.2 
 
11.9 
Note: Authors’ estimates, based on data from the 60th round (2004) of the National Sample Survey Organization that 
surveyed nearly 80 thousand households on health care utilization, expenditure and other information. We assumed 
that all respiratory illnesses among individuals 15 and over were NCD; and among those aged 15 and below, non-
NCD.    
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Table 4.3a: Estimating the Mincer Equation: 
Regression Results for All Workers Aged 15 Years and older, 2004 
 
 
Explanatory Variables 
Rural Urban 
Males Females Males Females 
 
Intercept  
3.657* 
(0.019) 
3.283* 
(0.034) 
4.260* 
(0.021) 
3.815* 
(0.042) 
Primary education = 1, if 
completed, 0 otherwise  
0.155* 
(0.010) 
0.0927* 
(0.036) 
-0.0724* 
(0.018) 
0.050 
(0.039) 
Middle Education = 1, if 
completed, 0 otherwise 
0.266* 
(0.012) 
0.109* 
(0.026) 
0.060* 
(0.018) 
0.124* 
(0.045) 
Secondary education = 1, if 
completed, 0 otherwise 
0.607* 
(0.019) 
0.611* 
(0.057) 
0.421* 
(0.019) 
0.824* 
(0.050) 
Higher-secondary education 
= 1 if completed, 0 
otherwise 
0.883* 
(0.146) 
0.323 
(0.562) 
1.188* 
(0.061) 
1.168* 
(0.238) 
 = 1 if college educated or 
higher, 0 otherwise  
1.335* 
(0.038) 
1.439* 
(0.068) 
1.083* 
(0.023) 
1.409* 
(0.036) 
= 1, if technical 
diploma/certificate, 0 
otherwise 
0.532* 
(0.257) 
-0.572 
(0.579) 
0.360* 
(0.076) 
0.412 
(0.283) 
Experience 
0.003* 
(0.001) 
0.003 
(0.002) 
-0.005* 
(0.002) 
-0.009 
(0.029) 
Experience-squared 
-0.00001 
(0.00002) 
-0.00005+ 
(0.00003) 
0.00025* 
(0.00004) 
0.00012* 
(0.00005) 
 
R-squared 0.177 0.112 0.272 0.338 
 
Number of Observations 49,782 19,555 43,965 9,804 
Note: Authors’ estimates using household surveys on employment and unemployment undertaken by the National 
Sample Survey Organization for 2003-4. Estimates are based on OLS methods and do not consider selection and/or 
endogeneity problems. The dependent variable is the natural log of the daily wage. Self-employed individuals were 
excluded from the regression. 
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Table 4.3b:  Estimating the Mincer Equation:  
Regression Results for Casual Workers Aged 15 Years and older, 2004 
 
 
Explanatory Variables 
Rural Urban 
Males Females Males Females 
 
Intercept  
3.475* 
(0.013) 
3.192* 
(0.021) 
3.619 
(0.028) 
3.567* 
(0.079) 
Primary education = 1, if 
completed, 0 otherwise  
0.168* 
(0.010) 
0.095* 
(0.018) 
0.164* 
(0.024) 
0.095* 
(0.045) 
Middle Education = 1, if 
completed, 0 otherwise 
0.206* 
(0.010) 
0.096* 
(0.023) 
0.179* 
(0.023) 
0.029 
(0.064) 
Secondary education = 1, if 
completed, 0 otherwise 
0.274* 
(0.017) 
0.135* 
(0.037) 
0.295* 
(0.029) 
0.264* 
(0.109) 
Higher-secondary education 
= 1 if completed, 0 
otherwise 
-0.023 
(0.102) 
-0.848* 
(0.180) 
-0.063 
(0.197) 
0.373* 
(0.038) 
 = 1 if college educated or 
higher, 0 otherwise  
0.294* 
(0.053) 
0.193 
(0.147) 
0.332* 
(0.076) 
0.584* 
(0.163) 
= 1, if technical 
diploma/certificate, 0 
otherwise 
0.003 
(0.153) 
0.762* 
(0.206) 
0.672+ 
(0.359) 
No 
observations 
Experience 
0.013* 
(0.001) 
0.008* 
(0.002) 
0.024* 
(0.003) 
-0.002 
(0.005) 
Experience-squared 
-0.00018* 
(0.00001) 
-0.00013* 
(0.00002) 
-0.00033* 
(0.00005) 
-0.00002 
(0.00007) 
 
R-squared 0.036 0.007 0.055 0.021 
 
Number of Observations 36,271 16,843 11,595 3,151 
Note: Authors’ estimates using household surveys on employment and unemployment undertaken by the National 
Sample Survey Organization for 2003-4. Estimates are based on OLS methods and do not consider selection and/or 
endogeneity problems. The dependent variable is the natural log of the daily wage. Self-employed individuals were 
excluded from the regression. 
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Table 4.3c:  Estimating the Mincer Equation:  
Regression Results for Regular Workers Aged 15 Years and older, 2004 
 
 
Explanatory Variables 
Rural Urban 
Males Females Males Females 
 
Intercept  
4.254* 
(0.022) 
3.831* 
(0.090) 
4.490* 
(0.023) 
3.950* 
(0.046) 
Primary education = 1, if 
completed, 0 otherwise  
-0.049 
(0.034) 
-0.036 
(0.201) 
-0.306* 
(0.021) 
-0.096 
(0.064) 
Middle Education = 1, if 
completed, 0 otherwise 
0.133* 
(0.033) 
0.001 
(0.079) 
-0.131* 
(0.019) 
-0.026 
(0.060) 
Secondary education = 1, if 
completed, 0 otherwise 
0.537* 
(0.031) 
0.624* 
(0.089) 
0.184* 
(0.020) 
0.651* 
(0.060) 
Higher-secondary education 
= 1 if completed, 0 
otherwise 
0.898* 
(0.154) 
0.540* 
(0.725) 
0.881* 
(0.060) 
0.922* 
(0.240) 
 = 1 if college educated or 
higher, 0 otherwise  
0.958* 
(0.047) 
1.077* 
(0.085) 
0.797* 
(0.023) 
1.200* 
(0.048) 
= 1, if technical 
diploma/certificate, 0 
otherwise 
0.154* 
(0.259) 
-1.818* 
(0.725) 
0.375* 
(0.074) 
0.463* 
(0.280) 
Experience 
-0.015* 
(0.003) 
-0.016* 
(0.006) 
-0.001 
(0.002) 
-0.002 
(0.004) 
Experience-squared 
0.00047* 
(0.00007) 
0.00025* 
0.00012) 
0.00024* 
(0.00004) 
0.000039* 
(0.00009) 
 
R-squared 
 
0.167 
 
0.182 0.251 0.267 
 
Number of Observations 
 
13,511 
 
2,712 32,370 6,653 
Note: Authors’ estimates using household surveys on employment and unemployment undertaken by the National 
Sample Survey Organization for 2003-4. Estimates are based on OLS methods and do not consider selection and/or 
endogeneity problems. The dependent variable is the natural log of the daily wage. Self-employed individuals were 
excluded from the regression. 
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Table 4.5: Annual Income Losses to Households Affected by NCDs in India, 2004  
(Estimate 1: Imputed wages for all working and non-working adults) 
 
 
Health Condition 
 
 
Income Losses (in Billions of INR) due to 
 
Illness 
 
Care-giving 
 
Premature 
death 
 
Total 
CVD (excl. 
hypertension) 
 
83.9 
 
43.0 
 
16.7-30.7 
 
144-158 
 
Hypertension 
 
131.9 
 
66.1 
 
1.2-1.4 
 
199 
Respiratory 
Conditions 
 
48.5 
 
38.4 
 
0.5-5.2 
 
87-92 
 
Asthma 
 
66.3 
 
35.4 
 
0.5-5.2 
 
102-107 
Disorders of 
Joints/Pain 
 
116.2 
 
59.2 
 
0.1-0.3 
 
175 
Disease of 
kidney/urinary system 
 
26.6 
 
14.6 
 
2.3-4.8 
 
44-46 
Neurological 
Disorders 
 
37.9 
 
21.4 
 
2.0-2.8 
 
61-62 
Psychiatric 
Disorders 
 
12.9 
 
7.0 
 
0.1-0.7 
 
20-21 
 
Diabetes 
 
106.6 
 
53.7 
 
2.2-2.3 
 
163 
 
Accidents & Injuries 
 
36.3 
 
22.2 
 
5.3-20.3 
 
64-79 
Cancers & Other 
Tumors 
 
12.7 
 
6.7 
 
3.0-8.0 
 
22-27 
 
All NCD 
 
679.8 
 
367.8 
 
46.3-65.5 
 
1,094-1,113 
NCD (excluding 
injuries) 
 
643.5 
 
345.6 
 
41.0-45.2 
 
1,030-1,034 
Note: Authors’ estimates, based on data from the 60th round (2004) of the National Sample Survey Organization that 
surveyed nearly 80 thousand households on health care utilization, expenditure and other information; combined 
with mortality data from the Medical Certification of Causes of Death (MCCD) of the Registrar General of India 
and the Burden of Disease statistics of the World Health Organization. The range of estimates for income losses 
arises due to premature death reflects the differing composition of causes of death in the National sample Survey, 
MCCD and the WHO data.    
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Table 4.6: Annual Income Loss due to NCDs, 2004 
(Estimate 2: Imputed Wages only to working adults) 
 
 
Health Condition 
 
 
Income Losses in (Billions of INR) due to: 
 
Illness 
 
Premature death 
 
Total 
CVD (excl. 
hypertension) 
 
29.7 
 
7.6-12.5 
 
37-42 
 
Hypertension 
 
42.3 
 
0.2-0.6 
 
43 
Respiratory 
Conditions 
 
23.8 
 
0.2-1.5 
 
24-25 
 
Asthma 
 
25.5 
 
0.2-1.8 
 
26-27 
Disorders of 
Joints/Pain 
 
41.0 
 
0.0-0.2 
 
41 
Disease of 
kidney/urinary system 
 
12.9 
 
0.7-2.5 
 
14-15 
Neurological 
Disorders 
 
10.3 
 
0.3-0.8 
 
11 
Psychiatric 
Disorders 
 
3.0 
 
0.0-0.3 
 
3 
 
Diabetes 
 
40.5 
 
0.5-0.8 
 
41 
 
Accidents & Injuries 
 
21.7 
 
3.5-10.1 
 
25-32 
Cancers & Other 
Tumors 
 
4.4 
 
1.1-2.9 
 
5-7 
 
All NCD 
 
255.4 
 
22.5-27.5 
 
278-283 
All NCD (excluding 
injuries) 
 
233.5 
 
17.7-17.9 
 
251 
Note: Authors’ estimates, based on data from the 60th round (2004) of the National Sample Survey Organization that 
surveyed nearly 80 thousand households on health care utilization, expenditure and other information; combined 
with mortality data from the Medical Certification of Causes of Death (MCCD) of the Registrar General of India 
and the Burden of Disease statistics of the World Health Organization. The range of estimates for income losses 
arises due to premature death reflects the differing composition of causes of death in the National sample Survey, 
MCCD and the WHO data.   
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C H A PT E R  5. I M PA C T  OF  NC DS ON I NDI A ’ S NA T I ONA L  I NC OM E  A ND 
A G G R E G A T E  W E L L -B E I NG  
 
5.1. Introduction 
We now direct our attention to a second key element of the “cost” of NCDs: namely the 
implications for the economy/society as a whole. In this chapter we develop estimates of two 
different versions of aggregate impacts: one on the gross domestic product (GDP) or national 
income, and the other on the value of statistical lives lost.  
5.2. Methods and Data  
Estimating Annual Income Losses: The Production Function Approach 
A standard way to estimate national income losses associated with ill health is to 
visualize an aggregate production function that links national output (or GDP) to indicators of 
“base” labor, capital and human capital indicators (such as educational achievement, work 
experience and health). To calculate the impact of NCDs on GDP we need to answer the 
following question: How much would national income change when there are changes in 
educational achievement, number of workers, life expectancy and capital stock due to ill health 
and death associated with NCD? A technical way of putting this is to say we are interested in the 
total-derivative of national income with respect to NCD. 
The usual way to get at this total derivative is to use specific functional forms for the 
aggregate production function, such as a Cobb-Douglas formulation such as in equation (5.1) 
below 
 (5.1)  ββ −= 1HAKGDP   
Here, K is an indicator of the stock of physical capital, and H is an indicator of the stock 
of human capital. The parameter β denotes the share of physical capital in total income and, 
therefore, β−1  is the share of human capital in national income. A is a technology parameter. 
Furthermore, we could write the human capital stock H as a function of a unit of labor (or “base” 
labor) times an indicator of the human capital embedded in labor (Q), which depends on health 
(such as life expectancy at birth), schooling, and experience (see equation (5.2)). That is  
 (5.2)  
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We obtained one set of parameter estimates of 321 ,,,, θθθαβ from a recent paper by 
Bloom, Canning and Sevilla (2004) that used a panel of a cross-section of countries, and another 
set of estimates from Duraisamy and Mahal (2005) who estimated a similar (but not identical) 
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specification for a panel for a cross-section of Indian states. Table 5.1 reports the results of 
regression coefficients from these two papers.  
The impact of NCD on national output was then assessed by estimating the impact on 
each of its determinants. We estimated the impact of NCD on the labor force and on other 
indicators of human capital - life expectancy at birth, schooling, and experience – factors that 
enter into the aggregate production function. Specifically, we inquired what the life expectancy 
at birth would have been had there not been any NCD cases in the population in India, and 
similarly for schooling and experience. To figure out the impact of eliminating NCD on life 
expectancy at birth, we used the most recent abridged life tables from the Registrar General of 
India. Assuming that the share of NCDs in total deaths in each age group was the same as that 
reported in the MCCD data, we re-estimated age-specific mortality rates after “removing” all 
mortality due to NCD, and constructed a new set of life tables with these lowered mortality rates. 
In recalculating life-tables in the absence of NCD, one option is to assume that the risks of death 
from other (non-NCD) causes are statistically independent of NCD. This is not a realistic 
assumption, but to address the possibility that the risks are dependent across illnesses is an entire 
project in and of itself. To partially address this concern, in our calculations we assumed that age 
specific mortality rates after the age of 65 years remain unchanged even after NCDs are 
eliminated, owing to co-morbidities and competing risks. This is an area where further work 
might be useful (Honore and Lleras-Muney, 2006). Under our assumptions, we obtained an 
estimated of 71.0 years after elimination of deaths due to NCDs (compared to 63.6 years prior to 
the elimination of NCDs).  
Sample survey data on experience and educational attainment of individuals with (and 
without) NCD was used to assess what the experience and educational levels would have been in 
the absence of NCD in the Indian population. Specifically, we inquired whether accounting for 
the experience and educational levels of individuals who were ill and/or died of NCD would 
have substantially changed the average levels of education and experience in the labor force. In 
this exercise, we assumed that any labor time “gained” (in the 15 years and over age-group) on 
account of less time spent being ill (or dying prematurely), or not being involved in care-giving 
activities acts to add to the labor force in the 15+ age category. Again, a more careful analysis 
(that we did not pursue) would need to examine the potential labor market impacts of adding 
these individuals back to the labor force. Estimates of average schooling, experience and 
experience squared in the baseline were obtained for two groups in the population – those with 
NCDs and for the population as a whole (for our projections, only the latter is relevant and 
shown in Table 5.2). To get at the values of these variables in the case where there were no 
NCDs, we considered the higher labor force (715 million and 671 million in Table 5.2) and 
assumed that all the extra laborers were endowed with the average schooling and experience of 
individuals currently reporting NCDs. The additional labor time included not only the persons 
who would now be alive, but also the additional labor time saved by reduced morbidity from 
NCDs. Because the education and experience variables among the NCD-population are higher, 
the reduction in NCDs increases the average of these variables for the population as a whole.  
Given the econometric specifications in Table 5.1, we also needed to make assumptions 
about how the physical capital stock will be affected by NCDs. Presumably, both foreign and 
domestic investment would respond to improvements in health, such as the elimination of 
morbidity and mortality due to NCDs. Given that foreign direct investment flows into India are 
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relatively small compared to the size of its economy we focused on the impact of NCDs on 
domestic investment. Even here, we limited ourselves to the impact of NCD related health 
expenses on net domestic investment and capital, public and private. We considered three 
possible scenarios relating to the impact of NCD on domestic investment: (a) all of the out of 
pocket spending on NCD came out of savings (and investment); (b) only half of the spending on 
NCD was from reduced savings; and (c) savings were not affected at all by NCD expenditures. 
These scenarios had virtually no effect on our results and so in Table 5.2 we report the results for 
the case where all of the savings come out of investment. Table 5.2 also presents our estimates of 
different explanatory variables under two major alternative scenarios – with and without 
morbidity and mortality due to NCDs.           
A technical issue of direct relevance to these calculations was the estimation of the stock 
of capital. We used data provided by India’s Central Statistical Organization (CSO) on a time 
series of net private investment to construct a corresponding capital stock series. This was done 
was assuming an annual depreciation rate of 5 percent, following a “straight-line” depreciation 
method. No information on annual government investment was available; although data on 
government spending was available from government budget documents. We assumed that the 
portion of government spending under the “capital account” was essentially government 
investment, with the rest being consumption expenditure. With this information, estimates of 
government capital stock were constructed using methods identical to that of private capital 
stock. Three scenarios of the impact of public spending on health associated with NCD on 
government investment were considered. Government subsidies on health were assumed to 
directly come out of government investment allocations. Because the BCS and the DM models 
do not distinguish between public and private capital, we add up the two sets of estimates (for 
public and private stocks of capital) for our simulation exercises.    
Our analysis does not consider other factors that might also influence national output. 
Specifically, it underplays demand-side factors, such as the fact that increased health spending 
might lead to rising incomes via some type of multiplier effect. The reason for doing so is our 
reliance on the empirical counterpart of the neoclassical (Solow) model of economic growth that 
assumes full employment via flexible prices. Bringing in health spending as a demand factor in 
this model will essentially result in health spending influencing relative prices and the 
composition of national output. This possibility is probably best modeled in terms of computable 
general equilibrium (CGE) models that have their own problems (Bloom and Mahal 1997). In 
the presence of a demand-side effect, our method of calculating the aggregate economic impacts 
of NCDs will probably result in an overestimate of the true effect of NCDs on national output.  
Estimating Welfare Loss: The Value of Statistical Life Years Lost due to NCDs 
To complement estimates of the potential impact of NCDs on India’s GDP, we estimated 
the value of statistical life years foregone due to NCDs in 2004. This exercise is quite different 
from estimating losses to national income and is best interpreted as an indicator of the “welfare 
loss” that occurs due to NCDs.  
There are a number of other technical issues that are worth noting here, and which have 
to do with the allocation of the value of statistical life year losses to a specific year (2004 in our 
case). First, as a practical matter, since all individuals must die at some point in time it makes 
little sense to attribute the entire welfare loss associated with a death (the value of a statistical 
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life) to its specific cause. Indeed the most appropriate option is to value the years lost by 
‘premature’ nature of the death associated with NCDs. For instance, if were to focus on a single 
birth cohort, what matters for our purposes is that the life expectancy at birth in India would rise 
to 71 years (from 63.6 years), were NCDs to be eliminated without increasing the risks of death 
from other causes until the age of 65.8
Second, there are two ways of approaching this valuation: we could seek to value the 
years of life foregone by individuals who die in a given year due to NCDs (ex post) or value the 
number of years that a cohort born in a given year would not enjoy (ex ante valuation). If we 
value the years lost by deaths from NCDs in a given year, we would need to figure out the 
collective numbers of years that they would have lived, had they not acquired a NCD. On the 
other hand, if we focus on births, we would value the addition to the life expectancy (at birth) 
that a birth cohort in a given year would enjoy were there to be no NCD. Because, the additional 
years of life occur some time in the future, discounting will be necessary. The ex-post method 
will yield higher estimates because the additional years gained from eliminating NCDs are much 
closer to the time they are being valued. To be conservative, we simply use the ex ante method – 
that is value the difference in the value of statistical life years of a given birth cohort with (and 
without) NCDs. 
 It is this average loss of 7.4 years of life that we wish to 
evaluate monetarily.     
Third, it should be noted that our estimates will not provide anything more than an 
indicative assessment of the potential welfare gains foregone, since we are valuing only the 
addition to the (statistical) lives of individuals who were born in 2004. The value of a healthy life 
foregone to individuals with NCD who do not die (including any persons disabled due to NCD) 
is excluded from the calculations for that specific year. Similarly, the life tables we use do not 
allow for the likelihood of ongoing technological change that might lower the risk of NCD 
mortality for the cohort born this year and thus we might even overestimate the welfare gains 
from eliminating NCDs.   
The financial value of a life lost was calculated on the basis of the estimates reported in 
Viscusi and Aldy (2003). They summarize the results of a very large number of cross-country 
studies, in addition to providing estimates of their own, and suggest that the income elasticity of 
the value of a statistical life ranges between 0.5 and 0.6 (a mid-point of 0.55). Studies for the 
United States suggest a value of statistical life of the order of US$6 million (Kniesner et al. 
2005) for workers with incomes in the range from US$30,000-US$40,000. We use the 
information on average imputed daily wages (as well as per capita income based on a simple 
division of GDP by the working age population) as our indicators of incomes to construct two 
corresponding indicators of the value of a statistical life using the Viscusi-Aldy results. In 
general, GDP per worker (INR 41,096) is higher than the imputed wages (INR 23,225) estimated 
from household survey data and results in higher estimates of the value of life.  
Based on the estimated value of a statistical life of given duration, we calculated the 
annualized value of a statistical life year for a person born in 2004, using a standard annuitization 
formula (Viscusi and Aldy 2003). Specifically, if VSLY is the value of a statistical life year 
(constant for the rest of a person’s life) for a person of a specific age, V the value of a statistical 
                                                 
8After the age of 65 years, we assume that competing risks increase by just enough to balance any reduction in 
mortality associated with NCDs. 
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life, “r” the rate of discount, and L the number of years this person can expect to live, we have 
that 
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5.3. Findings and Discussion 
 
  Referring again to Table 5.2, we compared two scenarios to the baseline (the existing 
situation). Under the first of these scenarios we estimated the values on the set of baseline 
explanatory variables used in Bloom, Canning and Sevilla (2004) and in Duraisamy and Mahal 
(2005), if mortality and morbidity due to NCD were completely eliminated and labor time lost 
equaled the total number of days individuals reported as ill from NCDs but half the year for a 
person dying during the year. Under the second scenario, the number of days of work-time lost 
was assumed to be half a year each for a person dying during the year, and the number days 
spent as an inpatient of a hospital during the year. These reflect the possibility of changing work 
force participation rates on account of death or morbidity associated with NCDs. The two 
scenarios are referred to as Case 1, and Case 2, respectively.     
Table 5.3 reports our main findings. Our analysis suggests that were NCD to be 
completely eliminated, the estimated GDP in a year such as 2004 would have been 5 to 10 
percent higher under the Bloom, Canning and Sevilla estimates, and 4 to 9 percent higher under 
the Duraisamy and Mahal estimates. Per capita GDP would also be higher. The primary driver of 
these results on GDP is the change that is due to life expectancy at birth. In this, our findings 
differ from those of Abegunde et al. (2007) whose focus is on a Solow-type production function 
downplays the influence of the quality of labor (life expectancy) on national output.  
Estimating Impacts on the Value of Statistical Life Years 
If our interest is in the welfare implications of eliminating NCDs, the size of the GDP (or 
GDP per capita) is probably not the right metric as it captures only one dimension of the 
potential gains that result. Indeed, the more significant gain is likely to be the increase in the 
number of years lived. For this reason, we focus on the value of statistical lives that could be 
saved by eliminating NCDs. We used two sets of estimates for annual income in India – the 
average imputed wage for people with NCDs in our sample survey; and GDP per adult worker. 
This information was combined with information on the value of a statistical life of US$4.35 
million for a sample of workers in the United States, and an income elasticity of the value of a 
statistical life of 0.55 (US$1=INR 45 in 2004), to obtain the value of a statistical life for India. 
This was roughly INR 90.9 million if we used the GDP per worker as an estimate of income and 
INR 89.7 million if we used the imputed wage method (or about US$2 million in both cases).  
Using a discount rate of 5 percent and a life expectancy for a worker aged 25 of 47.5 
years (based on life tables for India) we obtained the value of a statistical life year as INR 473 
thousand (using the GDP per worker method) and INR 467 thousand (using the imputed wage 
method). These estimates were used to assess the potential gains to newborns in the year 2004 in 
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terms of the value of additional life years lived. Because the gains in 7.4 additional life years (on 
average) due to the elimination of NCDs occurring far in the future, the present discounted 
monetary value of this gain was in the range of INR 133 thousand and INR135 thousand. With 
roughly 25.9 million births in 2004, the potential gains to the cohort born in 2004 could be 
anywhere between INR 3,445 billion and INR 3,497 billion. These (potential) welfare gains 
amount to between 13 percent and 14 percent of GDP – slightly higher than our estimates of the 
impact of NCDs on GDP reported in Table 5.3.  
More precise estimates must await the availability of better quality data that provides us 
with good disease-specific information, as well as on analyses that can better help address the 
challenge of isolating the impact of competing health risks. In addition, for our calculations we 
relied upon the implicit assumption that competing risks are statistically independent, an 
assumption that simplifies our task of estimating the value of life lost on account of disease, a 
somewhat unsatisfactory state of affairs. In the next chapter we take up this issue more directly.  
Overall, there appear to be significant aggregate economic impacts of NCDs on India, 
whether measured in terms of potential GDP (or GDP per capita) foregone, or a welfare measure 
such as the combined statistical value of life years that could be gained were NCDs to be 
eliminated for any birth cohort. This conclusion is similar in spirit to that of Abegunde et al. 
(2007) and others who have used alternative methods to assess the aggregate economic impacts 
of NCDs. Thus there are potentially large gains to be had from investing in cheap interventions 
that can help either treat (or prevent) NCDs. Were we to include the income (or welfare) losses 
resulting from disability associated with NCDs, the potential welfare (and income) gains are 
likely to be considerably higher.  
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Table 5.1: Estimates of Regression Coefficients Used to Simulate Impact of NCD on GDP 
 
 
Explanatory 
Variables 
 
 
Ln GDP 
BCS Specification 
 
Ln GDP 
DM Specification 
 
Ln (Labor) 
 
0.708 
 
0.522 
 
Ln (Capital) 
 
0.342 
 
0.340 
Life Expectancy at 
Birth 
 
0.013 
 
 
Ln  
(Life Expectancy at 
Birth) 
  
0.723 
 
Years of Schooling 
 
0.082 
 
Ln (Years of 
Schooling) 
 
 
 
0.256 
 
Experience 
 
0.266 
 
 
Experience-Squared 
 
-0.005 
 
Sources: Duraisamy and Mahal (2005), Table 6 (DM); Bloom, Canning and Sevilla (2004) Table 3 (BCS). The DM 
specification did not include experience variables owing to the high degree of multi-collinearity across schooling 
and experience in the cross-province panel dataset for India.    
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Table 5.2: Values of Key Explanatory Variables for Simulating Impact of NCD  
on GDP in 2004 
 
 
Variables 
 
With NCD 
 
Without NCD 
Case 1 Case 2 
 
Labor (15+) 
(millions) 
 
667.69 
 
715.11 
 
670.58 
 
Private Capital 
(INR billions) 
 
29,552 
 
29,952 
 
29,952 
“Public” Capital  
(INR billions) 
 
13,476 
 
13,588 
 
13,588 
 
Life Expectancy at Birth 
(Years) 
 
63.6 
 
71.0 
 
71.0 
 
Average Schooling 
(Years) 
 
4.65 
 
4.64 
 
4.65 
 
Experience 
 
 
25.89 
 
26.93 
 
25.96 
 
Experience-Squared 
 
 
1008.22 
 
1,084.28 
 
1,013.16 
Note: In our calculation of life expectancy at birth, with and without NCDs, we assumed competing risks of 
mortality (from communicable diseases) to be independent of risks of mortality from NCD. The baseline estimate of 
life expectancy at birth (63.6 years) differs from official estimates owing to our use of abridged life tables so as to 
correspond better with age distribution of deaths reported in MCCD. The “increase” in labor force is artificial in that 
we are adding labor time saved on account of avoided illness, lower care-giving and avoided deaths. Case 1 
assumes that labor time lost occurs both due to illness as well as health. Case 2 assumes that only the time spent as 
an inpatient in a hospitals (plus death) is not recovered. 
 
Table 5.3: The Impact of NCD on GDP and Per Capita GDP in India, 2004 
 
 
 
Variables of Interest 
BCS Method DM Method 
 
Case 1 
 
Case 2 
 
Case 1 
 
Case 2 
 
Change in GDP (percent) 
 
 
4.48 
 
10.25 
 
12.62 
 
8.95 
 
Change in Per Capita GDP  
(percent) 
 
4.35 
 
10.02 
 
12.39 
 
8.72 
Note: BCS Estimates are based on regression results reported in Table 3 of Bloom, Canning and Sevilla (2004, 
p.10), and the numbers presented in Table 5.2. DM estimates are from Duraisamy and Mahal (2005), Table 6. Per 
Capita GDP estimates were calculated as percent change in GDP minus the percent change in population..  
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C H A PT E R  6. T H E  I M PA C T  OF  NC DS ON E C ONOM I C  OUT C OM E S I N I NDI A :  
T A K I NG  A C C OUNT  OF  C OM PE T I NG  R I SK S 
 
6.1. Introduction 
As noted in Chapter 2, standard methods for assessing the cost of illness and/or economic 
losses typically assume that the risks of morbidity/mortality from NCDs and other (non-NCD) 
conditions are statistically independent. While this generally makes it easier to undertake the 
desired analyses, this assumption is inappropriate owing to the existence of statistically 
dependent competing risks. In this chapter we aim to partially address this difficulty. Our 
purpose is to illustrate, using cross-sectional household survey data for India, the use of a 
propensity score matching approach to address the bias resulting from not taking account of 
interdependent competing risks when attributing direct health care expenses, and other economic 
impacts to NCD.  
For each individual with NCD (in this chapter we use CVD, cancers and injuries for 
illustrative purposes), we find a control possessing similar observed pre-determined 
characteristics. We can then assess the economic impact of acquiring NCD by comparing the 
outcome for each person with his, or her, matched control. We show below that our matched 
control group is quite different from our random sample of people, both in terms of their 
observed characteristics such as education level, age, location of residence, and in terms of their 
health and economic outcomes. Matching to the control group therefore makes a significant 
difference to our estimates of the economic impact of CVD, cancers and injuries.  
The dataset - the 60th round of the National Sample Survey Organization, conducted in 
2004 – has been previously described. As noted, the survey collected information on the 
socioeconomic and demographic characteristics of the households and their members, in addition 
to hospitalization in the year preceding the survey, and on reported morbidity in a reference 
period of 15 days preceding the survey. We had information on the work status of household 
members, including whether they were involuntarily unemployed, not currently working, self 
employed, whether working for wages, and so forth. Information was collected on the nature of 
ailments, the type of treatment sought (public or private) and on the number of outpatient visits 
and inpatient days. Moreover, information was collected on the amounts spent on treatment for 
each health condition. Self-reported information was available for several health conditions. 
Because our purpose in this chapter is to illustrate the potential consequences of competing risks, 
we focus on three conditions: cardiovascular disease, cancers and injuries. In the 60th round 
survey, respondents who reported suffering from “heart disease” or “hypertension” were 
classified as experiencing CVD. The survey data were combined with independent information 
on poverty lines (or survival expenditure levels) obtained from the Indian Planning Commission 
for the two years in question.    
6.2. Methods 
We focused on the association between NCDs and economic outcomes. Firstly we 
inquired about the relationship between a person’s work status and NCD. For this purpose we 
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considered a broader definition of ‘not working,’ including, besides the involuntarily 
unemployed, individuals attending educational institutions, or involved in domestic work and 
pensioners. This was done owing to the extremely small numbers of involuntarily unemployed 
individuals in Indian household surveys and high rates of “disguised unemployment,” which 
suggested a need to consider alternative ways to assessing individuals’ employment status.  
Following Xu et al. (2003) and Doorslaer et al. (2006, 2007), we considered two
ijD
 
measures of the impact of NCD-related health sending on the economic status of individuals. 
The first was an indicator of whether the health spending was “catastrophic.” Here “catastrophic” 
spending (for each individual) was defined as occurring when hospitalization spending for that 
person as a proportion of ability to pay (household consumption spending less combined survival 
income for all household members) exceeded a certain threshold: we used a threshold of 30 
percent for our analysis, although other cut-offs are obviously possible. Survival income was 
defined as the poverty line level of expenditure multiplied by household size. Mathematically, 
for each individual “i” in household “j”, we defined a variable  as 
PnE
h
D
jj
ij
ij −
=  
Here, ijh is the health spending of individual “i” in household “j”, jE is total household 
consumption spending, jn is the size of household “j”, and P is the poverty line level of spending 
in this economy. Catastrophic spending is said to occur whenever ijD exceeds 0.3 in our 
framework. Note that this approach to defining catastrophic spending at the individual level 
ascribes to each individual the potentially catastrophic implications (to their household) of their 
individual-specific health spending. Non-sick members of the household would not impose any 
catastrophic financial consequences on the household under this method. This approach seems to 
us reasonable, with one caveat. The measure of the impact of NCD-related health spending on 
catastrophic spending that we use underestimates the contribution of individual-specific health 
spending to the household’s economic burden. This is because if there are multiple individuals 
who spend on hospitalization within the same household, their expenditures may be catastrophic 
in ‘combination’ but not individually so. Of course, the same argument holds for the economic 
burden of communicable diseases. To an extent, matching, by putting similar individuals 
together, addresses this concern if both NCDs and CDs are experienced within the same 
household. However, this ‘correction’ will not work if households have multiple members with 
NCDs.  
We also used an indicator of the impoverishing effects of an individual’s health spending. 
Specifically, we considered health spending as impoverishing to the household if, after 
subtracting it from household spending, an individual household member’s per capita 
expenditure moved him/her from above a poverty-line level of spending to below it. Again, 
consider an individual “i” and household “j” and a variable ijE , where (a)
j
j
ij
b
n
E
E = indicates the 
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individual’s spending (gross of health spending); (b)
j
ijj
ij
a
n
hE
E
−
= as the individual’s spending 
net of his (her) specific health spending.  
If PE ijb > and PE ija < if , we say that the health expenses of this individual are 
impoverishing the household in question. Of course, modelling the poverty impact in the manner 
of the previous paragraph requires the assumption that there are no economies of scale in the 
allocation of household spending. Incorporating such considerations, by using equivalence 
scales, such as in Xu et al. (2003), or as in Doorslaer et al. (2006) is straightforward.   
We used the propensity score matching method to compare hospitalization rates, length 
of inpatient stays, amounts spent out-of-pocket for health care, unemployment status, work 
status, and measures of catastrophic spending and impoverishment for individuals who reported 
CVD, cancer, and injuries, respectively with those who did not.   
The sampling approach of India’s National Sample Survey Organization introduced some 
complications in this endeavour. Because self-reported morbidity information on individuals was 
available only for those individuals who were hospitalized in the year preceding the survey, and 
in the 15-day reference period preceding the survey, it is possible that some individuals with 
chronic conditions were under-recorded in our analysis. Consider an individual who suffered an 
acute myocardial infarction two years earlier and is now taking medication to keep blood 
pressure and other complications in check. While the specific question in the survey instrument 
does allow for such conditions to be reported – namely, “ailments that started more than 15 days 
ago and are continuing,” it is not clear, if under field conditions, an individual did (or did not) 
adequately identify them. There is some evidence of this phenomenon based on estimates of 
survey-based NCD prevalence in Table 2.1 If such omissions are significant, our method may 
understate the potential health care costs of NCD. As another example, many individuals may 
not be aware (and, therefore, would not have reported) suffering from hypertension. This last 
omission could result in propensity score matching methods overstating the per person health 
care costs of CVD because severe cases are more likely to be reported.  
The major worry, however, is that having a specific NCD and being counted in our 
“treatment” group is itself non-random and may correlate with an individual’s other confounding 
characteristics. Propensity score matching methods help to generate a set of controls (individuals 
who self-report themselves not to have that NCD condition) corresponding to treatment cases 
(individuals who report themselves to have the specific NCD). Specifically, individuals who 
have a specific NCD are matched to individuals who do not have that specific NCD but do 
possess similar predicted probabilities (propensity score) of having that NCD, conditional on a 
set of observable characteristics.  
The key assumption in this approach is that conditional on the propensity score, 
assignment to the treatment (with NCD) and control (without NCD) groups can be taken to be 
random (Rosenbaum and Rubin 1982).  If this is the case, then the difference in outcomes 
between treatment and control groups can be directly compared to give the effect of "treatment". 
However, the control group is only truly valid if the likelihood of reporting the specific health 
condition is equal for each individual after conditioning on the controls we use. One test of this 
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assumption is that conditional on the propensity score, the observable predetermined 
characteristics of the two groups have similar distributions. Even if this “balancing” property is 
satisfied, we still have to assume that selection to the treatment group is not based on 
unobservable characteristics that also affect our outcome variables. If the likelihood of reporting 
a CVD is correlated with unobserved confounders we may be measuring the effect not of the 
CVD but of these confounders. In the absence of real experimental data, estimating the effect of 
having CVD adjusting for observable confounders, as we do, seems better than not adjusting at 
all, even if it falls short of adjusting for all possible confounding effects and likely to better 
address biases relating to competing risks. Our cross-sectional data are ill equipped to address 
this concern, which a longitudinal dataset is better equipped to address. 
We used two procedures, which all use propensity scores, to assess “nearness” between 
control and treated cases: the stratification method and the nearest neighbour method (Becker 
and Ichino 2002). Both methods all yielded very similar estimates of the impact (three types) of 
NCD conditions on outcomes. These conditions were cardiovascular disease, cancers and 
injuries that accounted for nearly one-sixth of all hospitalizations in 2004 according to NSS data. 
Treatment cases and control cases were further restricted to a common support, thereby 
eliminating cases in which the treatment and nearest control may be quite far apart. The 
“propensity score” on which these individuals were matched was constructed by a logit 
regression of treatment status (for example, 1 if CVD, 0 if not) on observables that included age 
categories, region of origin (north, south, central, west), rural origin, indicators of primary, 
secondary and higher levels of education; indicators of caste. Separate matching exercises
6.3. Findings  
 were 
undertaken for males and females. The list of explanatory variables used for this matching 
exercise includes only individual characteristics, and does not include household expenditures, 
household size, marital status, health expenditures, or asset holdings, since these variables are all 
likely to be endogenous. Including endogenous household level variables in the matching would 
bias our results. 
We describe our results separately by cardiovascular disease, cancers and injuries. 
According to the National Sample Survey data of 2004, there were nearly 1.7 million hospital 
stays on account of heart disease, 0.9 million hospital stays due to cancer and 3.0 million hospital 
stays associated with accidents and injuries. In addition, there were 68 million outpatient visits 
each associated with CVD and accidents/injuries and about 13 million visits for cancer. In 
presenting our findings, we do not report results for the first stage logit regressions that were 
used to construct propensity scores except to note that the likelihood of reporting cancers and 
CVD rises with age and educational attainment and is lower for members of lower castes. In 
addition, there were regional variations in reported prevalence rates of cancers, CVD and 
injuries. 
Cardiovascular Disease  
We used the estimated propensity scores from the first-stage logit regressions to match 
each individual reporting CVD (the treatment group) with a control individual who did not report 
CVD (including individuals who might have reported other health conditions classified as NCD). 
We use the nearest neighbour matching (random assignment if equidistant and with replacement) 
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methods. Tables 6.1a and 6.1b summarize sample means for three groups, separately for males 
and females: individuals with CVD (the treatment group); individuals from the random sample 
who are matched to the treatment group under the nearest neighbour rule (the non-CVD control 
group); and the full set of individuals without CVD in the random sample. Notice that for our 
pre-determined variables--age, sex, religion, and ethnicity--there are considerable differences in 
the sample means between the treatment group (the column 1 in Table 6.1a and Table 6.1b) and 
the unmatched group (column 3). However, once the nearest neighbour criterion is used to 
generate a matched set of controls, the sample means of the pre-determined variables of the 
matched control group, shown in column 2 of Table 6.1a and 6.1b, are considerably closer to 
those of the treatment group (individuals reporting CVD). In the analysis that follows, this 
similarity between matched treated and control groups occurs repeatedly, so we limit our focus 
to outcome variables.  
Tables 6.1a and 6.1b also show that when we compare the outcomes of interest of the 
treatment with the matched control group -- hospitalization rates, likelihood of outpatient visits, 
health expenditures, impoverishment, and catastrophic spending rates -- the differences in 
sample means, with few exceptions, are large (in contrast to the set of pre-determined variables). 
These differences, all else the same, will be due to CVD. Moreover, the outcome variables can 
be very different between the matched control group and the full set of individuals in the survey 
who do not report a CVD. This indicates that individuals with the same pre-determined 
characteristics as individuals with CVD differ in their outcomes from the average of the non-
CVD sample.                 
Table 6.2 presents our findings on the effect of CVD on health care utilization, health 
spending, the likelihood of catastrophic spending and impoverishment among households and 
employment status. For each variable we compare the outcome for the individuals with CVD 
with that for a set of matched controls. All health care utilization and spending is measured for 
the individual (most surveys look at household utilization and expenditure – we have individual 
level data). Columns 2 and 3 of Table 6.2 report the differences in outcomes using the nearest 
neighbor matching where each individual with CVD is matched with the individual in the 
random sample with the closest propensity score. In cases where two or more individuals are 
equally close we choose between them randomly to make the match. In the context of our 
analysis, there is very large number of potential matches. In columns 4 and 5 we split individuals 
with CVD into strata, based on their propensity scores, and match them with all the individuals 
from the random sample that fall in the same stratum. We report the size of the average 
difference between the outcome for individuals with CVD and the matched control group, and a 
standard error of this difference.  
The results of the two matching methods are quite similar. We find that individuals with 
CVD report greater use of health services, higher levels of out of pocket health spending and 
resulting catastrophic spending and impoverishment in their households in comparison to their 
counterparts in the control group. For instance, males with CVD are about 46 percentage points 
more likely to report hospitalization in the last year than the matched controls. They are likely to 
report 4.3 days more of inpatient care, 19.4 percent point greater likelihood of imposing 
catastrophic expenses on the households to which they belong and an 8.1 percent point greater 
likelihood of impoverishing their household. They also use more health care services in both the 
public and the private sectors. Females with CVD too, report higher health care use, health 
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spending, and risks of impoverishing their households than their matched counterparts. 
Compared to their matched counterparts, however, males with CVD impose a greater economic 
burden than females with CVD. Specifically, the likelihood of incurring catastrophic spending in 
the case of a woman with CVD is 13.2 percent, and of impoverishment, 5.3 percent. These 
estimates would suggest that the number of individuals incurring catastrophic spending on 
account of CVD in 2004 was likely to be at least 1.4-2.0 million; and CVD would have 
impoverished at least 0.6-0.8 million people. The actual numbers may actually be much higher 
due to the fact that our analysis excludes individuals who may have underreported cases for 
which acute conditions occurred outside the reference period, and any CVD-related income 
losses; and because we excluded individuals who died in the year preceding the survey because 
of missing information on covariates in the first-stage propensity score regression. 
We also carried out similar analyses for the 1995-96 health care utilization and 
expenditure survey of the National Sample Survey Organization here, although we do not present 
the detailed results here. Given the cross-sectional nature of the data, the controls are obviously 
different in the two surveys. It is noteworthy though that additional health care expenses due to 
CVD (in current INR) more than doubled over the period from 1995-96 to 2004, and inpatient 
lengths of stay declined. The impacts on catastrophic spending appear not to have changed much 
over the two periods, possibly reflecting the substantial gains in household incomes in India over 
this period. The impacts on measures of unemployment also are roughly similar in the two 
periods.      
In contrast, the average treatment effect of CVD on poverty increased quite sharply from 
1995-96 to 2004, despite rising incomes and lowered overall poverty rates. This would suggest a 
story where rising incomes from a process of economic growth over the period led to the poor 
crossing over above the poverty line over this period, but these gains were partially eroded by 
out of pocket spending associated with CVD that led others to fall below the poverty line. This 
argument is also consistent with constrained public sector health spending characteristic of this 
period.  
Cancers 
Table 6.3a and 6.3b report summary statistics for the treatment group, the matched 
control group (no cancers) and unmatched control group (no cancers) using nearest neighbour 
matching (random assignment if equidistant and with replacement). Note from these tables that 
when we compare the outcomes of interest of the treatment with the matched control group -- 
hospitalization rates, the likelihood of outpatient visits, health expenditures, impoverishment, and 
catastrophic spending rates -- the differences in sample means, with few exceptions, continue to 
be large. These differences, all else the same, can be considered the effects of cancer. Note also 
that the outcome variables are often very different between the matched control group and the 
full set of individuals in the survey who do not report cancer (unmatched control group). This 
indicates that individuals with the same pre-determined characteristics as individuals with cancer 
differ in their outcomes from the average of the non-cancer sample.  
Table 6.4 presents our findings on the effect that cancer has on health care utilization, 
health spending, the likelihood of catastrophic spending and impoverishment among households 
and employment status. For each variable we compare the outcome for the individuals with 
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cancer with a set of matched controls. Columns 2 and 3 of Table 6.4 report the differences in 
outcomes using the nearest neighbor matching; and in columns 4 and 5 we report results based 
on the “stratification” method.  As in the case of results for CVD, the results of the two matching 
methods are quite similar in the case of cancer.  
We find that individuals with cancer report greater use of health services, higher levels of 
out of pocket health spending and greater rates of catastrophic spending and impoverishment in 
their households in comparison to their counterparts in the control group, who do not report 
cancer. For instance, males with cancer are about 73 percentage points more likely to report 
hospitalization in the last year than matched controls. They are likely to report  an extra 12.5 
days of inpatient care, a 43.9 percentage point greater likelihood of imposing catastrophic 
expenses on the households to which they belong and a 24 percent point greater likelihood of 
impoverishing their household. They also use more health care services in both the public and 
the private sectors. Females with cancer also report higher health care use, health spending, and 
risks of impoverishing their households than their matched counterparts.  
Compared to persons with CVD, individuals with cancer whether male or female, report 
much greater spending on and utilization of inpatient care, a greater likelihood of incurring 
catastrophic expenditures and impoverishment of the household. Individuals reporting CVD, on 
the other hand, report a greater use of outpatient services. Overall, cancers seem to pose a greater 
threat to the economic well being of the households. Overall, cancers are likely to have resulted 
in at least 0.6 million individuals reporting catastrophic levels of health spending and at least 0.4 
million people falling into poverty. As noted in the case of CVD, these are likely to be 
substantial underestimates of the true impact of cancers on catastrophic spending and 
impoverishment on India’s population.  
We undertook a similar matching score analysis using data from the 1995-96 survey 
round of the National Sample Survey.  Although the detailed results are not presented here, we 
found that additional health care expenses due to cancer (in current INR) relative to matched 
controls (which differ for 1995-96 and 2004) increased multi-fold over the period from 1995-96 
to 2004; and both inpatient care and outpatient care use increased. The average treatment effect 
of cancer on poverty, and the incidence of catastrophic expenditures increased quite sharply from 
1995-96 to 2004. Prima facie, the adverse economic impacts of cancers are larger than CVD. 
The impacts on measures of unemployment were roughly similar in the two periods. 
Injuries 
 Table 6.5a and 6.5b and Table 6.6 summarize our findings on the effect that injuries 
have on health care utilization, health spending, the likelihood of catastrophic spending and 
impoverishment among households and employment status. For each variable we compared the 
outcome for the individuals with cancer with a set of matched controls. Columns 2 and 3 of 
Table 5.15 report the differences in outcomes using the nearest neighbor matching; and in 
columns 4 and 5 we report results based on the “stratification” method.   
We find that individuals with injuries report greater use of health services, higher levels 
of out of pocket health spending and greater rates of catastrophic spending and impoverishment 
in their households in comparison to their counterparts in the control group, who do not report 
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injuries. For instance, males with injuries are about 77 percentage points more likely to report 
hospitalization in the last year than the matched controls. They are likely to report 11.4 days 
more of inpatient care, 32.2 percentage point greater likelihood of imposing catastrophic 
expenses on the households to which they belong and a 17 percentage point greater likelihood of 
impoverishing their household. They also use more health care services in both the public and 
the private sectors. Females with injuries too, report higher health care use, health spending, and 
risks of impoverishing their households than their matched counterparts. Overall, injuries seem 
to lie between CVD and cancers in terms of the economic impact on households – and likely to 
have resulted in at least 1.7 million individuals incurring catastrophic levels of health spending; 
and 0.9 million falling into poverty at least. 
A recent study by Mohanan (2008) for India compares economic outcomes for 
households that had one (or more members) experiencing a traffic injury in the state of 
Karnataka with “similar” households, with similarity defined in terms of age, choice of transport, 
educational attainment, household size, sex and caste. Our estimates of additional health 
spending on injury (although not directly comparable), reported in table 6.6 are remarkably close 
to estimates of traffic injury-related health spending (Mohanan 2008, p.17). Our results are also 
similar in that the treatment group reports lower levels of labour activity (at work) than the 
control group.  
6.4. Discussion 
The analysis of this chapter lends further support to the arguments made in earlier 
chapters (and in other papers on the subject) that individuals with NCD in India (and the 
households to which they belong) face serious economic challenges compared to their 
counterparts who have not been affected by NCD. These challenges include a substantial risk of 
income losses, an increased burden of care-giving and out-of-pocket health care spending. It is 
possible that some of these lost incomes and health expenditures may be recouped by allowances 
for sick leave, health insurance and reimbursements for health expenses by employers, or 
financial support from the extended family or community. It is well known, however, and this is 
further supported by our analyses in Chapter 3, that formal health insurance coverage in India is 
still relatively limited. Although insurance by means of financial support from friends and family 
members may exists and there is de facto insurance in the form of subsidized public sector 
services, there are large numbers of people in India who are exposed to a large burden of out of 
pocket spending from NCDs. 
Our analysis suggests that estimates of the impact of NCDs ought to adjust for competing 
risks in assessing the economic impacts of disease. The preliminary results in this chapter point 
to a 5 percent to 20 percent reduction in estimates of household economic impacts that do not use 
matched controls. The significance of our findings is tempered by our relatively small-sized 
treatment group, and the fact that we had only a limited set of pre-determined variables to match. 
Ideally, one would have liked information on smoking history, alcohol consumption, family 
history of heart disease/cancer and obesity. Unfortunately, the National Sample Surveys do not 
include this type of historical information in the survey instrument. Indeed, the lack of a 
longitudinal dataset to examine these questions (which really underpins the preceding sentence) 
is serious issue of concern. If unobservable characteristics influenced the risk for acquiring an 
NCD, or health care utilization – such as high rates of discounting the future, or if health 
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facilities were in close proximity in the past (enabling early treatment and medical advice), 
matching on currently observable characteristics will not yield reliable estimates of the economic 
impact of NCDs in India. This remains an area of potential importance for future research in 
NCDs.   
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Table 6.1a: Summary Statistics for Males Reporting CVD (Treatment) and Males  
Not Reporting CVD (Control), 2004 
 
 
 
Variable 
 
Treatment 
Individuals  
(CVD) 
 
Matched Control  
Individuals  
(No CVD) 
 
All Individuals (Not 
Reporting CVD) 
 
Explanatory Variables in Propensity Score regression 
 
Average age (in years) 
 
 
57.33 
 
53.74 
 
 
26.81 
 
Share of Age Group 
(20-49) (%) 
 
22.50 
 
22.50 
 
40.48 
 
Share of Age Group 
(50-79) (%) 
 
69.24 
 
69.24 
 
14.97 
 
Share of Age Group 
(80+) (%) 
 
5.27 
 
5.27 
 
0.79 
 
Share North (%) 
 
 
9.82 
 
9.82 
 
10.07 
 
Share West (%) 
 
 
20.45 
 
20.45 
 
16.49 
 
Share South (%) 
 
 
35.43 
 
35.43 
 
18.88 
 
Share Central (%) 
 
 
13.53 
 
13.53 
 
22.62 
 
Completed Primary 
Only (%) 
 
32.13 
 
32.13 
 
31.76 
 
Completed Secondary 
Only (%) 
 
21.50 
 
21.50 
 
13.77 
 
College Education or 
Higher (%) 
 
15.98 
 
15.98 
 
6.11 
 
Rural Residence (%) 
 
 
41.30 
 
41.30 
 
66.01 
 
Proportion belonging to 
SC/ST (%) 
 
14.37 
 
14.37 
 
28.78 
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Outcome Variables 
 
 
Outpatient Visit in Last 
2 Weeks (%) 
 
78.70 
 
20.50 
 
9.02 
 
Health Expenses in 
Last 2 weeks (INR) 
 
350.35 
 
83.20 
 
28.60 
 
 
Hospitalization in Last 
One Year (%) 
 
60.51 
 
14.51 
 
 
7.95 
 
Hospital Expenses in 
Last One Year (INR) 
 
10,492 
 
1,192 
 
581 
 
Inpatient Days 
 
 
5.85 
 
1.54 
 
0.83 
Likelihood 
Catastrophic Spending 
(%) 
 
24.68 
 
 
5.28 
 
2.70 
 
Likelihood of 
Impoverishment (%) 
 
10.19 
 
2.09 
 
1.18 
 
Involuntary 
unemployed (%) 
 
0.48 
 
0.98 
 
1.54 
 
Individuals not 
working (%) 
 
45.01 
 
33.41 
 
48.23 
 
Number of 
individuals 
 
2,484 
 
177,550 
 
192,698 
Source: Authors’ calculations, using household survey data for 2004 for India.  
Note: Matched control group for the treatment group was generated by identifying the individual with the closest 
propensity score under the nearest neighbor (random matching) methodology. See Becker and Ichino (2002) for 
more details.  
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Table 6.1b: Summary Statistics for Females Reporting CVD (Treatment) and 
Females Not Reporting CVD (Control), 2004 
 
 
Variable 
Treatment 
Individuals  
(CVD) 
Matched Control  
Individuals  
(No CVD) 
All Individuals (Not 
Reporting CVD) 
 
Explanatory Variables in Propensity Score regression 
 
 
Average age (in years) 
 
 
55.93 
 
52.09 
 
27.57 
 
Share of Age Group 
(20-49) (%) 
 
28.47 
 
28.47 
 
41.55 
 
Share of Age Group 
(50-79) (%) 
 
63.79 
 
63.79 
 
16.48 
 
Share of Age Group 
(80+) (%) 
 
5.33 
 
5.33 
 
0.79 
 
Share North (%) 
 
 
10.77 
 
10.77 
 
9.78 
 
Share West (%) 
 
 
20.96 
 
20.96 
 
16.48 
 
Share South (%) 
 
 
37.05 
 
37.05 
 
20.38 
 
Share Central (%) 
 
 
12.45 
 
12.45 
 
22.01 
 
Completed Primary 
Only (%) 
 
27.13 
 
27.13 
 
25.10 
 
Completed Secondary 
Only (%) 
 
9.27 
 
9.27 
 
9.15 
 
College Education or 
Higher (%) 
 
4.37 
 
4.37 
 
3.50 
 
Rural Residence (%) 
 
 
44.83 
 
44.83 
 
66.08 
 
Proportion belonging to 
SC/ST (%) 
 
14.67 
 
14.67 
 
28.85 
 
Outpatient Visit in Last 
2 Weeks (%) 
 
82.76 
 
21.76 
 
9.82 
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Health Expenses in 
Last 2 weeks (INR) 
 
289.66 
 
64.29 
 
26.90 
 
Hospitalization in Last 
One Year (%) 
 
47.93 
 
11.93 
 
7.43 
 
Hospital Expenses in 
Last One Year (INR) 
 
6,241 
 
1,104 
 
502 
 
Inpatient Days 
 
 
4.27 
 
 
1.17 
 
0.68 
Likelihood 
Catastrophic Spending 
(%) 
 
17.16 
 
3.96 
 
2.48 
 
Likelihood of 
Impoverishment (%) 
 
6.86 
 
1.56 
 
1.01 
 
Involuntary 
unemployed (%) 
 
0.15 
 
0.25 
 
0.45 
 
Individuals not 
working (%) 
 
86.70 
 
79.90 
 
81.89 
 
Number of 
individuals 
 
2,610 
 
164,556 
 
184,527 
Source: Authors’ calculations, using household survey data for 2004 for India.  
Note: Matched control group for the treatment group was generated by identifying the individual with the closest 
propensity score under the nearest neighbor (random matching) methodology. See Becker and Ichino (2002) for 
more details.  
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Table 6.2: Average “Treatment” Effects of CVD 
Matching Methods, 2004 
on Health Care Use, Health Spending, 
Employment and Poverty: Estimates from 2 Different  
 
 
 
Indicator 
Nearest Neighbor 
Method(Random Draw) 
Stratification Method 
 
Males 
 
Females 
 
Males  
 
Females 
 
Last 2 Weeks 
    
Health spending 
(INR) 
267.15 
(14.14) 
225.37 
(10.05) 
269.56 
(14.51) 
227.85 
(10.11) 
Outpatient visits 
(percent) 
58.20 
(0.80) 
61.00 
(0.80) 
58.10 
(0.80) 
61.70 
(0.70) 
 
Last One Year 
    
Health Spending 
(INR) 
9,030 
(633) 
5,137 
(646) 
9,030 
(634) 
5,192 
(646) 
Inpatient Stays 
(percent) 
46.00 
(1.00) 
36.00 
(1.00) 
45.90 
(1.00) 
36.30 
(1.00) 
Inpatient Days 
(Number) 
4.31 
(0.20) 
3.10 
(0.23) 
4.32 
(0.20) 
3.14 
(0.23) 
Inpatient Days 
(Public) 
1.95 
(0.16) 
1.43 
(0.15) 
1.94 
(0.16) 
1.44 
(0.14) 
Inpatient Days 
(Private) 
2.37 
(0.15) 
1.66 
(0.19) 
2.39 
(0.15) 
1.70 
(0.19) 
 
Economic Impact 
    
Catastrophic 
Expenditure 
(percent) 
 
19.40 
(0.90) 
 
13.20 
(0.70) 
 
19.40 
(0.90) 
 
13.30 
(0.70) 
Poverty Impact 
(percent) 
8.10 
(0.60) 
5.30 
(0.50) 
8.00 
(0.60) 
5.40 
(0.50) 
Involuntarily 
unemployed 
(percent) 
 
-0.50 
(0.20) 
 
-0.10 
(0.10) 
 
-0.50 
(0.10) 
 
-0.10 
(0.10) 
Not currently 
employed 
(percent) 
 
11.60 
(1.00) 
 
6.80 
(0.70) 
 
11.00 
(0.90) 
 
6.80 
(0.70) 
Observations 
(Treatment) 
 
2,484 
 
2,610 
 
2,484 
 
2,610 
Observations 
(Control) 
 
177,550 
 
164,556 
 
192,698 
 
181,151 
Note: Estimates are of the average treatment effect, under each matching method; the radius was taken to be 0.01 under the 
“radius method”; t-statistics are reported in parentheses below estimates of the average treatment effect. 
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Table 6.3a: Summary Statistics for Males Reporting Cancers (Treatment) and  
Males Not Reporting Cancers (Control), 2004 
 
 
 
Variable 
 
Treatment 
Individuals  
(Cancer) 
 
Matched Control  
Individuals  
(No Cancer) 
 
All Individuals  
(Not Reporting 
Cancer) 
 
Outcome Variables 
 
Outpatient Visit in Last 
2 Weeks (%) 
 
64.58 
 
16.28 
 
9.82 
 
Health Expenses in 
Last 2 weeks (INR) 
 
704.35 
 
56.75 
 
31.53 
 
Hospitalization in Last 
One Year (%) 
 
86.01 
 
12.71 
 
 
8.49 
 
Hospital Expenses in 
Last One Year (INR) 
 
18,307 
 
1,226 
 
676 
 
Inpatient Days 
 
 
13.94 
 
1.41 
 
0.87 
Likelihood 
Catastrophic Spending 
(%) 
 
48.81 
 
4.91 
 
2.90 
 
Likelihood of 
Impoverishment (%) 
 
26.19 
 
2.09 
 
1.25 
 
Involuntary 
unemployed (%) 
 
1.49 
 
1.39 
 
1.52 
 
Individuals not 
working (%) 
 
46.73 
 
29.73 
 
48.20 
 
Number of 
individuals 
 
336 
 
139,937 
 
194,846 
Source: Authors’ calculations, using household survey data for 2004 for India.  
Note: Matched control group for the treatment group was generated by identifying the individual with the closest 
propensity score under the nearest neighbor (random matching) methodology. See Becker and Ichino (2002) for 
more details.  
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Table 6.3b: Summary Statistics for Females Reporting Cancers (Treatment) 
and Females Not Reporting Cancers (Control), 2004 
 
 
Variable 
Treatment 
Individuals  
(Cancer) 
Matched Control  
Individuals  
(No Cancer) 
All Individuals (Not 
Reporting Cancer) 
 
Outcome Variables 
 
Outpatient Visit in Last 
2 Weeks (%) 
 
57.98 
 
15.88 
 
10.70 
 
Health Expenses in 
Last 2 weeks (INR) 
 
468.51 
 
39.88 
 
29.28 
 
Hospitalization in Last 
One Year (%) 
 
90.46 
 
10.86 
 
7.76 
 
Hospital Expenses in 
Last One Year (INR) 
 
18,536 
 
882 
 
530 
 
Inpatient Days 
 
 
15.99 
 
0.99 
 
0.68 
Likelihood 
Catastrophic Spending 
(%) 
 
48.99 
 
3.79 
 
2.55 
 
Likelihood of 
Impoverishment (%) 
 
27.16 
 
1.56 
 
1.02 
 
Involuntary 
unemployed (%) 
 
0.00 
 
0.40 
 
0.45 
 
Individuals not 
working (%) 
 
80.00 
 
74.40 
 
81.96 
 
Number of 
individuals 
 
545 
 
137,149 
 
186,592 
Source: Authors’ calculations, using household survey data for 2004 for India.  
Note: Matched control group for the treatment group was generated by identifying the individual with the closest 
propensity score under the nearest neighbor (random matching) methodology. See Becker and Ichino (2002) for 
more details.   
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Table 6.4: Average “Treatment” Effects of Cancer
 
 on Outpatient Visits, Hospitalization and Health 
Spending: Estimates from 2 Different Matching Methods, 2004 
 
 
Indicator 
Nearest Neighbor 
Method(Random Draw) 
Stratification Method 
 
Males 
 
Females 
 
Males  
 
Females 
 
Last Two Weeks 
 
    
Health spending 
(INR) 
647.60 
(131.74) 
420.63 
(55.75) 
647.72 
(131.79) 
425.61 
(55.64) 
Outpatient visits 
(percent) 
48.30 
(2.60) 
42.10 
(2.10) 
48.70 
(2.60) 
43.00 
(2.10) 
 
Last One Year 
 
    
Health Spending 
(INR) 
17,081 
(2,029) 
17,654 
(1,521) 
17,141 
(2,017) 
17,771 
(1,517) 
Inpatient Stays 
(percent) 
73.30 
(1.90) 
79.60 
(1.30) 
73.70 
(1.90) 
80.10 
(1.30) 
Inpatient Days 
(Number) 
12.53 
(1.15) 
15.00 
(1.01) 
12.62 
(1.14) 
15.04 
(1.01) 
Inpatient Days 
(Public) 
7.88 
(1.09) 
8.07 
(0.86) 
7.94 
(1.09) 
8.08 
(0.86) 
Inpatient Days 
(Private) 
4.65 
(0.63) 
6.93 
(0.73) 
4.68 
(0.63) 
6.97 
(0.73) 
 
Economic Impact 
    
Catastrophic 
Expenditure 
(percent) 
 
43.90 
(2.70) 
 
45.20 
(2.10) 
 
44.20 
(2.70) 
 
45.40 
(2.10) 
Poverty Impact 
(percent) 
24.10 
(2.40) 
25.60 
(1.90) 
24.20 
(2.40) 
25.70 
(1.90) 
Involuntarily 
unemployed 
(percent) 
 
0.10 
(0.70) 
 
-0.40 
(0.02) 
 
0.10 
(0.70) 
 
-0.50 
(0.02) 
Not currently 
employed 
(percent) 
 
17.00 
(2.70) 
 
5.60 
(1.70) 
 
17.00 
(2.50) 
 
5.10 
(1.70) 
Observations 
(Treatment) 
 
336 
 
545 
 
336 
 
545 
Observations 
(Control) 
 
139,937 
 
150,201 
 
186,101 
 
185,976 
Note: Estimates are of the average treatment effect, under each matching method; standard errors are reported in parentheses 
below estimates of the average treatment effect. INR = Indian Rupees. 
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Table 6.5a: Summary Statistics for Males Reporting Injuries (Treatment) and  
Males Not Reporting Injuries (Control) 
 
 
 
Variable 
 
Treatment 
Individuals  
(Injuries) 
 
Matched Control  
Individuals  
(No Injuries) 
 
All Individuals (Not 
Reporting  Injuries) 
 
Outcome Variables 
 
Outpatient Visit in Last 
2 Weeks (%) 
 
41.07 
 
10.97 
 
9.48 
 
Health Expenses in 
Last 2 weeks (INR) 
 
185.48 
 
36.71 
 
30.60 
 
 
Hospitalization in Last 
One Year (%) 
 
85.69 
 
8.69 
 
7.56 
 
Hospital Expenses in 
Last One Year (INR) 
 
9,792 
 
705 
 
582 
 
Inpatient Days 
 
 
12.30 
 
0.87 
 
0.73 
Likelihood 
Catastrophic Spending 
(%) 
 
35.35 
 
 
3.15 
 
2.54 
 
Likelihood of 
Impoverishment (%) 
 
17.98 
 
1.28 
 
1.07 
 
Involuntary 
unemployed (%) 
 
1.48 
 
1.68 
 
1.52 
 
Individuals not 
working (%) 
 
38.38 
 
37.18 
 
48.33 
 
Number of 
individuals 
 
2,642 
 
189,862 
 
192,540 
Source: Authors’ calculations, using household survey data for 2004 for India.  
Note: Matched control group for the treatment group was generated by identifying the individual with the closest 
propensity score under the nearest neighbor (random matching) methodology. See Becker and Ichino (2002) for 
more details.  
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Table 6.5b: Summary Statistics for Females Reporting Injuries (Treatment)  
and Females Not Reporting Injuries (Control) 
 
 
Variable 
Treatment 
Individuals  
(Injuries) 
Matched Control  
Individuals  
(No Injuries) 
All Individuals (Not 
Reporting Injuries) 
 
Outcome Variables 
 
Outpatient Visit in Last 
2 Weeks (%) 
 
49.49 
 
15.69 
 
10.62 
 
Health Expenses in 
Last 2 weeks (INR) 
 
308.39 
 
43.75 
 
29.54 
 
Hospitalization in Last 
One Year (%) 
 
80.30 
 
9.50 
 
7.58 
 
Hospital Expenses in 
Last One Year (INR) 
 
6,968 
 
739 
 
545 
 
Inpatient Days 
 
 
9.57 
 
0.87 
 
 
0.68 
Likelihood 
Catastrophic Spending 
(%) 
 
30.63 
 
3.23 
 
2.52 
 
Likelihood of 
Impoverishment (%) 
 
13.63 
 
1.33 
 
1.02 
 
Involuntary 
unemployed (%) 
 
0.37 
 
0.27 
 
0.45 
 
Individuals not 
working (%) 
 
81.23 
 
78.73 
 
81.96 
 
Number of 
individuals 
 
1,071 
 
180,183 
 
186,066 
Source: Authors’ calculations, using household survey data for 2004 for India.  
Note: Matched control group for the treatment group was generated by identifying the individual with the closest 
propensity score under the nearest neighbor (random matching) methodology. See Becker and Ichino (2002) for 
more details.   
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Table 6.6: Average “Treatment” Effects of Injuries on Outpatient Visits, Hospitalization 
and Health Spending: Estimates from Twp Different Matching Methods, 2004 
 
 
Indicator 
Nearest Neighbor 
Method(Random Draw) 
Stratification Method 
 
Males 
 
Females 
 
Males  
 
Females 
 
Last 2 Weeks 
    
Health spending 
(INR) 
148.77 
(11.91) 
164.64 
(19.48) 
148.77 
(11.91) 
166.42 
(19.34) 
Outpatient visits 
(percent) 
30.10 
(1.00) 
33.80 
(1.50) 
30.20 
(1.00) 
34.40 
(1.50) 
 
Last One Year 
    
Health Spending 
(INR) 
9,087 
(420) 
6,229 
(468) 
9,088 
(418) 
6,246 
(458) 
Inpatient Stays 
(percent) 
77.00 
(0.70) 
70.80 
(1.20) 
77.10 
(0.70) 
70.90 
(1.20) 
Inpatient Days 
(Number) 
11.43 
(0.45) 
8.70 
(0.53) 
11.45 
(0.45) 
8.70 
(0.53) 
Inpatient Days 
(Public) 
5.60 
(0.35) 
4.63 
(0.46) 
5.60 
(0.35) 
4.62 
(0.46) 
Inpatient Days 
(Private) 
5.83 
(0.33) 
4.07 
(0.33) 
5.85 
(0.33) 
4.09 
(0.33) 
 
Economic Impact 
    
Catastrophic 
Expenditure 
(percent) 
 
32.20 
(0.90) 
 
27.40 
(1.40) 
 
32.30 
(0.90) 
 
27.40 
(1.40) 
Poverty Impact 
(percent) 
16.70 
(0.70) 
12.30 
(1.00) 
16.70 
(0.70) 
12.40 
(1.00) 
Involuntarily 
unemployed 
(percent) 
 
-0.20 
(0.20) 
 
0.10 
(0.20) 
 
-0.10 
(0.20) 
 
-0.00 
(0.20) 
Not currently 
employed 
(percent) 
 
1.70 
(1.00) 
 
2.50 
(1.20) 
 
0.90 
(0.80) 
 
3.00 
(1.20) 
Observations 
(Treatment) 
 
2,642 
 
1,071 
 
2,642 
 
1,071 
Observations 
(Control) 
 
189,862 
 
180,183 
 
192,539 
 
185,786 
Note: Estimates are of the average treatment effect, under each matching method; the radius was taken to be 0.01 under the 
“radius method”; t-statistics are reported in parentheses below estimates of the average treatment effect. 
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C H A PT E R  7. C ONC L USI ON:  R E SE A R C H  A ND POL I C Y  I M PL I C A T I ONS  
 
7.1. Research 
Along with other recent efforts in the field, this paper constitutes a first step in the overall 
research goal of assessing the economic impacts of NCDs in India and other similarly placed 
developing countries. As noted at various points in the preceding text, there are several 
methodological weaknesses in the study, ranging from its use of household survey data that may 
underestimate the prevalence of disease, not taking full account of disabilities associated with 
NCDs, the inadequate treatment of competing disease risks in assessing economic impacts, and 
perhaps in its inability to adequately consider (and bring together) scenarios that take a more 
careful account of disease prevalence estimates from elsewhere in the literature, such as those of 
the Shah et al. (2004), the World Health Survey data, and so forth. We believe that all of these 
are valid concerns and ought properly, to belong to any reasonable agenda for future work on the 
economic impacts of NCDs in India. Here we consolidate some of more important research ideas 
emerging from earlier chapters, add some new ones, and highlight what we think are likely to be 
some of the more productive avenues for further work.  
Perhaps the biggest single gap that exists in India relates to information on disease-
specific morbidity and mortality on a scale appropriate for India and an appropriate linkage of 
this information to economic variables, ranging from health spending to socioeconomic status of 
households. In a major recent effort to address at least part of this challenge, Prabhat Jha and 
colleagues at the University of Toronto, along with researchers in India and the Registrar 
General in India (RGI) are seeking to improve cause of death reporting in data collected by the 
RGI. We are unsure whether this (ongoing) study will also collect information on morbidity 
patterns and construct prevalence estimates of various health conditions. In fact, it provides an 
ideal opportunity collect such information, perhaps in the form of sub-studies and pilots that 
could be simultaneously undertaken.   
We also believe that longitudinal studies that focus on the economic angle of health are 
needed to better take account of the poverty impacts of NCDs (and other health conditions). 
There are none that we are currently aware of on a suitably large scale, although one example of 
an exceptionally high quality work is that of Angus Deaton, Abhijit Bannerjee and colleagues 
around the district of Udaipur in Rajasthan. Another interesting survey in the pipeline is the NIH 
funded Longitudinal Ageing Study of India (LASI) led by David Bloom and colleagues at 
Harvard and Rand, the first wave of which is expected to take place in 2010-11. Other, small 
scale multi-period studies have been undertaken by the World Health Organization and other 
groups.  
It may be a while before these studies can bear fruition. Thus, it might be more useful, at 
least in the short-run, to exploit what appear to be excellent sources of longitudinal information 
on health and financing – namely the Indian railways and the armed forces. On the one hand, 
their employees (current or retired), because of their access to subsidized facilities, are less likely 
to fall into poverty than the average Indian. On the other hand, the excellent record-keeping that 
is likely at these organizations offers the opportunity (if accessible) to really explore the linkages 
between health spending, lost work days and NCDs in a setting which is likely to allow for better 
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estimation of the challenges arising from the existence of co-morbidities and competing risks. 
Disease-specific information on economic outcomes, a particularly serious gap, is more likely to 
become available if such studies were to be undertaken.     
Missing also in the existing work is good information on care-giving and support within 
the family, as well as within communities, related to the financial and disease burdens associated 
with NCDs. The NSS health care utilization and expenditure data offer a useful data source for 
this purpose, given that they document some information on the support systems for Indians aged 
60 years and above. But this information is very limited, and is generally expressed in qualitative 
terms. Moreover, we know little about how families respond to crises in the presence of NCDs 
(or NCD-related deaths) among prime income earners, who appear to be increased risk of NCDs 
in India.     
7.2. Policy Implications 
 Irrespective of what these more refined analyses may or may not conclude at some point 
in the future, it is unlikely that they will overturn the major conclusions reported here - that 
NCDs constitute a significant economic burden on India. This study specifically points to the 
high levels of out of pocket spending incurred by households that have members with NCDs, the 
limited levels of insurance coverage (including subsidized public services) and the income losses 
that befall affected households. Moreover, these findings strengthen conclusions by other recent 
studies on the economic implications of ill health for India (Garg and Karan 2008; Doorslaer et 
al. 2006; Yip and Mahal 2008) that emphasize the associated risks of catastrophic spending and 
impoverishment. The study also points to the adverse aggregate economic implications of NCDs.    
How to address these economic challenges in a cost effective and equitable manner while 
ensuring financial risk protection for affected households is an obviously important policy goal. 
Governments at the national and state levels in India are beginning to wake up to this challenge. 
The Indian state of Andhra Pradesh, for instance, launched the Arogyasri health insurance 
scheme in 2007 on a pilot basis and is now in the final stages of extending it throughout the state. 
The scheme provides for a tax funded insurance plan that (fully) covers all poor people in the 
state for care sought for a wide range of high-end treatments at public and private health care 
providers. Moreover, the state government has used the financial clout resulting from the large 
financial base of the scheme to negotiate quite reasonable rates for a range of different 
interventions in tertiary facilities. On a national level, the government of India also recently 
introduced the Rashtriya Swasthya Bima Yojana (RSBY) that provides financial coverage for 
health care for up to INR 30 thousand to poor households. These schemes run on a “cashless” 
basis in that any health care expenses covered under the schemes are paid directly by the insurer 
to the health care provider, greater reducing inconvenience to households who might otherwise 
have to run after insurance agencies to get their out of pocket expenses reimbursed.   
Clearly these schemes mark a fairly radical departure from the situation until the first half 
of this decade where a long period of decline (following the 1991 fiscal crisis) in public 
financing of health led households to increasingly rely on the private sector and out of pocket 
spending to meet their health care requirements. Whether these new schemes provides adequate 
financial risk protection  to people who need such protection the most, and their ability to do 
so in an efficient manner is, however, still open to question. There are questions about how well 
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they target poor households and there are serious questions about their ability to contain health 
care costs. The Arogyasri scheme, although ostensibly directed towards the poor, has ended up 
covering nearly 80 percent of the population of Andhra Pradesh (about 64 million people) owing 
to the way it has defined a ‘poor’ household as one holding a ration card. Moreover, the scheme 
does not emphasize preventive aspects of health, so that it is likely to lead to pressures for more 
advanced treatment methods and promote either health care cost inflation, or alternatively, 
financial breakdown. Similarly, the RSBY scheme appears not to have any built-in mechanisms 
to promote preventive care, and is geared primarily to curative treatment. It is also unclear what 
the implications of these schemes would be for the public health care sector, that has often 
served as a provider of the last resort and as a competitor to the private sector, albeit 
inefficiently, for the less well off. Moreover, there are concerns about the quality of care 
provided to the insurees given the limited regulatory capacity over health care provision in India. 
As further steps are taken towards scaling up, our analysis points to the need to evaluate these 
schemes from a variety of different perspectives.   
Treatment, however, ought to be only part of the picture. Long term sustainability of 
financing mechanisms, requires the diffusion of more effective prevention methods, so that early 
onset of NCDs can be prevented and their effects on long term disability limited. This calls 
firstly for curtailing tobacco consumption and smoking that have been linked to cardiovascular 
disease and different types of cancers. To be sure, the Indian government has recently initiated 
steps such as the banning of smoking in public places. However, there is a long way to go in 
terms of implementation, particularly in the use of ‘bidis’ that are popular among lower 
socioeconomic groups. Other interventions, such as the promotion of physical exercise, may not 
be as urgent for rural populations; although the same is not true for urban populations in India. 
Sedentary lifestyles, common among Indian middle classes probably reflect some combination of 
prevailing social norms, and importantly a lack of opportunity for undertaking physical exercise, 
particularly in the larger cities. Existing constraints include limited spaces for walking or 
bicycling and call for a fundamental rethinking about urban planning in India. Dietary habits of 
Indian households could also be targeted, whether by means of changing agricultural pricing 
policies, taxes (subsidies) on less (more) nutritionally desirable foods and public health 
messages; and the significant costs of respiratory conditions points to addressing indoor air 
pollution and workplace conditions, particularly in the informal sector that tends to stay under 
the policy radar. Prevention ought also to be a major focus of concern in education in Indian 
medical schools, where the predominant focus has been on high-end clinical interventions at the 
cost of expertise in community medicine and public health.   
By highlighting the large economic consequences of injuries and deaths, a significant 
portion of which are traffic-related in India, our study points to the need for effective measures to 
promote traffic safety, including better training of drivers, the use of seat belts and helmets, 
improved vehicle designs and roads, separate lanes for different classes of traffic (when 
possible), developing trauma centers and so forth. The existing literature points to a number of 
lacunae in this regard, including the extensive use of bribes in the grant of drivers’ licenses and 
lack of helmet use, particularly in the smaller towns and cities of India. The well known 
problems of private sector providers turning away traffic injury ‘police’ cases needs increased 
policy attention, as also a focus on trauma centers that are urgently needed. The increasing use of 
108 ambulance services on a call-center platform to speedily recover and help direct patients to 
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needed emergency care in many parts of India is an important innovation in this direction. 
Further work on assessing the net economic benefits from 108 services is obviously desirable.      
Traffic injuries are only one component of the category of accidents and injuries. 
Particularly important are suicides and burn injuries, underpinned in India by significant violence 
against women, often in the context of dowry demands. As is usually the case in India, there 
already exist a range of laws and regulatory mechanisms to this end, so the issue is often one of 
implementation and information provision. The emergence of women’s groups in different 
settings in India – among sex workers, self-help groups in villages and elsewhere – has helped in 
some cases to empower women and to help protect them against this violence. Policies to further 
strengthen these groups including providing economic opportunities via expanded microfinance 
mechanisms may be a useful direction to pursue.  
Finally, we wish to highlight a very important closing observation. Many of the issues 
highlighted here are not specific to NCDs.  An efficient and equitable health care system 
becomes a key tool for NCD control as it is for control of other health conditions. However, with 
the NCDs becoming more common, improving efficiency, quality, and access to a sound health 
care system is good strategy for NCD control. Likewise, efforts to improve health care delivery 
and access for NCDs will improve the infrastructure for the broader health care system. The 
ultimate challenge is to strategically focus on policies that will yield the best returns.   
-108- 
 
References 
 
D. Abegunde, A. Stanciole. 2006. “An estimation of the economic impact of chronic non-
communicable diseases in selected countries” unpublished. Geneva: World Health Organization, 
Department of Chronic Diseases and Health Promotion, [http://www.who.int/chp], accessed June 
14, 2008. 
 
D. Abegunde, C. Mathers, T. Adam, M. Ortegon, K. Strong. 2007. “The burden and costs of 
chronic diseases in low-income and middle-income countries” The Lancet 370(December 
8):1929-38. 
 
American Diabetes Association (ADA). 2008. “Economics costs of diabetes in the U.S. in 2007” 
Diabetes Care 31:596-615. 
 
K. Arrow. 1963. “Uncertainty and the welfare economics of medical care” American Economic 
Review 53(5):941-73. 
 
A. Basu, D. Gupta, D. Krishna. 1997. “The household impact of adult morbidity and mortality: 
Some implications of the potential epidemic of AIDS in India” In David Bloom and Peter 
Godwin (editors) The Economics of HIV and AIDS: The Case of South and Southeast Asia. New 
Delhi: Oxford University Press.  
 
Sasha Becker, Andrea Ichino. 2002. “Estimation of average treatment effects based on 
propensity scores.” Stata Journal 2(4):358-77. 
 
J. de Beyer, B. Waverley. 2003. Tobacco Control Policy: Strategies, Successes and Setbacks. 
Washington, D.C.: The World Bank. 
 
D. Bloom, N. Bennett, A. Mahal, W. Noor. 1996. “The impact of AIDS on human development” 
unpublished. New York, NY: Columbia University, Department of Economics. 
 
D. Bloom, D. Canning, J. Sevilla. 2004. “The effect of health on economic growth: A production 
function approach” World Development 32(1):1-13. 
 
D. Bloom, J. Lyons (editors). 1992. Economic Implications of AIDS in Asia. New Delhi: Oxford 
University Press. 
 
A. Boutayeb, S. Boutayeb. 2005. “The burden of non-communicable diseases in developing 
countries” International Journal for Equity in Health 4(2):1-8 
 
J. Broome. 1985. Weighing goods: Equality, uncertainty and time. London: Blackwell. 
 
Sahana Charan. 2007. “Treatment for cancer” The Hindu, August 24. 
 
J. Cuddington. 1993. “Modeling the macroeconomic effects of AIDS with an application to 
Tanzania” World Bank Economic Review 7(2):173-89. 
 
-109- 
 
E. Doorslaer, O. O’Donnell, R. Rannan-Eliya, A. Somanathan, S. Adhikari,  C. Garg, et al. 2006. 
“Effect of payments for health care on poverty estimates in 11 countries in Asia: An analysis of 
household survey data.” The Lancet 368(October 4):1357-64 
 
W. Dow, T. Philipson, X. Sala-i-Martin. 1999. “Longevity complementarities under competing 
risks” American Economic Review 89(5):1358-71. 
 
J. Doyle (Jr.). 2007. “Returns to local-area health care spending: using health shocks to patients 
far from home” Working paper no. 13301. Cambridge MA: National Bureau of Economic 
Research. 
 
P. Duraisamy. 2000. “Changes in the rate of return to education in India, 1983-94: By gender, 
age-cohort and location” Discussion paper no. 815. New Haven, CT: Yale University, Economic 
Growth Center. 
 
P. Duraisamy, A. Mahal. 2005. “Health, poverty and economic growth in India” In Health 
Systems in India: Delivery and Financing of Services, National Commission on Macroeconomics 
and Health, Ministry of Health and Family Welfare, Government of India, New Delhi, pp. 1-14. 
 
Economic Intelligence Unit. 2007. The Silent Epidemic: An Economic Study of Diabetes in 
Developed and Developing Countries. London, United Kingdom: The Economist, Economic 
Intelligence Unit. 
 
D. Fryback, B. Craig. 2004. “Measuring economic outcomes of cancer.” Journal of the National 
Cancer Institute 33:134-41. 
 
V. Gajalakshmi, R. Peto, T. Santhanakrishna, P. Jha. 2003. “Smoking and mortality from 
tuberculosis and other diseases in India: Retrospective study of 43,000 adult male deaths and 
35,000 controls” The Lancet 362 (August 16):507-15   
 
J. Gallup, J. Sachs. 2001. “The economic burden of malaria” American Journal of Tropical 
Medicine and Hygiene 64(1-2):85-96. 
 
A. Ghaffar, S. Reddy, M. Singhi. 2004. “Burden of non-communicable diseases in South Asia.” 
British Medical Journal 328 (April 3):807-10.  
 
P. Gertler, J. Gruber. 2002. “Insuring consumption against illness” American Economic Review 
92(1):51-70. 
 
S. Grover, A. Avasthi, A. Bhansali, S. Chakrabarti, P. Kulhara. 2005. Cost of ambulatory care of 
Diabetes Mellitus: A study from North India Postgraduate Medical Journal 81(956):391-5. 
 
A. Gumber. 1997. “Burden of injury in India: utilization and expenditure pattern” Working paper 
no. 88. Boston, MA: Harvard School of Public Health. 
[www.hsph.harvard.edu/takemi/RP88.pdf], accessed June 13, 2008. 
 
I. Gupta, S. Kandamuthan, D. Upadhyaya. 2006. “Economic impact of cardiovascular diseases in 
India” unpublished. New Delhi, India: Institute of Economic Growth, University of Delhi. 
-110- 
 
 
G. Gururaj. 2005. “Injuries in India: A national perspective” In Background Papers: Burden of 
Disease. New Delhi: The National Commission on Macroeconomics and Health, Ministry of 
Health and Family Welfare, pp. 325-47. 
 
G. Gururaj, N. Girish, M. Isaac. 2005. “Mental, neurological and substance abuse disorders: 
Strategies towards a systems approach” In Background Papers: Burden of Disease. New Delhi: 
The National Commission on Macroeconomics and Health, Ministry of Health and Family 
Welfare, pp. 226-50. 
 
Health Canada. 2002. Economic burden of illness in Canada. Ottawa: Health Canada. 
 
S. Hiddleston. 2008. “Meeting the high cost of cancer treatment” The Hindu, May 4. 
 
D. Himmelstein, E. Warren, D. Thorne and S. Woolhandler. 2006. “Illness and injury as 
contributors to bankruptcy.” Health Affairs 25(2):w74-83.  
 
B. Honore, A. Lleras-Muney. “Bounds in competing risks models and the war on cancer” 
Econometrica (forthcoming) 
 
A. Hyder. 2006. “Research on violence and injuries.” Global Forum Update on Research for 
Health 3:100-9. 
 
S. Hyman, D. Chisholm, R. Kessler, V. Patel, H. Whiteford. 2006. “Mental disorders”. In D. 
Jamison, J. Breman, A. Measham, G. Alleyne, M. Claeson, D. Evans (editors) Disease Control 
Priorities in Developing Countries Washington, D.C.: The World Bank and Oxford University 
Press, pp. 605-26. 
 
T. Insel. 2008. “Assessing the economic costs of serious mental illness” American Journal of 
Psychiatry 165(6):663-5. 
 
International Diabetes Federation. 2007. Diabetes Atlas (3rd edition). Brussels: International 
Diabetes Federation. 
 
P. Jha, B. Jacob, V. Gajalakshmi et al. 2008. “A nationally representative case control study of 
smoking and death in India.” The New England Journal of Medicine 358:1137-47. 
 
C. Jones. 2002. “Why have health expenditures as a share of GDP risen so much?” Working 
paper no. 9325. Cambridge, MA: National Bureau of Economic Research. 
 
B. Jonsson. 2002. “Revealing the cost of Type II diabetes in Europe” Diabetologia 45:S5-12. 
 
R. Joshi, M. Cardona, S. Iyengar, A. Sukumar, C. Ravi Raju, K. Rama Raju, K. Raju, K. Srinath 
Reddy, A. Lopez and B. Neal. 2006. “Chronic diseases now a leading cause of death in rural 
India – mortality data from the Andhra Pradesh Rural Health Initiative” International Journal of 
Epidemiology 35:1522-29 
 
-111- 
 
R. Kessler, S. Heeringa, M. Lakoma, M. Petukhova, A. Rupp, M. Schoenbaum, P. Wang, A. 
Zaslavsky. 2008. “Individual and societal effects of mental disorders on earnings in the United 
States: Results from the national co-morbidity survey replication” American Journal of 
Psychiatry 165(6):703-11.  
 
U. Kiiskinen, E Vartiainen, M Pekurinen, P. Puska. 1997. “Does prevention of cardiovascular 
diseases lead to decreased costs of illness? Twenty years of experience from Finland” Preventive 
Medicine 26:220-6. 
 
Kniesner, Thomas, W. Kip Viscusi, Christopher Woock, James Ziliak. 2005. “How unobservable 
productivity biases the value of a statistical life.” Discussion paper no. 524. Cambridge MA: 
Harvard Law School. 
 
E. Kopits, M. Cropper. 2003. “Traffic fatalities and economic growth.” Policy Research Working 
Paper number 3035. Washington, D.C.: The World Bank. 
 
A. Krishna. 2007. “For reducing poverty faster: Target reasons before people.” World 
Development 35(11):1947-60. 
 
Stephen Leeder, Susan Raymond, Henry Greenberg, Hui Liu, Kathy Esson. 2004. A Race 
against Time: The Challenge of Cardiovascular Disease in Developing Countries. New York, 
NY: Columbia University Press. 
 
J. Liu, N. Maniadakis, A. Gray, M. Rayner. 2002. “The economic burden of coronary heart 
disease in the United Kingdom” Heart 88:597-603. 
 
S. MacDonald, J. Roberts. 2006. “AIDS and economic growth: A human capital approach” 
Journal of Development Economics 80:228-50. 
 
A. Mahal. 2005. “The case for investing in health” Background paper for the Report of the 
National Commission on Macroeconomics and Health. New Delhi, India: Ministry of Health and 
Family Welfare. 
 
A. Mahal, S Sakthivel, S. Nagpal. 2005. “National Health Accounts for India” In Health Systems 
in India: Delivery and Financing of Services, National Commission on Macroeconomics and 
Health, Ministry of Health and Family Welfare, Government of India, New Delhi, pp. 222-8, 
200. 
A. Mahal. 2004. “Economic implications of inertia on HIV/AIDS and the benefits of action” 
Economic and Political Weekly 39(10):1049-63. 
-112- 
 
P. Mahapatra, C. Rao. 2001. “Cause of death reporting in India: a performance analysis” 
unpublished. Hyderabad, India: Institute for Health Systems. 
 
D. Mannino, S. Buist. 2007. “Global burden of COPD: risk factors, prevalence and future 
trends.” The Lancet 370(September 1):765-73. 
 
C. Mathers, D. Loncar. 2006. “Projections of global mortality and burden of disease from 2002 
to 2030” PloS Medicine 3:e442 
 
W. Meerding, S. Mulder, E. van Beeck. 2006. “Incidence and costs of injuries in the 
Netherlands.” European Journal of Public Health 16(3):271-7. 
 
D. Mohan. 2004. “The road ahead: traffic injuries and fatalities in India” New Delhi, India: 
Indian Institute of Technology, Transportation Research and Injury Prevention Program. 
 
M. Mohanan. 2008. “Consumption smoothing and household responses: Evidence from random 
exogenous health shocks,” unpublished. Cambridge, MA: Harvard University. 
 
S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, B. Ustun. 2007. “Depression, chronic 
diseases, and decrements in health: results from the World Health Surveys.” The Lancet 
370(September 8): 851-8. 
 
J. Mulligan, D. Walker, J. Fox-Rushby. 2006. “Economic evaluations of non-communicable 
disease interventions in developing countries: A critical review of the evidence base” Cost 
Effectiveness and Resource Allocation 4(7): online journal 
 
K. Murthy, J. Sastry. 2005a. “Economic burden of chronic obstructive pulmonary disease,” In 
Background papers: The Burden of Disease. New Delhi: Ministry of Health and Family Welfare, 
National Commission on Macroeconomics and Health, pp. 265-74.  
 
K. Murthy, J. Sastry. 2005b. “Economic burden of Asthma” In Background papers: The Burden 
of Disease. New Delhi: Ministry of Health and Family Welfare, National Commission on 
Macroeconomics and Health, pp. 251-63.  
 
M. Krishnan Nair, C. Varghese, R. Swaminathan. 2005. “Cancer: current scenario, intervention 
strategies and projections for 2015” In Background papers: The Burden of Disease. New Delhi: 
Ministry of Health and Family Welfare, National Commission on Macroeconomics and Health, 
pp. 219-26   
V. Nantulya, M. Reich. 2002. “The neglected epidemic: Road traffic injuries in developing 
countries” British Medical Journal 324:1139-41. 
V. Narayan, P. Zhang, A. Kanaya, D. Williams, M. Engelgau, G. Imperatore, A. Ramachandran. 
2006. “Diabetes: the pandemic and potential solutions” In D. Jamison, J. Breman, A. Measham, 
G. Alleyne, M. Claeson, D. Evans (editors) Disease Control Priorities in Developing Countries 
Washington, D.C.: The World Bank and Oxford University Press, pp. 591-603. 
-113- 
 
National Institutes of Health (NIH): 2005. Fact Book Fiscal Year 2004. 
[http://www.nhlbi.nih.gov/about/04fackbk.pdf], accessed June 14, 2008.  
M. Over. 1992. “The macroeconomic impact of AIDS in sub-Saharan Africa” Technical working 
paper no.3. Washington, D.C.: The World Bank, Africa Technical Department. 
 
B. Popkin, S. Horton, S. Kim, A. Mahal, J. Shuigao 2001. “Trends in diet, nutritional status, and 
diet-related non-communicable diseases in China and India: The economic costs of the nutrition 
transition” Nutrition Reviews 59:379-90 
 
P. Rayappa, K. Raju, A. Kapur, S. Bjork, C. Sylvest, K. Kumar. 1999. “Economic cost of 
diabetes care: The Bangalore urban diabetes study,” International Journal of Diabetes in 
Developing Countries 19:7-16. 
 
Registrar General of India. 2007. Medical Certification of Cause of Death 2001. New Delhi, 
India: Ministry of Home Affairs, Office of the Registrar General of India. 
 
D. Rice. 1966. “Estimating the cost of illness” Health Economics series no.6, PHS no. 947-6. 
Washington, D.C.: U.S. Government Printing Office. 
 
P. Rosenbaum, D. Rubin. 1983. “The central role of the propensity score in observational studies 
for causal effects.” Biometrika 70(1):41-55. 
 
T. Roy. 2003. “Alternative data sources for demographic and health statistics in India.”  Paper 
presented at the workshop “Enhancing Social and Gender Statistics”, June 24-27, Bangkok, 
Thailand. 
 
S. Russell. 2004. “The economic burden of illness for households in developing countries: A 
review of studies focusing on malaria, tuberculosis and HIV/AIDS.” American Journal of 
Tropical Medicine and Hygiene 71(Supplement 2):147-55.  
 
S. Sadikot, A. Nigam, S. Das, S. Bajaj, A. Zargar, K. Prasannakumar et al. 2004. “The burden of 
diabetes and impaired glucosa tolerante in India using the WHO 1999 criteria: Prevalence of 
Diabetes in India study (PODIS)” Diabetes Research and Clinical Practice 66(3):301-7.  
 
B. Shah, N. Kumar, G. Menon, S. Khurana, H. Kumar. 2004. Assessment of Burden of Non-
Communicable Diseases. New Delhi: Indian Council for Medical Research. 
 
G. Simon, D. Chisholm, M. Treglia, D. Bushnell. 2002. “Course of depression, health services 
costs and work productivity in an international primary care study” General Hospital Psychiatry 
24:328-35.  
 
R. Shobhana, P. Rama Rao, A. Lavanya, R. Williams, V. Vijay, A. Ramachandran. 2000. 
“Expenditure on healthcare incurred by diabetic subjects in a developing country – a study from 
southern India.” Diabetes Research and Clinical Practice 48(1):37-42. 
 
-114- 
 
R. Shobhana, P. Rama Rao, A. Lavanya, R. Williams, C. Padma, V. Vijay, A. Ramachandran. 
2000. “Expenditures incurred by families having type-1 diabetes in a developing country – a 
study from southern India.” Diabetes Research and Clinical Practice 55(1):45-8. 
 
B. Stewart, P. Kleihaus (editors). 2003.  World Cancer Report. Lyons, France: IARC Press.  
 
A. Thomas, G. Jacobs, B. Sexton, G. Gururaj, F. Rahman. 2004. “The involvement and impact of 
road crashes on the poor: Bangladesh and India case studies,” unpublished. Bangalore: National 
Institute of Mental Health and Neurological Sciences (NIMHANS).  
 
D. Thompson and A. Wolf. 2001. “The medical care cost burden of obesity” Obesity Review 
2:189-97.  
 
Viscusi, W. Kip, Joseph Aldy. 2003. “The value of a statistical life: A critical review of market 
estimates throughout the world” Working paper no. 9487. Cambridge MA: National Bureau of 
Economic Research. 
 
P. Wang, A. Aguilar-Gaxiola, J. Alonso, M. Angermeyer, G. Borges, E. Bromet et al. “Use of 
mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO 
world mental health surveys.” The Lancet 370(September 8): 841-50. 
 
S. Wild, G. Roglic, A. Green, R. Sicree, H. King. 2004. “Global prevalence of diabetes: 
Estimates for 2000 and projections for 2030 Diabetes Care 27:1047-53. 
 
World Bank. 2007. World Development Report: Development and the Next Generation. 
Washington, D.C.: The World Bank. 
 
World Health Organization. 2002. Non-communicable Diseases in the Southeast Asia Region: A 
Profile. New Delhi: WHO, Southeast Asia Regional Office. 
 
World Health Organization (WHO). 2004. “Death and DALY estimates for 2002 by cause.” 
[http://www.who.int/healthinfo/bod/en/index.html], accessed June 3, 2008. 
 
World Health Organization (WHO). 2007. ICD version 2007. 
[http://www.who.int/classifications/apps/icd/icd10online/], accessed June 15, 2008. 
 
K. Xu, D. Evans, K. Kawabata, R. Zeramdini, J. Klavus, C. Murray. 2003. “Household 
catastrophic health expenditure: A multi-country analysis” The Lancet 362(July 12):111-117. 
 
D. Yach, C. Hawkes. 2004. Towards a WHO long-term strategy for prevention and control of 
leading chronic diseases. Geneva: The World Health Organization. 
 
D. Yach, C. Hawkes, L. Gould, K. Hofman. 2004. “The global burden of chronic diseases: 
Overcoming impediments to prevention and control” Journal of the American Medical 
Association 291:2616-22.  
 
T. Yamane, T. Jayne. 2004. “Measuring the impacts of working age adult mortality on small-
scale far households in Kenya.” World Development 32(1):91-119. 
-115- 
 
 
B. Yang. 1992. “The economic impact of AIDS on the republic of Korea.” In D. Bloom and J. 
Lyons (editors) Economic Implications of AIDS in Asia, New Delhi: Oxford University Press. 
 
W. Yip, A. Mahal. “Health systems in India and China,” Health Affairs, forthcoming 
 
A. Young. 2005. “The gift of dying: The tragedy of AIDS and the welfare of future African 
generations” Quarterly Journal of Economics 120:423-62. 
 
S. Yusuf, S. Reddy, S. Ounpuu, S. Anand. 2001a. “Global burden of cardiovascular diseases: 
part I (general considerations, the epidemiologic transition, risk factors and the impact of 
urbanization)” Circulation 104:2746-53. 
 
S. Yusuf, S. Reddy, S. Ounpuu, S. Anand. 2001b. “Global burden of cardiovascular diseases: 
part II (variations in cardiovascular disease by specific ethnic groups and geographic regions and 
prevention strategies)” Circulation 104:2855-64. 
 
 
 
 
 
 
 
D   O   C   U   M   E   N   T   O      D  E      T   R   A   B   A   J   O
About this series...
This series is produced by the Health, Nutrition, and Population Family
(HNP) of the World Bank’s Human Development Network. The papers
in this series aim to provide a vehicle for publishing preliminary and
unpolished results on HNP topics to encourage discussion and debate.
The findings, interpretations, and conclusions expressed in this paper
are entirely those of the author(s) and should not be attributed in any
manner to the World Bank, to its affiliated organizations or to members
of its Board of Executive Directors or the countries they represent.
Citation and the use of material presented in this series should take
into account this provisional character. For free copies of papers in
this series please contact the individual authors whose name appears
on the paper.
Enquiries about the series and submissions should be made directly to
the Editor Homira Nassery (hnassery@worldbank.org) or HNP
Advisory Service (healthpop@worldbank.org, tel 202 473-2256, fax
202 522-3234). For more information, see also www.worldbank.org/
hnppublications.
THE WORLD BANK
1818 H Street, NW
Washington, DC USA 20433
Telephone: 202 473 1000
Facsimile: 202 477 6391
Internet: www.worldbank.org
E-mail: feedback@worldbank.org
La gestión de los hospitales en América Latina
Resultados de una encuesta realizada en cuatro países
Richard J. Bogue, Claude H. Hall, Jr. y Gerard M. La Forgia
Junio de 2007
